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ABSTRACT OF THE DISSERTATION 
Deciphering mechanisms governing the development of the rod epigenome 
by 
Philip Andrew Ruzycki 
Doctor of Philosophy in Biology and Biomedical Sciences 
Molecular Genetics and Genomics 
Washington University in St. Louis, 2017 
Professor Shiming Chen, Chair 
Precisely coordinated expression of distinct sets of genes is essential for cellular 
development and function, especially in complex multicellular organisms. This regulation is 
achieved by the action of transcription factors (TF), proteins that bind specific genomic locations 
and alter the activity state and packaging of the DNA to promote or repress gene expression. 
However, while tremendous effort has defined networks of transcription factors that work 
together to drive specific phenotypes, little is known about their differential activity at the 
hundreds or thousands of sites where they bind. There are also many questions regarding the 
basic principles of the packaging of DNA within the nucleus, its influence on gene expression, 
and how transcription factors regulate this process. 
To address these questions, I have investigated gene regulatory mechanisms that control 
the development of rod and cone photoreceptors. Photoreceptors are the neurons of the retina 
responsible for the initial conversion of a visual stimulus into an electrical signal. Photoreceptors 
are a complex, accessible, and highly disease relevant neuronal cell population, the lessons from 
which are relevant for many other cell types across the body. A primary TF in photoreceptor 
 xv 
development is CRX. This TF when mutated in humans can cause severe vision loss, and its 
deletion in mice leads to a severe condition with no functional photoreceptors. 
First, I determined the functional consequences of human disease-causing variants when 
modelled in mice. I functionally classified a new model as causing a previously un-determined 
dominant disease, and discovered that all CRX diseases are the result of graded differences in 
gene expression of the same core set of genes. Second, I examined the dependency of all 
genomic binding sites on CRX activity and identified a core set of regulatory elements that 
require CRX for activation of the target genes. Third, I interrogated the broader organization of 
the rod photoreceptor epigenome and demonstrated that the rod packages its DNA according to 
epigenomic activity state. Perturbations to this state can override this organization, resulting in 
functional consequences on gene expression beyond the local sequence. 
In summary, my in-depth investigation has uncovered new insights into the molecular 
mechanisms controlling development and maintenance of the rod epigenome and its organization 
in the nucleus. This new knowledge will provide 1) a new understanding of where and how 
mutations in a key photoreceptor TF cause gene mis-regulation, and 2) guidance for future 
human genetic studies to identify new disease-causing mutations affecting photoreceptor 
integrity, not only in the protein coding sequences but also in specific non-coding regulatory 
regions.  
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1.1 The Genome and Its Regulation 
The genome is the evolutionary substrate of all life on earth. The precise order, or 
sequence, of the nucleotides creates the diversity differentiating one individual from the next and 
one species from the other. The most basic function of this sequence is to transmit instructions 
for the generation of proteins. To this end, the genome must first be converted into a single 
stranded RNA molecule, in a process called transcription. This message is subsequently 
translated into the appropriate peptide units by other machinery in the cell. 
Primitive organization of single celled organisms allows for the regulation of 
transcription to be relatively simple. However, with added complexity through evolutionary time, 
organisms have adopted highly complex body plans. It is only logical to assume that such an 
increase in complexity would necessitate a more complex set of DNA instructions. Prior to the 
sequencing of the human genome, it was thought that this increase in complexity would arise 
from an increase in gene number and genetic material. While this is the case on the basis of gross 
genome size, especially when compared to simple bacteria (E. coli) or the fly (D. melanogaster), 
there is a surprisingly small increase in gene number between lower vertebrates and mammals 
(Figure 1.1). The only logical conclusion, therefore, is that higher vertebrates have evolved new 
methods to control the expression of these same genes to drive the increase in functional 
complexity. 
1.1.1 Transcription Factors Control Gene Expression 
Gene expression is controlled by regulatory proteins called transcription factors (TFs). 
These proteins bind to defined sites throughout the genome, and can direct the modification of 
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the local active state. Together, the activity and specificity of distinct combinations of TFs allow 
a neuron and a fibroblast to have the exact same genomic sequence, but each only creates its own 
set of proteins in the correct amount at the proper time. 
The canonical TF is comprised of two domains; one binds DNA (DNA binding domain 
or DBD) while the other regulates transcription (e.g. activation domain, or AD) by interacting 
with other co-regulatory factors.[Ma & Ptashne, 1987] TFs fall within a number of broad 
families (homeodomains, zinc-fingers, leucine zippers, among others) based on the structure of 
their DNA binding domain.[Luscombe et al., 2000] Very subtle variation within a family can 
have implications on the sequence specificity, precluding a priori prediction of the optimal DNA 
targets. Many experimental methods have been employed to understand and classify sequence 
specificity including promoter bashing reporter assays, binding assays such as EMSAs, or large 
scale HT-SELEX experiments.[Chen et al., 1997, 2002; Jolma et al., 2010] However, the 
knowledge of the optimal motif is not always indicative of in vivo activity. The analysis of the 
genome-wide binding of a TF may discover complex binding features; Many bound sites contain 
the characteristic cognate motif, but other bound sites lack that sequence, while some DNA 
regions harboring even strong motifs are not bound.[Boyle et al., 2011; Neph et al., 2012; 
Verfaillie et al., 2016; Zhu et al., 2009] 
TFs rarely bind to a genomic location alone, and their binding is often primed by or 
directly mediated by another factor (or factors). [Iwafuchi-Doi et al., 2016] This combinatorial 
nature of TF binding and activity allows for both complexity and redundancy, all of which is 
encoded in the sequence of the regulatory site by number, orientation and spacing of various TF 
binding motifs. (reviewed in [Long et al., 2016; Slattery et al., 2014; Spitz & Furlong, 2012] 
New methods such as Massively Parallel Reporter Assays (MPRAs) have begun to unravel such 
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regulatory logic,[Inoue & Ahituv, 2015; Santiago-Algarra et al., 2017] but unfortunately, this 
technique is only currently available as a plasmid-based reporter assay. This is a major deficit in 
the field, as the function of a TF once bound to the proper site is to recruit other general factors 
and enzymes to modulate the local DNA regulatory environment that is not applicable on a 
plasmid. New methods must be developed to understand the differential activity of a TF at its 
thousands of binding sites in the genomic context.  
1.2 Organizing the Genome  
A single human genome stretches 6 feet in length which must be compacted into the 
nucleus of every single cell in the body. To achieve this, there are a number of discrete levels at 
which DNA compaction is organized. The double helix of DNA is first wrapped 1.65X around 
an octamer of proteins called histones to create the nucleosome structure.[Hewish & Burgoyne, 
1973; Richmond et al., 1984] Further compaction by the association and wrapping with other 
adjacent nucleosomes creates a chromatin fiber. This fiber has been visualized by in vitro 
methods,[Song et al., 2014] but many questions still remain as to the precise association between 
nucleosomes and coiling in vivo. 
1.2.1 Nucleosomes and modifications   
At the level of the nucleosome, there is substantial control on the activity of the local 
genomic environment.[Han & Grunstein, 1988] Histone proteins have extended N-terminal tails 
that are well conserved, the loss of which causes the histone to lose its function.[Kayne et al., 
1988] Histone tails are highly modified within the nucleus.(reviewed in [Li et al., 2007]) These 
modifications affect the interaction between DNA and the nucleosome [Zhao et al., 2005] and 
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determine the activity state of that site in the genome.[Strahl & Allis, 2000] Whole genome 
methods have been used to map the locations of specific modifications and have determined the 
regulatory logic that defines conventional promoters, enhancers, and other important 
elements.[Birney et al., 2007; Dixon et al., 2015; Dunham et al., 2012; Heintzman et al., 2007; 
Roadmap Epigenomics Consortium et al., 2015] The modification of histone H3 is highly 
relevant for the active state of promoters and enhancers; tri-methylation of K4 is associated with 
positive gene expression,[Santos-Rosa et al., 2002] the acetylation of K27 is associated with 
gene expression and enhancer activity,[Creyghton et al., 2010] while the tri-methylation of the 
same residue creates a strongly repressed environment.[Plath et al., 2002] 
These modifications reflect a major element of the ‘epigenome,’ a layer of gene 
regulation beyond the individual nucleotide bases. The epigenome is not static, and varies 
dramatically between cell types and over development.[Birney et al., 2007] The epigenome has 
been theorized to act as a barrier to ensure the continuous progression toward a mature cell (e.g. 
Waddington’s Landscape) and an efficient means to ensure proper activity post 
developmentally.[Moris et al., 2016; Waddington, 1942] 
A number of enzymes are necessary to modify the epigenome and remodel promoters and 
enhancers both over development and in response to environmental changes in adult cells. 
General enzymes such as CBP/P300 have no sequence specificity, but rather are guided by cell 
type specific TFs.[Vo & Goodman, 2001] Other chromatin modifying enzymes include lysine 
methyl transferase enzymes MLL1-4 and the repressive PRC2 complex. All of these enzymes are 
essential for cellular development and homeostasis and their disruption has been associated with 
a multitude of diseases.[Attar & Kurdistani, 2017; Hess, 2004; Pasini et al., 2004] The specific 
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roles of these enzymes and their guidance by cell type specific TFs remain to be elucidated in the 
development of many tissues. 
1.2.2 Genome organization beyond the nucleosome 
The notion that DNA is packaged at a scale beyond the molecular level has actually been 
studied for decades in D. melanogaster. Cells within the fly salivary gland produce many copies 
of their genome which fuse into microscopically visible polytene chromosomes that have a 
distinct banding pattern. This pattern resembles the R/G bands visible in the mitotic genome of 
other species such as humans and mice under higher magnification. Microscopically, post-
mitotic nuclei also show organizational principles. By DAPI staining, DNA clearly forms 
densely packed dark clusters in the nucleus, but leaves other DNA less compact. 
Immunohistochemical staining of epigenetic modifying enzymes, TFs, and histones further 
support a stratified organization.[Corbo et al., 2010; Solovei et al., 2009] 
The gold standard technique to study the localization of specific DNA fragments is 
fluorescence in-situ hybridization (FISH). The method was originally developed using 
radioactive probes to localize genes on polytene chromosomes,[M. L. Pardue & Gall, 1969; M. 
Lou Pardue et al., 1970] but has since been adapted to use fluorescent probes and has been 
shown to be effective within many cell types. Advances in molecular biology and high 
throughput sequencing have only recently allowed for the interrogation of genomic organization 
at the molecular level.[Dekker et al., 2002] Careful analysis that compared the results of FISH 
and Chromosome Conformation Capture data suggests that they both faithfully report genome 
organization, but their results can be complementary and both are still necessary to fully 
understand the organizational state.[Williamson et al., 2014] There are a variety of Chromosome 
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Conformation Capture (C) techniques (Table 1.1), each with its own particular benefits and 
shortcomings.(reviewed in [Davies et al., 2017]) While targeted assays such as 3C can give very 
high precision or resolution, lower sequencing costs are making genome wide assays such as 4C 
and HiC accessible to answer global questions. 
HiC has been instrumental in defining a new understanding of the packing of interphase 
chromatin. By analyzing the data of this ‘all vs all’ approach, two primary concepts have 
emerged; first the Topologically Associating Domain (TAD) has been defined as another unit of 
genomic packaging, [Dixon et al., 2012] and second that the nucleus is generally organized into 
A and B compartments.[Lieberman-Aiden et al., 2009; Rao et al., 2014] A TAD is defined as a 
region of DNA, the sequences of which are more likely to interact with one another than with 
DNA outside of the TAD. In fact, the analysis of the Drosophila polytene chromosomes 
determined that TAD structure closely mirrored the order and distinction of banding patterns. 
Although these chromosomes are so unique in size, their molecular organization was virtually 
the same as that observed in normal diploid cells.[Eagen et al., 2015] TADs are largely 
conserved between cell types and the boundaries of TADs are enriched for the binding of 
CTCF,[Dixon et al., 2012; Hansen et al., 2017; Vietri Rudan et al., 2015] the loss of which 
disrupts these units.[Rao et al., 2017]  
The function of TADs is still under investigation, however they may serve to confine a 
genomic segment and ensure proper promoter-enhancer interactions to regulate gene 
expression.[Jin et al., 2013; Symmons et al., 2014; H. Zhang et al., 2013] They are largely 
invariable between cell types with some exceptions; subtle changes in TAD boundary locations 
are essential for some developmental processes.[Andrey et al., 2013] New genomic editing 
methods have been employed to disrupt principles of this packaging to test their function. The 
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HOX gene cluster that defines basic body plan in vertebrates has served as a robust and defined 
test platform. By the deletion of a CTCF element that defined a TAD boundary, the important 
strict delineation of active vs inactive chromatin was disrupted [Narendra et al., 2015] and gene 
mis-regulation resulted in severe developmental abnormalities.[Narendra et al., 2016] 
While the structure of TADs is quite stable across cell types, their locations within the 
nucleus are not. TADs can be generally classified as belonging to either an active (A) or inactive 
(B) compartment, the classification of which is strongly associated with the composition of 
repetitive elements, replication timing, lamin association, gene density, and gene function. 
[Dileep et al., 2015; Solovei et al., 2016] While the boundaries of A/B compartments do align 
with TAD boundaries, the inclusion of any individual TAD in either compartment is dynamic 
over development and highly cell type specific.[Dixon et al., 2015] The function of A/B 
compartments is not well understood. It is likely that this organization maintains the proximity of 
machinery to proper targets and separation from non-expressed genes.[Brown et al., 2008; Dorier 
& Stasiak, 2010; Feuerborn & Cook, 2015; Lamond & Spector, 2003; Lawrence & Clemson, 
2008; Razin et al., 2011; Shen et al., 2012] However, this segregation and any effects of its 
disruption have not yet been tested. In fact, the mechanisms of compartment assembly are not 
well understood. Recent studies that disrupted TAD formation globally discovered enhanced 
compartmental segregation, suggesting that the formation of TADs and compartments are 
somewhat opposed.[Rao et al., 2017; Schwarzer et al., 2017] More targeted analyses are 
necessary to elucidate the functions of and relationship between TADs and A/B Compartments. 
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1.3 The retina as model system 
The mouse retina offers a tractable but complex and highly relevant neuronal system to 
interrogate the principles of TF mediated gene regulation and genomic organization. The retina is 
the neural tissue that lines the posterior surface of the eye. The function of the retina is to convert 
a light stimulus into an electrical signal, perform some processing and filtering of the signal, and 
pass this information to the brain. The retina consists of 6 neural and 1 glial cell type to perform 
this function. These cells are organized into 3 layers; the outermost layer is comprised 
exclusively of rod and cone photoreceptors that capture photons of light and initiate the electrical 
response, the central layer contains 4 types of interneurons that perform basic signal processing, 
and the third layer contains ganglion cells that relay the signal to the brain. 
These cell types have been profiled extensively both morphologically and 
transcriptionally; many subtypes of the 3 interneurons and ganglion cells have been 
described.[Baden et al., 2016; Macosko et al., 2015; Shekhar et al., 2016; Siegert et al., 2012] 
Rods and cones, however, are very well conserved in terms of structure and function, and there is 
only a single type of rod photoreceptor. The mouse retina is composed of 80% rods,[Jeon et al., 
1998; Macosko et al., 2015] making the bulk analysis of the tissue highly representative of their 
signal. 
The retina develops over a 2-week period in the mouse. The cell types develop with a 
highly stereotyped birth order that has been studied extensively.[Young, 1985] This order of 
progenitor competence and cell fate specification is driven by a set of TFs that are still under 
investigation, however, many have been shown to drive certain cell fates.[Livesey & Cepko, 
2001; de Melo et al., 2016; Wang et al., 2014] 
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Rod photoreceptors are born from a set of multipotent progenitors, although recent 
evidence suggests that evolutionarily, rods were actually co-opted from cones and this derivation 
is visible in their very early development.[Kim, Yang, Oel, et al., 2016] The structure of a rod is 
highly specialized for the function of capturing photons of light by the photopigment Rhodopsin, 
and converting this into an electrical signal by a G-protein coupled cascade called 
phototransduction.(Reviewed in [Arshavsky et al., 2002; Kefalov, 2012] The signal is amplified 
and the rod passes the signal to the interneurons. Rhodopsin is stored in specialized membranous 
disc structures located in a modified cilia structure called the outer segment (OS). These discs are 
shed nightly, making the cell constantly responsible for renewing the membrane and protein 
components essential for phototransduction. To accomplish this, rods must produce an 
extraordinary amount of Rhodopsin on a daily basis; Rhodopsin transcript represent more than 
2% of the total RNA in the cell.[Blackshaw et al., 2001].  
1.3.1 Retinal transcription factors and disease 
Rod and cone cell fate specification and gene expression is determined by a cascade of 
TF activation.(Reviewed in [Swaroop et al., 2010]) This cascade is initiated by a homeodomain 
TF OTX2 that is necessary and (in the retina) sufficient for photoreceptor fate 
specification.[Nishida et al., 2003] OTX2 initiates the expression of cone-rod homeobox 
(CRX)[Nishida et al., 2003] that works with other TFs NRL and NR2E3 in rod photoreceptors to 
actively drive rod fate. In mice, the loss of NRL results in a transfated state, where rod cells 
instead adopt the S-cone cell fate.[Mears et al., 2001] The loss of NR2E3, which is activated 
downstream of NRL,[Oh et al., 2008] results in a mid-fate, where many rod genes are properly 
activated, but the cell did not properly repress cone related transcripts.[Cheng et al., 2006; G.-H. 
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Peng et al., 2005] Both of these TFs also cause vision related disease in human 
patients.[Jacobson et al., 1990; Milam et al., 2002; Wright et al., 2004] 
1.3.2 CRX 
CRX is a homeodomain TF expressed very early after the final mitotic event in 
photoreceptors and this expression is maintained throughout adulthood.[Chen et al., 1997; 
Furukawa et al., 1997] In humans, the mutation of CRX results in a number of diseases with 
varying functional deficits.(reviewed in [Tran & Chen, 2014]). As a TF, the basic function of 
CRX is to bind target sites throughout the genome to activate photoreceptor related transcripts. 
CRX has a very simple domain structure with a N-terminal canonical OTX homeodomain region 
and the C-terminal half of the protein comprises the activation domain.[Chau et al., 2000; Chen 
et al., 2002] 
Human disease causing mutations to CRX can be classified into 4 groups that are defined 
by the type of mutation and describe the associated severity of symptoms.[Tran & Chen, 2014] 
Class I mutations are the result of a point mutation to the homeodomain portion of the protein. 
This mutation disrupts DNA binding,[Chen et al., 2002] and results in a recessive condition both 
in humans and when modelled in mice (CrxR90W/W).[Tran et al., 2014] Class III mutants contain a 
truncation mutation that causes the translated CRX protein to lack a significant portion of the 
activation domain. Current models predict that mutant CRX retains the ability to bind DNA but 
lacks the ability to transactivate. In the heterozygous state, Class III mutations cause severe 
dominant disease, thought to be the result of mutant protein blocking the action of the WT 
protein.[Occelli et al., 2016; Tran et al., 2014; Tran & Chen, 2014] With the highly divergent 
nature of phenotypes as a result of mutation to CRX, experiments in Chapters 2-3 of this 
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dissertation are designed to better understand Class III mutants and to understand the 
downstream transcriptional effects of Class I and III mutations. 
Many studies have probed the function of CRX in normal photoreceptor development. 
ChIP experiments have determined sites throughout the genome bound by CRX and those co-
bound by NRL and/or NR2E3.[Corbo et al., 2010; Hao et al., 2012; Montana et al., 2011; G.-H. 
Peng et al., 2005; G.-H. Peng & Chen, 2005] Binding sites of CRX are enriched for the canonical 
homeodomain motif,[Corbo et al., 2010] and disruption of this site abolishes binding and 
activity.[Chen et al., 1997; Lee et al., 2010; Montana et al., 2011; White et al., 2016, 2013] 
Massively parallel reporter assays (MPRAs) have tremendously extended our knowledge of 
CRX and its interactions with other factors. The assessment of sequences bound by CRX 
discovered that bound sites activated transcription while unbound sites with a CRX motif did 
not.[White et al., 2013] This result suggested that activity is encoded in the sequence and 
depends not only on the presence of a CRX motif, but relies on neighboring sequence and the 
binding of other factors. This same experiment also proposed that CRX may in some instances 
act as a repressor; sites that displayed low expression in WT retinas expressed higher when tested 
in Crx-/- retina.[White et al., 2013] Synthetic arrays of strong CRX sites also displayed 
repressive activity, but the presence of NRL sites overrode this effect.[White et al., 2016] Such 
negative activity has not yet been demonstrated to be relevant in vivo. Together, these 
experiments suggest that gene regulation by CRX is not binary, but rather highly context 
dependent. 
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1.3.3 The photoreceptor epigenome 
These TFs direct a photoreceptor progenitor over a two-week period of terminal 
differentiation to become a functionally mature rod. This process requires a tremendous change 
in gene expression, the result of a dramatic remodeling of the epigenome. This remodeling of the 
WT rod epigenome has been characterized previously in terms of histone modifications, DNA 
methylation, genome accessibility, and TF binding, all of which were shown to correlate well 
with the changes to the transcriptome.[Aldiri et al., 2017; Hughes et al., 2017; Kim, Yang, 
Brooks, et al., 2016; Mo et al., 2016] However, this epigenome has not been systematically 
analyzed in mutant photoreceptors. For instance, very little is known about the state of the 
chromatin environment upon loss of CRX. There is also a lack of understanding of the activity of 
CRX in establishing an active chromatin state on a whole or at any individual site in the genome. 
Chapter 4 in this dissertation aims to extend the knowledge of CRX by in vivo analysis. 
1.3.4 Photoreceptor Genomic Organization 
The organization of the mouse rod photoreceptor genome is distinguishable from other 
retinal cell types simply by microscopic assessment. Condensed heterochromatin is packed into a 
dense core, while more active euchromatin is located at the periphery of the nucleus. This 
organization is not unique to the mouse. In fact, a very thorough analysis of many species 
discovered that this phenomenon was correlated with the activity state of the animal. Nocturnal 
animals across the evolutionary tree develop this nuclear organization. It was postulated that this 
organization acts as a condensing lens for photons of light, in contrast to the normal distributed 
organization of heterochromatin centers that would scatter light.[Solovei et al., 2009] 
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Further work suggested that this organization is the result of either the inactivation of 
Lamin B receptor (LBR) or Lamn A/C (LMNA), proteins that would normally tether 
heterochromatin to the nuclear membrane.[Solovei et al., 2013] Each cell type in the body 
normally expresses one of these genes, and in mouse rod photoreceptors, the specific inactivation 
of Lmna has been associated with this architecture change as compared to cones.[Hughes et al., 
2017] Genetic ablation of Lbr in cells that otherwise lack Lmna resulted in inverted nuclei 
suggesting that this loss is sufficient to induce inversion, and the removal of both caused 
dramatic expression changes in cell culture systems.[Solovei et al., 2013]  
This unique organization is altered in mouse models of photoreceptor disease. Studies 
have shown mis-organization in mutants of Crx, Nrl, Sca7, Rb, and Cbp/P300.[Helmlinger et al., 
2006; Hennig et al., 2013; Johnson et al., 2006; Roger et al., 2014; Tran et al., 2014; J. Zhang et 
al., 2004] In the Sca7 mutant, timing of nuclear chromatin changes was determined to predate 
functional deficits, suggesting that these changes could have resulted in expression 
differences.[Helmlinger et al., 2006] The interpretation of cause in other mutants is unclear, as 
photoreceptor precursor and other retinal cells display the normal chromatin state. It is difficult 
to decouple a change in fate decision or lack of the cue to repress Lmna vs a direct result of the 
disease.  
This unique organization has been associated with large scale changes in the chromatin 
landscape. Recent ATAC-seq data suggests that there are large regions of the genome that 
completely lack the normal nominal open regulatory sites.[Hughes et al., 2017] These regions 
largely correlate with traditional heterochromatin, and the interpretation must be that rod 
condensation causes these regions to become virtually completely inaccessible. This suggests 
that a rod nucleus is organized differently, or more strictly by chromatin state than observed in 
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other cell types. Indeed, immunohistochemistry and in situ hybridization have shown strict 
delineation of classes of chromatin. Activating TFs such as CRX are only located at the most 
peripheral level,[Corbo et al., 2010] while euchromatin vs heterochromatin associated DNA 
repeat sequences show very little overlap in the nuclear volume.[Solovei et al., 2009] Limited 
FISH experiments that probed the locations of particular genes also showed active genes are 
located at the far euchromatin periphery.[Aldiri et al., 2017; Solovei et al., 2009] 
Rod genomic organization has only been analyzed locally at the molecular level. 3C 
experiments described enhancer-promoter interactions and their dependency on cell type specific 
TFs.[G. Peng & Chen, 2011, 2012] Another recent study used 4C to analyze local compaction of 
a several Mb region. This work showed that genomic loci in that region clustered within the 
nuclear volume based on chromatin activity status, irrelevant of linear genomic distance.[van de 
Werken et al., 2017] Experiments presented in Chapter 5 of this dissertation are designed to 
interrogate the organization of whole chromosomes in the rod nucleus and to test several 
fundamental mechanisms and function of this packaging.  
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Table	1.1.	Summary	of	Chromosome	Conformation	Capture	Techniques	
	
Technique Bait vs Capture Data 
3C one vs one PCR 
4C one vs all Seq 
5C many vs many Seq 
HiC all vs all Seq 
ChIA-PET all vs all bound by specific protein Seq 
adapted from [de Wit & de Laat, 2012] 
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Figure 1.1: Humans and mice have more non-coding genomic sequence. Plot displays the 
approximate size of the genome vs the number of coding genes for each of the labelled species. 
Adapted from [Cooper, 2000]. 
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2.2 Abstract  
Purpose:  The Cone-Rod Homeobox (CRX) transcription factor is essential for photoreceptor 
gene expression, differentiation and survival. Human CRX mutations can cause dominant 
retinopathies of varying onset and phenotype severity. In animal models, dominant frameshift 
CRX mutations introduce a premature termination codon (PTC), producing inactive truncated 
proteins that interfere with normal CRX function. Previously, a mutant mouse, TVRM65, was 
reported to carry a recessive late	PTC mutation, Crx-L253X. More detailed phenotype analysis of 
Crx-L253X’s pathogenicity sheds new light on the variability of CRX-linked diseases. 
Methods:  Homozygous (L253X/X), heterozygous (L253X/+), Crx-/- and control C57BL/6J (WT) 
mice were analyzed at various ages for changes in retinal function (ERG), morphology 
(histology) and photoreceptor gene expression (qRT-PCR).	
Results:  L253X/X mice lack visual function at 1 month, show greater reductions in retinal 
thickness and distinct gene expression changes relative to Crx-/-, suggesting that L253X/X’s 
phenotype is more severe than Crx-/-. L253X/+ mice have reduced rod/cone function, but normal 
retinal morphology at all ages tested. qRT-PCR assays described a complex phenotype in which 
both developing and mature photoreceptors are unable to maintain proper gene expression. 
L253X mRNA/protein is overexpressed relative to normal Crx, suggesting a pathogenic 
mechanism similar to early PTC mutations. However, the overexpression is less pronounced, 
correlating with a relatively mild dominant phenotype.	
Conclusions:  The L253X mouse provides a valuable model for CRX-associated retinopathy. 
The pathogenicity of CRX frameshift mutations depends on the position of the PTC, which in 
turn determines the degree of mutant mRNA/protein overproduction.  
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2.3 Introduction  
 The Cone-Rod Homeobox protein (CRX) is a transcription factor (TF) that regulates 
expression of many photoreceptor genes essential for the development and maintenance of both 
rod and cone photoreceptors.[Freund et al., 1997; Furukawa et al., 1997; Hennig et al., 2008; 
Swaroop et al., 2010] Human CRX mutations are associated with various diseases, including 
Retinitis Pigmentosa (RP), Cone-Rod Dystrophy (CoRD) and Leber Congenital Amaurosis 
(LCA).[Rivolta et al., 2001; Swain et al., 1997] CRX-linked diseases are largely inherited in an 
autosomal dominant fashion or arise de novo, and vary widely in severity and age of 
onset.[Jacobson et al., 1998; Koenekoop et al., 2002; Nichols et al., 2010; Rivolta et al., 2001; 
Sohocki et al., 1998] Since CRX mutations can be detected with early genetic testing, we need to 
be able to predict their effects and to define effective treatment and gene therapy 
regimens.[Sohocki et al., 1998]   
 Previous research has divided disease causing CRX mutations into four classes.[Tran & 
Chen, 2014] Classes I and II are missense mutations that fall within or near the region coding for 
the DNA-binding homeodomain; Class I mutations reduce the binding of CRX to its DNA 
targets.[Chen et al., 2002] Previous work has shown by a variety of metrics that heterozygous 
mice carrying the Class I R90W mutation suffer from a mild form of CoRD, similar to human 
patients with such mutations, while homozygotes exhibit a LCA-like condition.[Tran et al., 
2014]  Class III and IV mutations represent frameshift mutations caused by insertions or 
deletions in the region coding for CRX’s transactivation domains.[Chen et al., 2002] Class IV 
mutations, modeled by the RIP mouse, cause translation of a much longer peptide sequence due 
to a frameshift and extension of the open reading frame (ORF) into the 3’ untranslated region 
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(3’UTR).[Roger et al., 2014]  In contrast to this extended peptide sequence, Class III mutations  
truncate CRX’s ORF with a premature termination codon (PTC) that results in a CRX protein 
with a shortened transactivation domain and lead to a severe dominant degenerative phenotype 
(LCA or CoRD).[Tran et al., 2014] This phenotype has been modeled by the E168d2 mouse 
[Tran et al., 2014] and Rdy (A182d1) cat [Occelli et al., 2016] (Figure 2.1A).  In vitro DNA 
binding and transactivation experiments determined that the E168d2 protein has a similar affinity 
for CRX target DNA sequences as normal CRX, but is unable to activate transcription on its own 
or in combination with other retinal TFs that normally synergize with CRX.[Chen et al., 2002; 
Tran et al., 2014]  Furthermore, when tested together with normal CRX, E168d2 protein 
interfered with normal CRX transactivation in a dominant-negative manner.[Tran et al., 2014]  
Class III PTC-causing CRX mutations also result in a novel untranslated region between 
the PTC and normal stop codon, which becomes a part of the mutant mRNA transcript’s 3’UTR 
(Figure 2.1A).[Tran & Chen, 2014] In the E168d2 mouse and the Rdy (A182d1) cat, longitudinal 
studies showed gradual accumulation of mutant protein and mRNA.[Tran et al., 2014],[Occelli et 
al., 2016] The mechanism for this accumulation is unknown, but was postulated to arise from 
decreased mutant RNA degradation,[Tran et al., 2014] possibly due to the presence of cryptic 
stabilizing elements within the PTC-expanded mutant 3’UTR. Therefore, the position of the PTC 
(relative to the normal termination codon) could determine the stability, and thus abundance of 
mutant RNA.  
Previously, another PTC mutant mouse, TVRM65 (Crx-L253X), was discovered in a 
chemical-induced mutagenesis screen conducted by The Jackson Laboratory[Won et al., 2011] 
(see Appendix 2 Methods section for nomenclature specifics). The L253X mutation (Figure 
2.1A) occurs later (closer to the normal termination codon) than E168d2 and A182d1. L253X 
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would be a candidate to model late PTC Class III mutations, such as L237i1 [Huang et al., 2012] 
and Q256X [Lu et al., 2015] associated with dominant CoRD. However, the initial histological 
assessments suggested that the L253X mouse phenocopies the recessive null (Crx-/-) 
condition.[Won et al., 2011] Here, we describe more detailed phenotypic analysis of L253X 
mice, which demonstrates that this mouse models a new dominant but mild form of Class III 
disease.  Our results support the hypothesis that Class III mutation pathogenicity depends on the 
position of the mutation-induced PTC (a late PTC produces a less severe phenotype than an early 
PTC), which correlates with the abundance of mutant protein products.  These findings have 
implications for predicting human CRX disease severity and progression.   
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2.4 Results 
2.4.1 L253X overproduces mutant mRNA/protein in affected retinas  
A hallmark of Class III CRX frameshift mutations is the overexpression of the mutant 
allele.[Occelli et al., 2016; Tran et al., 2014] To determine if L253X retinas accumulate mutant 
protein, we performed quantitative Western blots on total protein extracts from retinas of WT and 
heterozygous L253X/+ mice at postnatal day 10 (P10), 1  and 2 months old (mo), and 
homozygous L253X/X mice at P10 only (because photoreceptors degenerate before later 
ages).[Won et al., 2011] Immunoblotting with an anti-CRX antibody revealed a truncated L253X 
protein that ran faster than the normal full-length CRX protein in samples from both 
heterozygous and homozygous mutant retinas (Figure 2.1B).  We quantified the total amount of 
CRX protein and of each isoform. Both L253X/+ and L235X/X displayed a 1.5 to 2.2-fold 
increase in total CRX protein compared to the WT retinas (Figure 2.1C).  The increases can be 
attributed to an accumulation of mutant protein (black bar), since normal CRX protein levels 
(grey bar) in L253X/+ retinas with one normal allele were roughly half of the total CRX protein 
present in WT retinas with two alleles.  
To determine if the increased mutant protein corresponded with an increase in mutant 
mRNA, we quantified the relative allelic expression of L253X and normal Crx mRNA using 
droplet digital PCR (ddPCR).  First, using mutant and WT mouse DNA, we developed a ddPCR 
assay that clearly distinguished the L253X and normal Crx sequences (Figure 2.1D, DNA 
control). This assay was then used to quantify allele-specific mRNA species.  At all ages tested, 
the mutant transcript was overrepresented, accounting for 57% of total Crx mRNA (Figure 
2.1D). Total Crx transcript levels quantified by conventional qRT-PCR (Supplemental Figure 
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2.1) showed a statistically significant total Crx mRNA increase in 1 mo L253X/+ retinas relative 
to WT, although levels were comparable to WT retinas during development at P10 and by 3 mo.  
Overall, L253X/+ retinas develop and maintain an elevated level of mutant mRNA that translates 
into an imbalance of the two protein forms, but this misregulation is not as severe as observed in 
other Class III mutants.  These results identify Crx-L253X as a bona fide Class III mutation, but 
suggest that the position of the PTC determines the toxicity of the allele. 
2.4.2 L253X/X mice have no detectable rod and cone function 
 Homozygous animals carrying Class III or null Crx mutations lack measurable 
photoreceptor function.[Furukawa et al., 1999; Occelli et al., 2016; Tran et al., 2014] To confirm 
that L253X/X photoreceptors are functionally compromised, we quantified rod/cone light 
responses in L253X/X and WT control mice at 1 mo using electroretinogram (ERG).  Even at the 
highest light intensity stimuli, L253X/X retinas displayed very little response (Figure 2.2A-C). 
These results confirm that, like other Class III models, homozygous L253X/X animals lack 
photoreceptor visual responses, resembling human LCA.   
2.4.3 L253X/X photoreceptors degenerate earlier than Crx-/- 
Other Class III mutations show a greater impact on retina morphology and function than 
seen in Crx-/- mice.[Furukawa et al., 1999; Occelli et al., 2016; Tran et al., 2014] The original 
report noted that degeneration was more rapid in L253X/X than Crx-/-  retinas, but suggested 
differences in mouse background might be a factor.[Won et al., 2011] To directly compare the 
impact of the L253X mutation with that of complete loss of Crx, we collected retinas from 1 and 
3 mo WT, L253X/X, and Crx-/- mice (all backcrossed 10 generations onto C57BL/6J) and 
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assessed morphological changes in H&E stained sagittal sections through the optic nerve head 
(Figure 2.2D-K). At 1 mo both L253X/X and Crx-/- retinas lacked photoreceptor outer segments 
(OS) and had thinner Outer Nuclear Layers (ONL) than the WT control (Figure 2.2E&F vs. D). 
However, thinning was more pronounced in L253X/X than Crx-/-: L253X/X retina had only 4-5 
rows of ONL nuclei, while Crx-/- maintained 7-8 rows at the same age (Figure 2.2E vs. F). 
Quantitative morphometry measures showed that the ONL of L253X/X was significantly thinner 
than that of Crx-/- at multiple positions (Figure 2.2G, black vs. sold grey).  By 3 mo, both 
models had similarly degenerated retinas with only 2-3 rows of ONL cells left (Figure 2.2I vs. J; 
2K). Since both mutants showed normal ONL thickness at P7-P10 (Supplemental Figure 
2.2A&B and Tran et al.[Tran et al., 2014]), these results suggest that ONL degeneration occurs 
earlier or at a faster pace in L253X/X mice than in Crx-/-.   
In addition to progressive ONL loss, L253X/X also underwent age-dependent thinning of 
the Outer Plexiform Layer (OPL) (Figure 2.2E&I, Supplemental Figure 2.2D, I, N, and Won et 
al.[Won et al., 2011]). In contrast, non-photoreceptor cell layers (e.g. INL, GCL) were largely 
unchanged in L253X/X compared to WT controls at various ages (Supplemental Figure 2.2C-Q). 
These results suggest that the L253X mutation mainly affects photoreceptor structural integrity 
and survival.   
2.4.4 L235X/X mice exhibit photoreceptor gene misregulation distinct from 
Crx-/-  
 To further examine if the more severe morphological phenotype of L253X/X retinas 
reflected greater changes in CRX target gene expression, we collected RNA from L253X/X and 
Crx-/- retinas at P10 during photoreceptor terminal differentiation prior to cell death.[Tran et al., 
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2014] Transcripts of 14 known CRX-dependent genes were quantified by qRT-PCR and 
compared both with WT levels (Supplemental Figure 2.2R) and between the two models (Figure 
2.3A).  Although most of these genes were dysregulated in both mutants compared to WT mice 
(Supplemental Figure 2.2R), half of them showed statistically significant expression differences 
between L253X/X and Crx-/- (Figure 2.3A).[Ruzycki et al., 2015; Tran et al., 2014] Three of 
these, Gnat1, Grk1, and especially Rho differed markedly (>2 fold) between the two models 
(Figure 2.3A).  Such differences in essential photoreceptor gene expression likely contribute to 
the morphological and phenotype differences between the two models. 
 To confirm qRT-PCR results at the protein level, we performed immuno-fluorescent 
(IHC) staining for RHO on retinal sections of 1 mo L253X/X, Crx-/- and WT control mice.  RHO 
was chosen because it displayed the largest difference in the RNA level between L253X/X and 
Crx-/-.  As expected, in WT retina, RHO was predominantly localized to the rod outer segments 
(OS) with faint staining seen in ONL cell bodies (Figure 2.3B). In contrast, L253X/X retina 
displayed no detectable RHO immunostaining (Figure 2.3C), while Crx-/- retina still had weak 
and spotty RHO signals localized to individual ONL cell bodies and inner segments (Figure 
2.3D).  These results supported the RNA expression data and suggest that L253X mutant 
protein negatively affects transcription.   
Overall, the comparison between L253X/X and Crx-/- indicates that L253X/X disease is 
more severe than that resulting from loss of Crx, supporting a dominant effect of the 
mutation.[Jacobson et al., 1998; Tran et al., 2014] The more severe photoreceptor deficits in 
L253X/X thus presumably result from antimorphic activity of the truncated CRX protein. 
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2.4.5 Heterozygous L253X/+ mice show mild decreases in rod and cone 
function 
The L253X (TVRM65) mutation was originally reported to cause recessive retinal 
disease.[Won et al., 2011]  However, if the mutant protein possesses antimorphic activity, we 
would hypothesize that one copy would produce a photoreceptor phenotype.  To test this, we 
investigated photoreceptor function in L253X/+ retinas by assessing electrical responses to 
whole retina light stimulation. ERGs recorded at 1, 2, 3, and 5 mo revealed L253X/+ mice 
exhibit mild but significant reductions in ERG amplitudes compared to WT mice (Figure 2.4). At 
all ages tested, dark-adapted A-waves were reduced in L253X/+ mice, especially at high stimulus 
intensities (Figure 2.4A-D, black line vs. grey line).  Dark-adapted B-waves of L253X/+ mice 
were comparable to WT at 1 mo (Figure 2.4E), but significantly reduced at 2, 3, and 5 mo (Figure 
2.4F-H, black line vs. grey line). The degree of A-wave or B-wave reductions appeared to be 
constant, suggesting that the defects were unlikely a result of progressive degeneration. 
Reduction in cone function was also observed: Light-adapted B-waves were significantly 
decreased in L253X/+ mice at 2, 3 and 5 mo (Figure 2.4J-L), but not at 1 mo (Figure 2.4I).  
These results suggest that L253X/+ mice have deficits in both rod and cone function, resembling 
a mild retinopathy.    
2.4.6 L253X/+ retinas do not degenerate 
To test whether the functional defects correspond to morphological changes, we 
measured retinal thickness in H&E stained retinal sections, comparing L253X/+ and L253X/X 
with WT mice at three ages (Figure 2.5). Despite the progressive retinal degeneration seen in 
L253X/X mice (Figure 2.5C, D, G, H, K & L; Supplemental Figure 2.2C-Q), L253X/+ showed 
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no degeneration or morphological abnormalities compared to WT controls up to 3 mo of age 
(Figure 2.5B, D, F, H, J, & L; Supplemental Figure 2.2C-Q).  
2.4.7 L253X/+ retinas display dynamic changes of photoreceptor gene 
expression  
 To examine developmentally regulated photoreceptor gene expression in L253X/+ vs. 
WT mice, we performed qRT-PCR analyses at two early ages: P10, when rods/cones are still 
terminally differentiating, and 1 mo when rods/cones are fully mature in normal retinas. The 
genes tested were previously shown to dramatically change in expression during WT rod and 
cone development.[Kim et al., 2016]  Figure 2.6A shows expression changes of these genes in 
L253X/+ relative to WT mice at both ages. Gene expression conformed to three general trends in 
addition to the slight increase in total Crx expression (dashed black line) noted above: Gnat1, 
Rho, and Sop (solid black lines), markers of mature photoreceptors, were significantly decreased 
in L253X/+ at P10 but attained WT levels by 1 mo.  Rxrg (dotted grey line), which in WT retina 
loses expression over development,[Kim et al., 2016] was elevated in L253X/+ at P10 but 
decreased closer to WT levels by 1 mo. The other genes tested, which increase over development 
in WT retina, showed similar relative expression levels at both ages that did not vary 
considerably from WT (solid grey lines). Together, these gene expression trends suggest that 
L253X/+ retinas exhibit altered gene expression early in photoreceptor development, similar to 
other Crx mutant models.[Ruzycki et al., 2015] 
 To determine if L253X/+ retinas maintain photoreceptor gene expression after 
differentiation, we used qRT-PCR to examine expression of 17 essential rod and cone genes in 
WT and L253X mutants at other adult ages.  The results at 1, 2, 3 and 5 mo (presented in a 
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heatmap in Figure 2.6B) suggest a complex phenotype. Genes coding for transcription factors 
Crx, Rxrg, Otx2, and Nrl were upregulated at many of the time points tested. The expression of 
essential rod and cone phototransduction genes showed a less clear pattern across ages, but in 
general all exhibit phases of reduced expression relative to WT.   
2.4.8 Late PTC-caused C-terminal truncation reduces CRX’s transactivation 
function 
 As an initial step to understand the molecular mechanism underlying mis-regulation of 
gene expression in L253X mutant retinas, we asked whether a short C-terminal truncation caused 
by a late PTC affects CRX’s ability to transactivate target gene expression.  This was tested 
using transient transfection assays in HEK293T cells with a Rhodopsin (Rho) promoter-
luciferase reporter (BR130-luc) .[Chen et al., 2002]  Vectors expressing either the full-length 
(normal) or truncated CRX1-254 were co-transfected with a NRL vector to measure their ability to 
transactivate the BR130-luc reporter.  CRX1-254 did show some dose-dependent ability to activate 
the Rho promoter, suggesting that it does bind DNA and interacts with NRL, but the maximum 
activity was greatly reduced compared to the normal CRX protein (~30% of normal activity) 
(Figure 2.7).  
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2.5 Discussion 
2.5.1 L253X mouse provides a new Class III model for mild dominant cone-
rod dystrophy  
Although L253X (TVRM65) was originally identified as a recessive Crx mutation[Won et 
al., 2011] several pieces of evidence suggest that L253X is antimorphic with dominant 
inheritance. First, L253X retinas overexpress the mutant gene product, a hallmark of Class III 
mutations that amplifies the mutation’s effects. Second, the photoreceptors in homozygous 
L253X/X mice degenerate earlier than Crx-/-, and show patterns of photoreceptor gene 
dysregulation that are distinct from Crx-/-. Thus, the presence of the mutant L253X protein 
causes more severe pathology than absence of CRX altogether, which is consistent with the 
antimorphic effect of other Class III mutations[Occelli et al., 2016; Tran et al., 2014; Tran & 
Chen, 2014] Furthermore, heterozygous L253X/+ mice have early gene expression differences 
that largely resolve by 1 mo, suggesting that full maturation may be delayed in these retinas. 
Although gene expression changes in adults were modest, rod and cone functional deficits were 
detectable as early as 1 mo. Previous work on Class III mutants has emphasized the effects that 
small changes in gene expression over a large number of genes can have on photoreceptor 
function.[Ruzycki et al., 2015] Collectively, these findings identify L253X as a Class III Crx 
mutation with the phenotypes summarized in Table 2.1.   
Compared to previously reported Class III mutations, L253X’s pathogenicity is relatively 
mild.  Unlike E168d2/+ photoreceptors, which lose their OS and undergo progressive 
degeneration,[Tran et al., 2014] L253X/+ photoreceptors show normal morphology and do not 
degenerate. The ERG deficits do not worsen with age relative to C57BL/6J controls. The gene 
expression changes are also relatively modest with a multiphasic nature. This evolving 
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expression pattern with increased levels of many TFs, but modest depletion of phototransduction 
cascade components, likely reflects an inability of the cells to maintain a proper homeostasis. 
This data would suggest that unknown feedback mechanisms are operational but unable to 
achieve the necessary precision. In adults, L253X/+ photoreceptors are alive and functional 
through 5 mo, but it remains to be determined if the phenotype worsens at older ages or if the 
retina is more susceptible to environmental insults as reported with other Class III mutants. 
Nevertheless, given the huge phenotypic variability of human CRX diseases, the L253X mouse 
provides a valuable animal model for understanding the pathogenesis of Class III mutations and 
the underlying molecular mechanisms that determine phenotype severity, age of onset and 
disease progression.   
2.5.2 The molecular mechanism(s) underlying L253X pathogenicity  
The pathogenicity of Class III mutations is generally determined by two factors, the 
activity and dose of the mutant protein. L253X protein contains an intact DNA binding domain 
but lacks a portion of the C-terminal activation domain (Figure 2.1A). Thus, it likely retains the 
ability to bind DNA, but loses some aspect of transactivation function.  Transient transfection 
assays showed that CRX1-254, a truncated CRX protein similar to L253X, retained only 30% of 
the normal CRX activity, very similar to the published reports.[Chen et al., 2002; Roger et al., 
2014] By comparison, the Class III mutant protein E168d2 showed 25-30% of the transactivation 
activity under similar conditions.[Chen et al., 2002; Tran et al., 2014] Previous reports have also 
shown CRX1-254 binds appropriate DNA sequence elements very similar to full-length 
CRX.[Roger et al., 2014] It is conceivable that, as previously reported for E168d2,[Tran et al., 
2014] L253X protein may compete with normal CRX to bind to target genes, interfering with 
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normal CRX function in heterozygous mice. However, transient transfection assays testing this 
hypothesis did not show this effect on the Rho-promoter luciferase reporter (data not shown). 
The antimorphic competition may not be limited to CRX but could also affect other 
homeodomain transcription factors that bind to similar DNA targets, and as such transient cell 
transfection assays on a single reporter that lacks the native chromatin context and regulatory 
architecture may not be the proper experiment. Supporting this possibility, the retinas of 
L253X/X mutants, like E168d2/d2,[Tran et al., 2014] showed more severe degeneration and 
biochemical defects than Crx-/- retinas. Other potential targets could include OTX2,[Samuel et 
al., 2014] which is upregulated in L253X retinas (Figure 2.6B).  Additional experiments are 
required to demonstrate L253X’s dominant-negative activity on CRX and OTX2.  Despite the 
similarity between L253X and E168d2, L253X/+ mice have a remarkably milder phenotype than 
E168d2/+; it is unlikely that the <10% difference in transactivation activity can account entirely 
for the significant difference between the two models.  We therefore propose that the relative 
amounts of mutant and normal CRX protein must also play a role in phenotype severity.  
2.5.3 L253X allele-specific overproduction of mutant mRNA and protein has 
implications for the PTC position effect  
Careful analysis of Crx mRNA and protein in L253X/+ and L253X/X retinas clearly 
shows an increased ratio of mutant/normal protein and mRNA. This finding supports the 
hypothesis that, like other Class III models, L253X retinas accumulate mutant transcripts, leading 
to overproduction of the CRX mutant protein. Interestingly, however, the degree of mutant RNA 
accumulation in L253X/+ is lower than that of the other Class III models carrying early PTC 
mutations. L253X mice only display a modest accumulation (57% mutant / 43% normal), 
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especially when compared to that observed in E168d2/+ mice at the same age (85% mutant / 
15% normal).[Tran et al., 2014] Also, when considered with the quantification of total Crx 
mRNA, the L253X/+ must result in a downregulation of the normal allele as there is no 
aggregate overproduction of Crx. This suggests that the L253X mRNA is still ‘sensed’ by the 
feedback regulatory mechanism, which functions normally in the mutant retina. Future studies 
could probe this feedback mechanism by comparing to the E168d2/+ retinas where although 
there is a gross increase in total Crx mRNA, the normal allele maintains normal expression 
levels.[Tran et al., 2014] Both mouse models show overproduction of mutant protein relative to 
WT, but L253X accumulates at a slower rate than E168d2.  
The mechanism for allele-specific overproduction of mutant Crx in Class III models is 
not well understood, but likely stems from increased RNA stability due to the presence of the 
PTC in the last exon.  This hypothesis further predicts that the position of the PTC influences the 
rate of mutant RNA accumulation. Indeed, L253X with a later PTC showed less RNA 
accumulation than the two early PTC alleles, E168d2 and A182d1 (Figure 2.1).  Thus, the earlier 
the PTC is, the more mutant product accumulates. These differences between early vs. late PTCs 
may be attributed to the length of PTC-determined 3’UTR, within which multiple discrete 
elements could independently and additively contribute to mRNA hyperstability.  Future 
identification of novel RNA regulatory elements shared among different PTC mutations may 
shed light on the mechanisms for mutant transcript hyperstability and phenotype variability in 
Class III CRX disease.  It is also notable that the accumulation of mutant protein in L253X retinas 
is more prominent than mutant RNA, raising the new possibility that altered protein turnover rate 
could also contribute to mutant protein accumulation.  
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In conclusion, our in-depth characterization of the Crx-L253X (TVRM65) mouse supports 
the classification of L253X as a dominant Class III Crx mutation and provides a new animal 
model for understanding CRX-associated dominant retinopathies. The insights gained will 
hopefully lead to new treatment strategies for this complex disease.  
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Table 2.1. Summary of L253X related phenotypes 
 
Phenotype Crx-L253X/X Crx-L253X/+ 
Morphology (histology) ONL degeneration earlier than Crx-/-  
No detectable abnormality 
up to 5 mo 
Function (ERG) Lack of rod and cone responses to light 
Minor reductions in rod 
and cone function 
Gene expression     
(qRT-PCR) 
Altered gene expression 
distinct from Crx-/- 
Dynamic changes from 
WT 
CRX protein/RNA 
levels 
L253X protein/RNA 
overproduction 
Increased ratio of L253X 
vs Normal 
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Figure 2.1: Class III Crx mutations introduce a premature termination codon (PTC), 
resulting in accumulation of truncated CRX proteins and mutant mRNA with variable 
extended 3’UTR.  (A) Schematic representation of normal and mutant CRX mRNA species, 
showing untranslated (UTR, grey/black lines) and protein-coding (open/striped boxes) with their 
relative sizes (bp, base pairs), based on mouse (Normal, E168d2[Tran et al., 2014] and L253X) 
and cat (A182d1)[Occelli et al., 2016] models. The DNA-binding homeodomain (HD, dark 
strips) and the activation domain (AD, light strips) sequences[Chen et al., 2002] are indicated. 
All three mutant mRNAs encode the complete HD, but ADs are truncated at different positions 
due to their PTC (indicated as the right-hand end of the protein coding box) induced by the 
mutation (marked by *). These PTCs also expand the 3’UTR to include different lengths of the 
original coding region (indicated by black line) in front of the normal 3’UTR (grey line). The 
position of the PTC relative to the normal stop codon determines the length of expanded 3’UTR: 
Early PTC mutants, E168d2 and A182d1 (Rdy cat mutation) produce a longer 3’UTR than the 
late PTC mutant L253X. Since 5’UTR and 3’UTR sequences of feline Crx mRNA are not 
available, these regions of the A182d1 transcript are indicated by dotted lines. (B) Immunoblot of 
CRX in the retinas of WT, L253X/+, and L253X/X mutants at 1 month old (mo) with GAPDH as 
a protein loading control.  Black arrows indicate the running position for the normal and mutant 
(truncated) forms of CRX.  (C) Quantification of relative amounts of normal and mutant CRX 
proteins in the indicated retinas at three ages (mean ± SEM, n ≥ 3; * p<0.05, **p<0.01; 2-Way 
Anova with Tukey’s Multiple Comparisons Test).  (D) Droplet digital PCR (ddPCR) 
quantification of Mutant (L253X) and Normal Crx mRNA as percentage of total Crx. The 
specificity of the two allele-specific ddPCR assays was established using triplicate tail DNA 
samples (grey circles) from the indicated genotypes (DNA control). L253X/+ mRNA results are 
presented as percent of total Crx mRNA (Mutant plus Normal transcripts) (mean ± SEM, n ≥ 3; 
**** p<0.0001; Unpaired t-Test for mutant mRNA level relative to L253X/+ DNA control; n ≥ 
3).  
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Figure 2.2: L253X/X retinas lack rod and cone responses to light and degenerate earlier 
than Crx-/-.  Electroretinogram (ERG) was used to measure rod (dark-adapted) and cone (light-
adapted) responses to various light stimuli in 1 mo L253X/X and WT mice.  (A, B) Comparison 
of representative ERG traces at the highest light intensity: 0.89 log cd*s/m2 for dark-adapted 
responses, and 2.67 log cd*s/m2 for light-adapted responses.  (C) Bar graphs compare mean A-
wave and/or B-wave amplitude differences between the two genotypes at the highest light 
intensity tested (mean ± SEM, n ≥ 3; * p≤0.05, *** p≤0.0005, **** p<0.0001; 2-Way Anova 
with Sidak’s Multiple Comparisons Test). (D-F, H-J) H&E-stained paraffin-embedded sagittal 
retinal sections from the indicated mice at 1 and 3 mo. Images were taken approximately 500um 
from the Optic Nerve Head (ONH) at a 40X magnification (scale bar = 25um).  (G,K) 
Morphometry measures at five set distances (in microns) on either side of the ONH (mean ± 
SEM, n ≥ 3; * p≤0.05, ** p<.01, *** p≤.0003; 2-Way Anova with Sidak’s Multiple Comparisons 
Test).   
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Figure 2.3: L253X/X has measurable gene expression differences relative to Crx-/-.  (A) 
Expression at P10 of the indicated photoreceptor genes was measured by qRT-PCR and 
compared between L253X/X and Crx-/- at P10. The grey dash lines mark 2-fold differences (±1 
log2 relative expression) between the two genotypes (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, 
**** p<0.0001; Unpaired t-Test with Welch’s Correction). (B-D) RHO immunostaining of 
retinal sections of the indicated mice at 1 mo revealed less RHO expression in L253X/X retinas 
than Crx-/- (signal in black, scale bar 25um). (E-G) DAPI counterstaining of the above sections 
(signal in black).  
 48 
 
Figure 2.4: L253X/+ retinas exhibit reduced rod and cone light responses.  ERG responses of 
L253X/+ mice (black lines) and WT (gray lines) were tested at 4 adult ages, and dark-adapted 
and light-adapted A- and B-wave amplitudes quantified. 1 mo (A, E, I), 2 mo (B, F, J), 3 mo (C, 
G, K), and 5 mo (D, H, L) (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, *** p<0.0006, **** 
p<0.0001; 2-Way Anova with Sidak’s Multiple Comparisons Test).   
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Figure 2.5: L253X/+ retinas appear morphologically similar to WT up to 3 mo. H&E stained 
retinal sections from L253X/+, L253X/X, and WT mice at the indicated ages (A-C, 1 mo; E-G, 2 
mo; I-K, 3 mo) were imaged at 40X magnification (Scale bar 25um). Images were taken 
approximately 500 microns from the ONH, where differences in layer thickness are less 
significant. (D,H,L) ONL thickness was quantified by morphometry at five set distances (in 
microns) on either side of the ONH (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, *** p<0.001, 
**** p<0.0001; 2-Way Anova with Tukey’s Multiple Comparisons Test).   
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Figure 2.6: L253X/+ retinas display dynamic changes in photoreceptor gene expression. 
qRT-PCR analyses of L253X/+ expression levels (relative to WT mice) of the indicated rod/cone 
genes are shown at P10 and 1 mo (mean ± SEM, n ≥ 3). Lines connecting expression levels of 
each gene at the two ages show the dynamic changes in expression, and reveal four different 
expression trends indicated here by line color and solidity, as described in Results. (B) Heatmap 
depicting qRT-PCR-detected expression changes of the listed photoreceptor genes in L253X/+ 
relative to WT at the indicated ages. Data are clustered based on gene expression patterns (log2 
[mean fold-change], n ≥ 3). Colored gene names indicate expression in specific photoreceptor 
subtype(s). “TF” indicates transcription factors expressed by rods and/or cones that are essential 
for cell fate specification.  
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Figure 2.7: L253X retains minimal ability to transactivate Rhodopsin promoter in presence 
of NRL . Dual luciferase assays showing dose-dependent increase in CRX transactivation 
activity of normal or mutant (CRX1-254) in the presence of constant amount of NRL. (mean ± 
SEM, n = 3; **** p<0.0001; 2-Way Anova with Bonferroni’s Multiple Comparisons Test) 
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Supplemental Figure 2.1: L253X/+ retinas display variable excess total Crx mRNA. qRT-
PCR assays were used to quantify total Crx mRNA from mutant and WT control retinas at the 
indicated ages. The results are presented as relative expression to WT. (mean ± SEM, n=3, circles 
represent individual biological replicates; ** p< .01; 1-Way Anova with Tukey’s Multiple 
Comparisons Test).   
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Supplemental Figure 2.2: L253X/X retinas display normal ONL genesis but photoreceptor 
layer-specific progressive thinning, while all L253X/+ retinal layers unaffected. H&E stained 
retinal sections from P7 WT (A) and L253X/X (B) mice were imaged at 40X magnification (scale 
bar 25um). Morphometry quantification of five retinal layers in L253X/X and L253X/+ mutants 
along with WT controls at 1 mo (C-G), 2 mo (H-L) and 3 mo (M-Q). These layers include ONL-
outer nuclear layer, OPL-outer plexiform layer; INL–inner nuclear layer; IPL-inner plexiform 
layer; and GCL- ganglion cell layer. (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, *** p<0.001, 
**** p<0.0001; 2-Way Anova with Tukey’s Multiple Comparisons Test). (R) Expression levels 
of 14 essential photoreceptor genes in P10 L253X/X and Crx-/- mutants and WT controls were 
determined by qRT-PCR. The results are presented as expression changes relative to WT in a 
log2 scale with 2-fold differences (±1) marked by grey dash lines (mean ± SEM, n ≥ 3; * p<0.05, 
** p<0.01, **** p<0.0001; 1-Way Anova with Tukey’s Multiple Comparisons Test)   
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3.2 Abstract  
Background: Mutations in the cone-rod-homeobox protein CRX are typically associated with 
dominant blinding retinopathies with variable age of onset and severity. Five well-characterized 
mouse models carrying different Crx mutations show a wide range of disease phenotypes. To 
determine if the phenotype variability correlates with distinct changes in CRX target gene 
expression, we perform RNA-seq analyses on three of these models and compare the results with 
published data. 
Results: Despite dramatic phenotypic differences between the three models tested, graded 
expression changes in shared sets of genes are detected.  Phenotype severity correlates with the 
down-regulation of genes encoding key rod and cone phototransduction proteins. Interestingly, 
in increasingly severe mouse models, the transcription of many rod-enriched genes decreases 
decrementally, whereas that of cone-enriched genes increases incrementally. Unlike down-
regulated genes, which show a high degree of CRX binding and dynamic epigenetic profiles in 
normal retinas, the up-regulated cone-enriched genes do not correlate with direct activity of 
CRX, but instead likely reflect a change in rod cell-fate integrity. Furthermore, these analyses 
describe the impact of minor gene expression changes on the phenotype, as two mutants showed 
marginally distinguishable expression patterns but huge phenotypic differences, including 
distinct mechanisms of retinal degeneration. 
Conclusions: Our results implicate a threshold effect of gene expression level on photoreceptor 
function and survival, highlight the importance of CRX in photoreceptor subtype development 
and maintenance, and provide a molecular basis for phenotype variability in CRX-associated 
retinopathies.  
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3.3 Introduction  
Rod and cone photoreceptors are the two primary light detecting cell types of the retina 
and are essential for vision.  Each cell type preferentially expresses a set of genes critical for 
development and maintenance of its specialized function.  This cell type-specific gene 
expression is regulated by a network of transcription factors (reviewed in [Hennig et al., 2008; 
Hsiau et al., 2007]).  Disruptions in this regulatory network can have a dramatic effect on rod [J. 
Chen et al., 2005; Corbo & Cepko, 2005; Daniele et al., 2005; Mears et al., 2001] and cone 
[Roberts et al., 2005, 2006] development, function, cell-fate integrity and survival.  The 
homeodomain transcription factor CRX is expressed in both rods and cones and plays a central 
role in mediating photoreceptor transcription.  CRX works with rod-specific, cone-specific and 
general transcription factors to control photoreceptor gene expression [S. Chen et al., 1997; 
Hennig et al., 2013; Mitton et al., 2000; Onishi et al., 2009; G.-H. Peng et al., 2005; Tran & 
Chen, 2014].  In particular, CRX and the rod-specific transcription factor NRL cooperatively 
regulate rod gene transcription and have highly overlapping DNA-binding patterns [Brooks et 
al., 2011; Corbo et al., 2010; Hao et al., 2012].  Loss of CRX dramatically impairs both rod and 
cone photoreceptor gene transcription leading to failed photoreceptor maturation and rapid 
degeneration [Furukawa et al., 1999], while the loss of NRL converts rods into cells with cone-
like transcription and functional properties [Brooks et al., 2011; Daniele et al., 2005].   
 Mutations in the human CRX gene have been associated with dominant forms of retinal 
degenerative diseases such as Retinitis Pigmentosa (RP), Cone-Rod Dystrophy (CoRD) and 
Leber Congenital Amaurosis (LCA), with varied age of onset and severity (reviewed in [Huang 
et al., 2012; Rivolta et al., 2001; Tran & Chen, 2014]).  Disease-causing mutations fall into at 
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least four classes, based on mutation type, pathogenic mechanism and molecular properties of 
the mutant protein: I) hypomorphic substitution mutations with reduced DNA-binding activity; 
II) antimorphic substitution mutations with variable DNA-binding; III) antimorphic frameshift 
mutations with intact DNA-binding and IV) antimorphic frameshift mutations with variable 
DNA-binding (reviewed in [Tran & Chen, 2014]).  While each class of disease-causing 
mutations is associated with distinct clinical phenotypes, the underlying transcriptional changes 
mediating these phenotypes are poorly understood.   
 In this study, we used mRNA sequencing (RNA-seq) to examine gene expression in the 
developing and adult retinas of three Crx mutation Knock-IN mouse models that have distinct 
retinal phenotypes [Tran et al., 2014]: CrxR90W (R90W), CrxE168d2 (E168d2) and CrxE168d2neo 
(E168d2neo)  (Figure 3.1, Table 3.1).  The R90W mice carry a Class I mutation and their 
phenotypes resemble mild late-onset dominant CoRD and recessive LCA.  E168d2 and 
E168d2neo mice carry the same Class III mutation but E168d2neo mice express the mutant 
protein at a lower level, due to the retention of an intronic neomycin cassette.  E168d2 mouse 
phenotypes resemble severe dominant LCA, while E168d2neo mouse phenotypes resemble a less 
severe dominant CoRD phenotype, due to reduced mutant protein expression.  We assessed how 
each Crx mutation impacted the expression of retinal cell-type specific genes and investigated 
cellular pathways that may contribute to disease.  We correlated these transcriptional changes 
with the direct DNA-binding activity of CRX [Corbo et al., 2010] and NRL [Hao et al., 2012] 
and the epigenetic landscape of rods and cones [Popova et al., 2012; Vierstra et al., 2014].  
Additionally, we compared the expression profiles of these Crx Knock-IN mice to the previously 
characterized Crx-/- and CrxRip (Rip) mouse models.  Rip mice carry a Class IV mutation and 
have a more severe dominant LCA phenotype than E168d2 mice [Roger et al., 2014].  Our 
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results demonstrate that all five mouse models have graded changes in photoreceptor-specific 
gene expression that correlate with the severity of their phenotypes.  These graded changes 
include reduced expression of direct CRX target genes required for rod/cone photoreceptor 
function and survival, and derepression of ‘cone’ genes in rods through an indirect mechanism, 
suggesting that rod cell-fate integrity is compromised in the more severe models.  
 Lastly, we identified threshold effects of gene expression changes on retinal phenotype. 
Despite having only small differences in gene expression changes, heterozygous E168d2 and 
E168d2neo mice showed drastically different phenotypes, including light-independent vs. light-
dependent photoreceptor degeneration, respectively. These phenotypic and mechanistic 
differences between the two models are likely attributed to slight shifts in gene expression 
throughout several photoreceptor-specific pathways, particularly phototransduction and the 
retinoid (visual) cycle.  This highlights the delicate balance between photoreceptor gene 
transcription, function and cellular integrity.  These results demonstrate that the transcriptional 
landscape in models of retinal degeneration can dramatically affect disease pathology.  Effective 
therapeutic design may therefore be highly context specific.   
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3.4 Results 
3.4.1 Crx mutations cause graded expression changes in shared gene sets, 
correlating with phenotype severity 
 To assess the effects of Crx mutations on retinal gene expression we performed RNA-seq 
on retinas of the Crx mutant mouse models R90W, E168d2 and E168d2neo, and age-matched 
wild-type (WT) controls, in triplicate.  As listed in Table 3.2, we analyzed heterozygous mutants 
at both P10 and P21, but homozygous mutants at P10 only, as their retinas are severely 
degenerated at later ages.  Because they lack WT CRX to antagonize the antimorphic mutant 
CRX protein, homozygous E168d2 and E168d2neo mice show essentially the same severe 
phenotype at morphological, functional and gene expression levels [Tran et al., 2014] (Table 
S1A).  Thus, we only performed RNA-seq on E168d2/d2 to provide a reference for an extremely 
severe phenotype.  RNA-seq libraries were sequenced on the Illumina HiSeq2000 and each 
generated more than 28 million mapped reads (Table S2).  Sample quality was assessed by 
principal component analysis (PCA) of the expression values of all genes that passed the 5 
counts per million (CPM) threshold in any genotype (Supplemental Figure 3.1), and by visual 
inspection of mapped reads at individual gene loci using Integrated Genomics Viewer (IGV)  
[Robinson et al., 2011] (Supplemental Figure 3.2A,B).  PCA plots (Supplemental Figure 3.1) 
show that the genotypes clustered as expected with the E168d2/d2 samples showing the most 
variation from WT controls at both ages tested.  At P10 E168d2/+, E168d2neo/+ and R90W/W 
samples clustered between WT and E168d2/d2, corresponding to their intermediate phenotypes.  
In contrast, R90W/+ samples clustered with WT samples, consistent with their normal phenotype 
at this age.  At P21, despite increased replicate variability, differences between heterozygous 
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mutant genotypes and WT are consistent with their phenotypes.  Since the PCA analysis only 
described sample differences as a whole, we further determined the relationship of gene 
expression changes and phenotype differences, using multiple independent analyses of gene 
expression.  First, to determine differential expression, EdgeR [Nikolayeva & Robinson, 2014] 
was used to compare the triplicate samples.  Changes considered “significant” were 2-fold or 
greater (FC ≥ 2) with a false discovery rate (FDR) ≤ 0.05 from the appropriate WT control, 
unless otherwise noted.  Additional filtering and analysis details can be found in the Appendix 2 
Methods section.  Expression changes in subsets of RNA-seq identified genes were further 
validated using qRT-PCR (Table S1 A-C).  
- Homozygous Crx mutant mice show drastically changed expression of a large number of 
genes at P10 before photoreceptor degeneration 
 We first compared retinal gene expression in the homozygous mutants E168d2/d2 and 
R90W/W at P10 to that in age-matched WT controls.  As shown by the scatterplots (Figures 
3.2A,B), both mutants displayed ≥ 2-fold expression changes for a large number of genes.  
However, the number of genes affected in E168d2/d2 was much larger than R90W/W (Table 
3.2).  Among the changed genes, down-regulated genes outnumbered up-regulated genes (Table 
3.2), consistent with the established role of CRX in the activation of transcription.  Some of the 
affected genes (white highlighted in Figures 3.2A,B) encode well-characterized proteins essential 
for rod and cone identity, function and survival.  Next, we compared the changed gene sets 
between the two mutants.  Even though E168d2/d2 and R90W/W have mechanistically distinct 
mutant proteins and phenotypes [Tran et al., 2014], the significantly affected (FC ≥ 2 & FDR ≤ 
0.05) genes showed a high degree of overlap for both down-regulated and up-regulated gene sets 
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(Figures 3.2C,D).  In addition, for these shared genes the degree of change was generally greater 
in E168d2/d2 than R90W/W, as seen by visually inspecting the positions of the highlighted genes 
in Figure 3.2A vs B.  These changes were confirmed to be consistent between replicates by 
comparing the raw mapped reads for several of these genes (Supplemental Figure 3.2A).  
Homozygous mouse retina RNA-seq results for several genes were also consistent with previous 
qRT-PCR data [21] (Table S1B).  These data suggest that photoreceptor gene expression in 
R90W/W is less disrupted than in E168d2/d2, consistent with the phenotype differences between 
the two models. 
- Heterozygous Crx mutant mice have moderate expression changes in fewer genes than the 
homozygous mutants at P10, with few independently affected genes  
 To determine if heterozygous mutants also share gene expression changes between 
genotypes, we compared RNA-seq data from heterozygous mutants E168d2/+, R90W/+, as well 
as E168d2neo/+.  At P10, the heterozygous mutants showed fewer gene changes than the 
respective homozygous counterparts (Table 3.2).  Similar to the homozygous mutants, the 
number of significantly affected genes in heterozygotes correlated with phenotype severity in the 
order E168d2/+ > E168d2neo/+ > R90W/+.  Figures 3.3A-C and Supplemental Figure 3.2A 
show that, qualitatively, the white highlighted photoreceptor transcripts were most severely 
affected in the E168d2/+ mutant, less affected in the E168d2neo/+ and showed no change 
greater than 2-fold in the R90W/+ line.  Furthermore, affected transcripts in heterozygotes also 
showed a high degree of overlap between the genotypes (Figures 3.3D,E).  
Next, we analyzed whether the degree of expression changes correlates with phenotype 
severity. To gain quantitative results for the entire datasets, we compared the overall fold change 
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(relative to WT) for the union of all affected genes (see Table 3.2 for total numbers) in 
E168d2/+, E168d2neo/+ and R90W/+ mutants (Figures 3.3F,G).  Both down-regulated (Figure 
3.3F) and up-regulated (Figure 3.3G) groups showed a stepwise pattern of expression fold 
changes: E168d2/+ > E168d2neo/+ > R90W/+.  Thus, in addition to the number of affected 
genes, the degree of expression changes also correlates with phenotype severity in heterozygous 
mutants.  While this difference in expression was statistically significant (Figures 3.3F,G), the 
differences between the median log2 fold change for individual genes expressed in the different 
heterozygotes were rather small. This is in contrast to the large phenotype differences between 
these genotypes (see Table 3.1), demonstrating the importance of precisely regulated gene 
expression for photoreceptor integrity.  The expression changes of several genes in heterozygous 
mouse retinas as determined by RNA-seq results were reproducible (Supplemental Figure 3.2A) 
and consistent with previous qRT-PCR data [21] (Table S1B,C). 
 We also directly compared the data for overlapping and independently affected genes in 
age-matched (P10) heterozygote and homozygote Crx mutant animals.  Significantly fewer 
down-regulated and up-regulated genes were seen in the heterozygous E168d2/+ and R90W/+ 
mutants than in their homozygous counterparts (Supplemental Figure 3.3). There was only a 
small fraction of genes that was independently changed in either heterozygote mutant but 
unaffected in the homozygotes (Supplemental Figure 3.3). These data are consistent with the 
differences in phenotype severity between the heterozygous and homozygous mutants.  
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3.4.2 Crx mutations specifically affect rod- and cone-enriched genes including 
down-regulation of phototransduction genes  
 To ensure that decreased retinal function and impaired development of the Crx mutant 
mice are not a result of perturbations to other non-photoreceptor cell types, we analyzed the P10 
RNA-seq data for changes in expression of genes representing different types of retinal neurons.  
For each cell type, we chose the ten genes with the highest specificity ratio [Siegert et al., 2012] 
present in our data.  The heatmap in Figure 3.4A represents the fold change from WT for each of 
these genes in the P10 mutants, organized by the cell type they represent. The cell types that 
showed the greatest gene expression changes in all mutants were rod and cone photoreceptors, 
whereas large-scale changes in gene expression were not observed in other retinal cell types at 
the age of P10. 
 We also specifically analyzed expression of genes important for retinal visual function, as 
changes in this pathway in cell types other than photoreceptors could account for the decreased 
function as measured by ERG [Tran et al., 2014]. Supplemental Figure 3.4 shows that non-
photoreceptor specific genes encoding proteins involved in visual function had little to no change 
in expression in any of the mutants.  In contrast, expression changes were seen in many known 
photoreceptor-enriched components of the phototransduction cascade (Figure 3.4B). Nearly 
every constituent was negatively impacted in E168d2/+, but remained virtually unaffected in 
R90W/+.  E168d2neo/+ adopted an intermediate expression level, again emphasizing the 
stepwise and graded changes between the three genotypes.  
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3.4.3 Insights from E168d2/+ and E168d2neo/+: small changes in gene 
expression level strongly influence phenotype 
Since the above analysis detected little difference between the two phenotypically distinct 
mouse lines that both carry the same Crx mutation, E168d2/+ and E168d2neo/+, we expanded 
our analyses to directly compare these two datasets.  A scatterplot comparing E168d2/+ and 
E168d2neo/+ shows only subtle expression differences (Figure 3.4C), further confirming the 
analyses presented in Table 3.2 and Figure 3.3.  Differences in gene expression levels were 
within the 2-fold margin with only a few exceptions.  To decipher the genes that are likely to 
impact phenotype severity, we analyzed the 118 genes that passed the statistical threshold in the 
direct comparison of E168d2/+ vs. E168d2neo/+ (FDR ≤ 0.05, no FC cut-off, represented in 
white in Figure 3.4C).  To confirm the validity of the results of this comparison, we also 
calculated the Z-Score of each biological replicate from the mean expression level (Supplemental 
Figure 3.5), which showed reproducible differences between the two genotypes.  The list of 
down-regulated genes in E168d2/+ was highly enriched for those relevant to photoreceptor 
biology and function by Gene Ontology (GO) analyses (Figure 3.4D).  In contrast, the up-
regulated genes showed only a modest enrichment for a single photoreceptor-relevant GO 
category (Figure 3.4E).  These findings suggest threshold effects of expression level changes on 
photoreceptor phenotype, especially in those pathways represented in the down-regulated gene 
set illustrated in Figure 3.4D. 
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3.4.4 Heterozygous mutants show normal gene expression trends from P10 to 
P21, but many genes fail to reach the normal level at P21      
Crx mutant mice show early deficits in photoreceptor morphology and function 
[Furukawa et al., 1999; Tran et al., 2014].  In heterozygous Crx knockout and R90W mice, 
morphology and function recover at later ages, suggesting a transient developmental delay.  
E168d2neo/+ mice also recover rod morphology but have abnormal cone morphology and only 
partially recover rod and cone function in adulthood.  E168d2/+ mice remain impaired in 
adulthood with shortened outer segments and severely impaired retinal function [Tran et al., 
2014], suggesting a blockade in photoreceptor maturation.  To determine if differences in 
morphological and functional recovery are related to gene expression changes over time, we also 
performed RNA-seq analyses on heterozygous R90W, E168d2 and E168d2neo mutants at P21 
when photoreceptors are mature. The P21 gene expression data described a very similar scenario 
seen in the P10 datasets: The three heterozygous genotypes displayed a graded degree and 
number of genes affected in the mutants relative to the P21 WT control (Table 3.1, Supplemental 
Figures 3.6A-E).   
Next, we compared expression changes in the heterozygous mutants between P10 and 
P21 relative to P10 WT expression levels. In WT mice, 678 genes showed expression changes 
between P10 and P21 (FC ≥ ±2, FDR ≤ 0.5), as shown in a heatmap (Supplemental Figure 3.7A).  
These age-dependent gene expression changes likely reflect retina terminal differentiation: Gene 
Ontology analyses showed that the top 100 up-regulated genes were enriched for those important 
for developing mature photoreceptor structure and function, including visual perception, 
detection of light stimulus, photoreceptor outer segment formation and monovalent inorganic 
cation transport (Supplemental Figure 3.7B). In contrast, the down-regulated gene set was 
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composed of genes that are important for neurogenesis during development, including system 
development, cell adhesion and regulation of cell proliferation (Supplemental Figure 3.7B).  We 
next analyzed age-dependent gene expression changes in the Crx mutant lines, primarily 
focusing on E168d2/+ and E168d2neo/+ models, because of their distinct phenotype from WT 
mice. Unexpectedly, both mutants showed a trend of changes similar to WT mice for P21 up-
regulated and down-regulated gene sets (Supplemental Figures 3.7A,C).  However, in mutants, 
expression of many members of these two gene sets did not reach the WT level at P21 
(Supplemental Figures 3.7A,C).  As expected, this defect was more prominent in E168d2/+ than 
E168d2neo/+ mice.  This suggests that the E168d2/+ mutants continue to develop after P10 and 
recover some gene expression, but the degree of recovery is insufficient to achieve normal 
photoreceptor maturation.  Interestingly, R90W/+ also displayed slightly altered expression 
levels of many dynamically changed genes.  These subtle differences may eventually contribute 
to the minor functional deficits observed for R90W/+ at 6 months of age [Tran et al., 2014].  
Taken together, these data suggest that Crx mutant mice fail both in repressing developmental 
genes and in activating genes required for photoreceptor maturation.  These age-related gene 
expression changes support the morphological and functional observations that Crx mutant mice 
vary in their photoreceptor maturation rates. 
3.4.5 Down-regulated and up-regulated genes in Crx mutants show distinct 
epigenetic profiles in WT retinas 
 To determine the modality of CRX’s regulation of differentially expressed genes, we 
further investigated their expression patterns and the epigenetic landscape of their proximal cis-
regulatory regions in WT mice.  We first used hierarchical cluster analysis on P10 and P21 
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datasets to find sets of genes that were similarly affected in all mutants.  Figure 3.5A shows a 
heatmap representing log2 fold change relative to age matched WT samples for any gene that 
displayed significant change from WT (FC ≥ ±2, FDR ≤ 0.05) in any single genotype; the data is 
arranged by hierarchical clustering (clustering branches are shown to the left of the heatmap).  
By visual inspection of clustered data, we further subdivided affected genes into eight groups 
based on similarity of altered expression patterns.  These are designated as Groups 1-8 (shown to 
the right of the heatmap) (see Tables S3 and S4 for lists and order of genes).  Further analyses 
focused on Groups 1, 2, 3 and 6, as these represented the largest and most consistent clusters.  
Visual inspection of biological replicate data also confirmed the consistency of the expression 
changes in these groups (Supplemental Figure 3.8).  Group 1 genes were the most down-
regulated genes across all genotypes.  Group 2 genes were decreased compared to WT levels, but 
across the board were less affected than those in Group 1.  Groups 3 and 6 were composed of 
genes that were up-regulated in many of the genotypes.  Group 6 genes generally were up-
regulated to a greater extent. 
- The proximal cis-elements of down-regulated genes are enriched for CRX and NRL 
binding  
 To determine which of the above four major gene groups are directly regulated by CRX 
and its interacting rod-specific transcription factor NRL, we analyzed previously published CRX 
and NRL ChIP-seq data [Corbo et al., 2010; Hao et al., 2012] obtained from adult mouse retinas 
for all of the genes in these four clusters.  Since CRX is expressed by both rods and cones, CRX 
ChIP-seq data from both WT (predominantly rod) and Nrl-/- (predominantly cone) retinas were 
included in our analyses. The WT NRL ChIP-seq data represents rod data, since NRL is not 
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expressed in cones. The data are presented in heatmaps (Figure 3.5B, Columns 1-3), where each 
gene within the group is represented by a single line. The data within each column reports the 
average read depth of the indicated experiment +/- 1kb in 40bp bins centered on the transcription 
start site (TSS).  These results presented interesting contrasts between the various groups of 
genes: First, Groups 1 and 2 displayed a significant amount of CRX binding in rods (Column 1) 
and cones (Column 2) and NRL binding in rods (Column 3) around the TSS, while this binding 
was virtually absent in Groups 3 and 6 (Figure 3.5B, Columns 1-3; Supplemental Figures 3.9A-
C).  This suggests that the down-regulated genes in Groups 1 and 2 are enriched for direct 
CRX/NRL targets, but not the up-regulated genes in Groups 3 and 6, consistent with the primary 
role of CRX and NRL in transactivation.  Second, the more extensively down-regulated genes in 
Group 1 showed more CRX (Columns 1-2) and NRL (Column 3) binding than the less-severely 
down-regulated genes in Group 2 (Figure 3.5B, Columns 1-3; Supplemental Figures 3.9A-C), 
raising the possibility that Group 1 genes are more dependent on CRX/NRL transactivation 
activity than Group 2 genes. Third, comparison of CRX binding in rods (Column 1) vs. cones 
(Column 2) for Group 1 genes showed a high degree of CRX binding in both photoreceptor 
subtypes, suggesting that this group contains genes that are activated by CRX in both rods and 
cones.  In contrast, Group 2 genes showed CRX binding largely in rods, suggesting these genes 
are activated by CRX mainly in rods (Supplemental Figures 3.9A,B).  
- Down-regulated genes become more “open” during postnatal retinal development 
To determine which of the four major groups undergo epigenetic landscape changes 
during photoreceptor development, we analyzed three different sets of previously published and 
	 73 
publicly available epigenetic signature data (Figure 3.5B, columns 4-10). Results are presented 
as heatmaps in a similar format as CRX and NRL ChIP-seq data. 
We first analyzed retinal DNase I hypersensitivity (DHS) datasets at the age of P1, P7 
and 8 weeks (8wk) (Figure 3.5B, Columns 4-6) from the ENCODE project [22].  Enriched DHS 
is an indicator of ‘open’ chromatin and is a predictor of active transcription.  Both down-
regulated and up-regulated genes showed dynamic changes in their epigenetic landscapes with 
age. First, Group 1 genes showed increases in DHS signal from P1 to 8wk of age.  This pattern is 
not seen in Group 2 genes, in which high DHS signal was largely stable across the ages tested.  
Group 3 and 6 genes, on the other hand, showed different patterns, in which DHS signal 
decreased from P1 to 8wk of age.  Second, comparing across groups at 8wk of age, DHS data 
described Groups 1 and 2 as having more ‘open’ chromatin (higher DHS signal) around their 
TSS than Groups 3 and 6 (Figure 3.5B, Column 6).  These data suggest that the chromatin of 
genes down-regulated in Crx mutants (Groups 1 or 2) have ‘open’ chromatin in the adult wild-
type retina and the mostly strongly down-regulated genes (Group 1) are genes that develop a 
more ‘open’ chromatin conformation postnatally.  In contrast, up-regulated genes (Groups 3, 6) 
tended to have ‘open’ chromatin in the early postnatal retina that became more ‘closed’ with age.  
To determine if these dynamic DHS changes represented specific events for particular groups, 
we included a random control group in our analyses. A random set of genes was chosen from the 
UCSC gene list to match the size of the largest Group from the analysis (Group “Random”).  As 
illustrated by Supplemental Figures 3.9D-F, the Random group (grey lines) also showed a trend 
of reduction in DHS during postnatal retinal development.  Importantly, when compared to 
Random genes, Group 1 genes were less ‘open’ at P1 and P7 (Supplemental Figures 3.9D,E, blue 
line vs. grey line) but more ‘open’ at 8 weeks (Supplemental Figure 3.9F, blue line vs. grey line), 
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verifying the trend visible by eye in the Figure 3.5B heatmaps.  These results were consistent 
with the observation that Group 1 genes largely increased their expression from P2 to P21, 
during WT retinal development (Supplemental Figure 3.9K, based on published RNA-seq data by 
[Roger et al., 2014]).  Interestingly, Group 2 genes were more ‘open’ than Random genes at all 
ages tested (Supplemental Figures 3.9D,F, dashed blue line vs. grey line), consistent with an 
overall modest increase in their expression from P2 to P21 in WT mice (Supplemental Figure 
3.9L).  In contrast, Group 6 genes showed overall lower DHS than Random genes at all three 
ages analyzed, while Group 3 genes showed similar DHS patterns as Random.  Both Group 3 
and 6 genes normally showed no change or a slight decrease in expression from P2 to P21 
(Supplemental Figures 3.9M,N).  This data suggests the DHS changes identified in Group 1 
genes are dynamically regulated during retina development. 
- Down-regulated genes undergo histone modification changes during postnatal retinal 
development 
Next, we analyzed these gene groups for the presence of active (H3K4me2) (Columns 
7,8) and repressive (H3K27me3) (Columns 9,10) histone marks as determined by ChIP-Seq in 
P1 and P15 WT retinas [23] within the 2 kb window centered on the TSS of each gene.  
Consistent with gaining a more ‘open’ chromatin configuration, Group 1 genes gained the active 
mark H3K4me2 and lost the repressive mark H3K27me3 between P1 and P15 (Figure 3.5B, 
Columns 7-10; Supplemental Figures 3.9G-J, blue line vs. grey line).  Group 2 genes, showed 
similar changes in histone marks (increase in H3K4me2 and decrease in H3K27me3) from P1 to 
P15.  Group 2 genes also showed a higher level of the active mark H3K4me2 than Random 
genes at P1, while the level of the repressive mark H3K27me3 was similar to Random at this age 
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(Figure 3.5B, Columns 7-10; Supplemental Figure 3.9G-J, dashed blue line vs. grey line).  
Overall, the data is consistent with a postnatal constitutively open chromatin configuration for 
Group 2 genes as measured by DHS.  Finally, Groups 3 and 6 showed no difference relative to 
the Random group in either H3K4me2 or H3K27me3 occupancy through retina development 
(Figure 3.5B, Columns 7-10; Supplemental Figures 3.9G-J, red lines vs. grey lines), consistent 
with their overall constant low level of gene expression. 
Together, the above analyses suggest that Group 1 genes undergo dynamic epigenetic 
changes during retina maturation associated with their substantial transcriptional activation 
during postnatal photoreceptor development.  The expression pattern of these genes correlated 
with CRX and NRL expression, and their regulatory regions were directly bound by CRX and 
NRL in WT mice. These results suggest that Group 1 is enriched for genes that are inactive in 
precursor cells and actively turned on by key photoreceptor transcription factors during 
development. Thus, mutations in CRX have a profound negative impact on the expression of 
these genes.  Group 2 genes were similar to Group 1 in that their epigenetic landscape is 
supportive of high transcriptional levels in the WT retina and are likely regulated directly by 
CRX and NRL.  Interestingly, these genes do not show the time dependent chromatin ‘opening’, 
suggesting that CRX and NRL may not be necessary to initiate chromatin remodeling and could 
account for the fact that Group 2 genes lose expression to a lesser degree than Group 1 genes.  
Finally, Group 3 and 6 data suggest that these genes undergo chromatin remodeling in the WT 
retina that results in a less permissive state.  This is consistent with their low or even decreasing 
expression over time.  However, this process is not directly controlled by CRX or NRL, as ChIP-
seq binding of these two proteins was not observed in these Groups. 
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3.4.6 Up-regulated genes are characteristic of cone photoreceptors, likely 
resulting from de-repression in rods  
 Since CRX and NRL binding as well as epigenetic data implicate down-regulated genes 
as being active CRX targets in rods, we investigated if differentially-expressed genes normally 
have rod or cone cell-type-specific expression patterns.  Using published data [Roger et al., 
2014] to classify these genes as either rod- or cone-enriched (or non-specific – N.S.), we found a 
significant overrepresentation of rod genes in Groups 1 and 2, although a number of cone genes 
were also found in Group 1 (Figure 3.6A and Table S3).  This was expected considering the 
mouse retina is rod-dominant and CRX acts as a transcription activator for genes critical for 
photoreceptor structure and function.  However, surprisingly, up-regulated Groups 3 and 6 
contained a significant enrichment of cone transcripts (Figure 3.6A and Table S3).  
To determine whether this up-regulation of cone gene expression is a general trend 
beyond Group 3 and 6 genes, we expanded our analysis to all genes enriched in either rods or 
cones in adult mice.  Furthermore, to ensure the results are applicable to other classes of Crx 
mutants, we also analyzed three previously published RNA-seq datasets from other Crx mutant 
models, Crx-/-, Rip/+ and Rip/Rip.  The results, presented by heatmaps (Figures 3.6B,C), 
showed a broad switch in the global pattern of gene expression in all mutants, with loss of 
expression of a large set of rod genes (Figure 3.6B) and increased expression of transcripts 
normally enriched in cones (Figure 3.6C).  There were exceptions: expression of a small number 
of cone genes, indicated with an asterisk at the bottom of Figure 3.6C, was consistently 
decreased in all the Crx mutants. These represented key cone-specific phototransduction genes 
including Pde6h, Arr3, Opn1mw, Opn1sw, Gnat2 and others (Supplemental Figure 3.10B).  
Their loss of expression was similar to rod-specific phototransduction components that also 
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consistently decreased, including Rho, Gnat1, Cngb1, and Pde6g (Figure 3.6B marked by 
asterisk, Supplemental Figure 3.10A).  Again, rod-enriched genes and cone-enriched genes 
displayed graded changes that reflected phenotype severity in our models (E168d2/d2: most 
severe; R90W/+: least severe).  These results also place the Rip model (Rip/+ and Rip/Rip) in 
line with other Crx models, demonstrating even more severe expression changes than 
E168d2/d2, although the RIP protein is thought to cause disease by a distinct molecular 
mechanism [Roger et al., 2014].   
Because RNA-seq was performed on whole-retina samples, the down-regulation of rod 
genes and up-regulation of cone genes could represent a decrease in the number of rods and an 
increase in cones. However, previously published histology showed that in fact the proportions 
of these cell populations shift in the opposite direction, as the E168d2/+ retina has a very severe 
and early depletion of cone photoreceptors, prior to any loss of rod photoreceptors [Tran et al., 
2014].  In fact, all Crx mutant mouse models including Crx-/- and Rip/+ show a similar trend of 
rapid cone loss followed by slower rod degeneration.  This result was also unexpected 
considering the role of CRX in trans-activating cone as well as rod genes [S. Chen et al., 2004; 
Tran et al., 2014].  This raised the possibility that the up-regulated cone genes were abnormally 
derepressed in the mutant rods.  To further understand the molecular mechanism underlying mis-
expression of cone genes in mutant rods, we assessed all rod- and cone-enriched transcription 
factors for expression changes in the mutants.  Consistent with overall expression changes, we 
observed a general loss of rod transcription factors and enhanced expression of many cone-
enriched transcription factors (Supplemental Figures 3.11A,B).  However, the reduced 
expression of rod-specific factors that are essential for maintaining rod cell fate, such as Nrl and 
Nr2e3, was rather minor or even absent in the heterozygous E168d2 and R90W mutants, unlike 
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that reported for Rip mice [Roger et al., 2014].  Instead, these results suggest an unexpected role 
for CRX in rods to repress cone-enriched genes, including a number of cone-enriched 
transcription factors. To test whether CRX could play a direct role in repressing these cone-
enriched transcription factors, we examined the CRX ChIP-seq data (Supplemental Figures 
3.11A-C) for evidence to support a direct interaction of CRX with up-regulated cone 
transcription factors in rod cells.  Some up-regulated cone TFs showed low ChIP signal in WT 
retina, suggesting a potential repressive binding in rods, but the pattern was not consistent 
(Supplemental Figure 3.11C).  Thus, loss of repression of cone genes in mutants is likely a 
secondary effect.  In contrast, ~33% of rod genes were bound by CRX, significantly enriched 
over random genes (~8%). Furthermore, when compared with NRL ChIP-seq data, >73% of 
CRX-bound rod genes were also bound by NRL, but no enrichment of NRL binding was 
observed for cone genes (data not shown), consistent with CRX’s interaction with NRL to 
activate the expression of rod genes, but not cone genes. 
To verify that these cone transcripts are being de-repressed in mutant photoreceptors that 
normally would adopt a rod cell fate, we performed immunohistochemistry for several cone 
targets on retinal sections from three E168d2 sublines and WT control mice at P10. The nuclear 
receptor RXRg is preferentially expressed by cones in P10 WT retina, and is up-regulated in most 
Crx mutants by RNA-seq and qRT-PCR [Tran et al., 2014] (Table S1A,B; biological replicate 
RNAseq raw mapped sequencing reads displayed in Supplemental Figures 3.2A,B).  As shown 
in Figures 3.6D1-4, instead of the cone-expression pattern in normal retina (Figure 3.6D1), 
RXRg immunoreactivity was detected in most outer nuclear layer (ONL) cells of the 
homozygous and heterozygous E168d2 mutant retinas (Figures 3.6D2,D3), with a perinuclear 
distribution similar to the pattern reported for rod transcription factors [Roberts et al., 2005].  
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The ONL RXRg staining appeared stronger and more widely spread in E168d2/d2 than 
E168d2/+ retinas.  The enhanced RXRg immunoreactivity was not seen in E168d2neo/+ ONL 
where the rods were not disturbed.  Immunostaining of the second cone marker CNGB3 
displayed similar patterns of enhanced ONL expression in affected mutant rods (Figures 3.6D5-
D8).  We next assessed peanut agglutinin (PNA) binding (Figures 3.6D9-D12), which normally 
stains the cone sheath including cone outer segments and pedicles.  Figure 3.6D shows that, 
despite the lack of cones and rod outer segments in E168d2/d2 retinas, a strong and uniform 
PNA staining was seen across the outer margin of the entire retina (Figure 3.6D6), suggesting 
that mutant rods adopt cone-like characteristics of their sheath. E168d2neo/+ retinas did not 
show enhanced PNA binding at this age (Figure 3.6D12), while E168d2/+ showed an 
intermediate PNA staining that was higher than in WT but much lower than in E168d2/d2 retinas.  
Taken together, all three selected cone markers showed enhanced expression in mutant rods in 
the order E168d2/d2 > E168d2/+ > E168d2neo/+, thus confirming RNA-seq findings of the 
impact of Crx mutations on rod cell fate.  
 In summary, our RNA-seq analyses identified graded expression changes of shared gene 
sets in seven available mouse models for Crx-associated disease.  Using the data presented and 
referenced in this paper [Hsiau et al., 2007; Roger et al., 2014; Tran et al., 2014], these models 
can be ranked as illustrated in Figure 3.7, with the lightest bars representing the model with most 
severely affected rod and cone gene expression. This order correlates with phenotype severity by 
morphological and electrophysiological standards, and with changes in gene expression in rods 
and cones.  This correlation was seen not only for down-regulated rod and cone genes encoding 
phototransduction components, but also for those up- and down-regulated gene sets that 
highlight the partial rod to cone conversion of the developing photoreceptors. The schematic also 
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predicts the level of photoreceptor identity and function in various models.  Most importantly, 
the different gene expression changes between some phenotypically distinct Crx mutant models 
(such as E168d2/+ vs. E168d2neo/+) were rather modest, in contrast to their substantial impact 
on the disease phenotype.      
3.4.7 Testing the effect of gene expression changes on light dependent 
degeneration 
- E168d2neo/+ but not E168d2/+ mice are sensitive to light damage 
 To validate the phenotypic significance of the small differences in gene expression 
between E168d2/+ and E168d2neo/+ mice (Figure 3.4C), we analyzed expression of genes 
involved in the photoreceptor retinoid (visual) cycle that is responsible for the recycling of visual 
pigment chromophore 11-cis-retinal by RNA-seq (Figures 3.8a and Supplemental Figure 
3.2A,B) and qRT-PCR (Table S1C). This discrete set of visual cycle genes expressed in 
photoreceptors also showed a similar pattern of expression changes across the mutant lines 
(Figure 3.8A): R90W/+ showed little or no changes relative to WT, while E168d2/+ and 
E168d2neo/+ showed reduction in gene expression levels.  We validated the expression patterns 
of three visual cycle genes: Rbp3, Rdh12 and Abca4 by qRT-PCR and results were consistent 
with RNA-seq findings (Table S1C).  We hypothesized that, as a result of these changes 
combined with slight shifts in expression levels of phototransduction genes (Figure 3.4B), the 
two E168d2 sublines may have different sensitivity to light-induced damage (LD).  Exposing 
mice to high intensity light for an extended period of time puts stress on the retina and can lead 
to photoreceptor degeneration [Noell et al., 1966].  LD-related degeneration depends on three 
interconnected pathways (Figure 3.8B): 1) the phototransduction pathway, 2) visual cycle in the 
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retinal pigment epithelium (RPE) and 3) visual cycle in photoreceptor cells.  Most mouse models 
with disruptions to components of phototransduction are insensitive to LD [Grimm et al., 2000], 
while mice with an impaired visual cycle in photoreceptors generally have increased sensitivity 
to LD [A. Maeda et al., 2006, 2007, 2008; T. Maeda et al., 2009; Radu et al., 2003].  To test if 
the transcriptional defects in E168d2/+ and E168d2neo/+ mice alter their sensitivity to LD, we 
exposed 6 week old (wo) WT, E168d2/+ and E168d2neo/+ mice to a high intensity light (12-
13.5 KLUX; ~10-20x brighter than ambient light conditions) for 8 hrs.  Following LD exposure, 
mice were kept in 12 hr ambient light/dark cycle for 7 days before retinal function and 
morphology were assessed. All the mice tested were backcrossed to the C57BL/6J background 
for >10 generations, which is resistant to LD [Wenzel et al., 2001].  As expected, WT mice were 
highly resistant to LD and displayed normal retinal morphology (Figure 3.8D vs. 3.8C, left 
panels), normal ONL thickness as determined by morphometry (Figure 3.8E, left panel), and 
normal retinal function as measured by ERG (Supplemental Figure 3.12A; black dashed lines vs. 
black solid lines) compared to WT controls that were not exposed to LD.  E168d2/+ mice 
exposed to LD did not show differences in retinal morphology (Figure 3.8D vs. 3.8C, middle 
panels) or ONL thickness (Figure 3.8E, middle panel) and showed only minor ERG differences 
compared to normal light exposed E168d2/+ controls (Supplemental Figure 3.12A; red dashed 
lines vs. red solid lines).  In contrast, E168d2neo/+ mice exposed to LD showed shortened outer 
segments and a loss of ONL nuclei, ~3-4 nuclei compared to ~10-12 nuclei in normal light 
E168d2neo/+ mice (Figure 3.8D vs. 3.8C, right panels).  Morphometry revealed significant 
reduction in ONL thickness at the inferior -100 µm and superior 100 µm and 500 µm positions, 
with the thickness at 500 µm being most affected (~58% reduced) (Figure 3.8E, right panel).  
Retinal function was also affected with dark-adapted a-waves, dark-adapted b-waves and light-
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adapted b-waves all showing reduced maximal response amplitudes compared to E168d2neo/+ 
controls kept in normal light (Supplemental Figure 3.12A; blue dashed lines vs. blue solid lines).  
These data suggest that E168d2neo/+ mice are more susceptible to LD than either E168d2/+ or 
WT mice, providing further insight into the distinct pathobiology of E168d2/+ and E168d2neo/+ 
mice. 
- E168d2neo/+ sensitivity to light damage is linked to abnormal visual cycle in 
photoreceptors 
 To determine if the increased sensitivity to LD in E168d2neo/+ mice reflects changes in 
expression of visual cycle genes, mice were pre-treated with 13-cis retinoic acid (13-cis-RA; 
Accutane) before LD exposure.  13-cis-RA interferes with the regeneration of visual 
chromophore (11-cis-retinal) and is a strong antagonist of the RPE-driven phase of the visual 
cycle [Sieving et al., 2001].  Inhibiting the visual cycle at the earliest stage reduces the 
production of toxic retinoid intermediates in the retinoid pathway during LD (Figure 3.8B).  This 
treatment strategy was previously shown to effectively ameliorate retinal degeneration in mouse 
models with impaired visual cycle [T. Maeda et al., 2009; Radu et al., 2003; Sieving et al., 
2001].  Retinas of WT mice pretreated with 13-cis-RA and exposed to LD were morphologically 
indistinguishable from DMSO-injected controls (Figure 3.8F, two left panels).  In contrast, 
retinas of E168d2neo/+ animals pretreated with 13-cis-RA were almost completely protected 
from the rapid degeneration observed in DMSO-injected E168d2neo/+ controls (Figure 3.8F, 
two right panels).  Retinas of 13-cis RA-pretreated E168d2neo/+ mice revealed significant 
improvements in ONL thickness at the superior 500 µm and 1000 µm positions (Figure 3.8G, 
right panel) compared to those DMSO treated.  Retinal function was also better preserved in 13-
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cis-RA pretreated mice.  Amplitudes of dark-adapted ERG a-wave, dark-adapted b-wave and 
light-adapted b-wave were all significantly restored in 13-cis-RA pretreated E168d2neo/+ mice, 
compared to DMSO injected controls (Supplemental Figure 3.12B; green lines vs. blue dashed 
lines). To validate that LD sensitivity is linked to intrinsic defects in the visual (retinoid) 
pathway, we tested rod dark adaptation in WT and E168d2neo/+ mice.  Following >90% 
rhodopsin photobleach, the dark adaptation of E168d2neo/+ mouse rods was substantially 
delayed, as compared to that in WT mice (Supplemental Figure 3.12C, blue line vs. black line).  
Pretreatment of E168d2neo/+ mice with 13-cis-RA strongly delayed rod dark adaptation further 
(Supplemental Figure 3.12C, red line vs. blue line), indicating that 13-cis-RA effectively blocked 
regeneration of visual pigment by the RPE visual cycle.  Together, these data suggest that the 
increased sensitivity of E168d2neo/+ mouse retinas to LD is linked to intrinsic defects in the 
photoreceptor visual cycle.   
 Finally, to determine if the degeneration of photoreceptors in E168d2/+ mice is at all 
affected by ambient light conditions, we reared E168d2/+ mice under either normal 12 hr 
light/dark cycle or in constant darkness.  Retinal morphology of E1682/+ mice raised under 
either light condition was indistinguishable at 3 and 6 months of age (Supplemental Figure 3.13), 
suggesting that photoreceptor degeneration in E168d2/+ mice is independent of light conditions.  
These results illustrate that photoreceptor degeneration in E168d2/+ and E168d2neo/+ mice is 
mediated by discrete light-independent and light-dependent mechanisms, respectively.    
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3.5 Discussion 
3.5.1 Gene expression in animal models for CRX-associated retinopathies 
 Our RNA-seq results for mutant Crx E168d2 and R90W mouse retinas improve and 
expand upon previously published genomic expression microarray studies and qRT-PCR on 
these mouse lines [Tran et al., 2014].  The increased sensitivity of this platform allowed for the 
detection of more differentially expressed genes, especially for genes with low expression level, 
and also for the detailed analysis of the modest expression level differences between 
heterozygous animals. In combination with RNA-seq data from Crx-/- and Rip mice [Roger et 
al., 2014], a comprehensive dataset of retinal gene expression now exists for Crx mutant models 
with a range of phenotypes that reflect human disease.  We have used these datasets to identify 
key changes in gene expression that correlate with disease severity.      
 Our results suggest that even relatively small changes in gene expression level can have a 
profound effect on the delicate balance of cellular pathways critical for photoreceptor function 
and survival, especially phototransduction and the visual cycle.  Our RNA-seq analysis of retinal 
gene expression in mutant Crx mouse models by several methods indicates graded changes in 
photoreceptor gene expression at every level from overall expression patterns down to specific 
cellular pathways.  First, homozygous mice were always more severely affected than their 
heterozygous counterparts (Supplemental Figure 3.3).  Among homozygous and heterozygous 
mice, expression changes from least to most severe consistently followed the pattern: R90W, 
E168d2neo, E168d2.  These patterns were observed for both down-regulated and up-regulated 
genes.  A high degree of overlap existed in the differentially expressed genes among models 
(Figures 3.2, 3.3, and Supplemental Figure 3.6) and few genes displayed opposite expression 
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patterns between models (Figure 3.5).  This suggests that few unique gene targets exist between 
models, and non-overlapping genes largely result from genes with similar trends in expression 
that simply do not pass the significance threshold of the in silico analysis.  Graded changes were 
also observed for genes involved in retinal development; Crx mutants showed impairment in 
both the activation and repression of genes that shift expression patterns from P10-P21 
(Supplemental Figure 3.7).  Despite having collected mRNA from the whole retina, we were able 
to determine that the differentially expressed genes mostly occurred in rod and cone 
photoreceptors by using known patterns of cell-type specific retinal gene expression (Figure 
3.4A).  This was consistent with CRX’s expression pattern and role in photoreceptor maturation.  
Within photoreceptor-specific pathways involved in light response, namely rod and cone 
phototransduction and the visual cycle, all Crx mutant models displayed graded down-regulation 
(Figure 3.4B, Figure 3.8A).  Aside from these pathways, down-regulated genes tended to be rod 
genes, while up-regulated genes tended to be cone genes de-repressed in rods (Figure 3.6, 
Supplemental Figure 3.11).  We investigated genes that did not fall into either category (Table 
S3) but did not find any other major trends beyond this.  Expansion of this analysis by assessing 
expression of all known rod or cone-enriched genes again showed a graded pattern of expression 
changes in these genes (Figures 3.6B,C), including rod and cone-specific transcription factors 
(Supplemental Figures 3.11A,B).  Re-analysis of previously published microarray data [Tran et 
al., 2014] showed the same trends of gene expression changes (data not shown).  Finally, by 
analyzing RNA-seq results from two previously published animal models, Crx-/- and Rip, we 
were similarly able to detect graded expression changes in a common gene set (Figure 3.6).  In 
all, our analyses show graded changes in gene expression at several levels in Crx mutant mice 
for both down-regulated and up-regulated genes.   
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3.5.2 Different modalities for down-regulated and up-regulated gene 
expression 
 While Crx mutant mice showed both down-regulated and up-regulated expression (Table 
3.2), more genes were down-regulated in every mouse model tested.  This is consistent with 
CRX’s established role as a transcriptional activator, though CRX does act as a repressor in 
certain contexts [White et al., 2013]. Utilizing available CRX [Corbo et al., 2010] and NRL 
ChIP-seq [Hao et al., 2012] data sets and epigenetic data sets including DnaseI hypersensitivity 
from the ENCODE project [Vierstra et al., 2014] and active (H3K4me2) and repressive 
(H3K27me3) histone marks [Popova et al., 2012], we identified patterns in the proximal cis-
regulatory elements of differentially expressed genes.  CRX and NRL binding were enriched at 
genes that were down-regulated in Crx mutant models, suggesting these genes are direct targets, 
while genes that were up-regulated were not enriched for CRX or NRL binding, suggesting these 
genes are indirect targets (Figure 3.5).  DNase hypersensitivity data showed that a group of 
strongly down-regulated genes in mutant models shifted from ‘closed’ to ‘open’ chromatin from 
P1 to 8 wk in WT rods, suggesting these genes are normally activated during postnatal retinal 
development (Figure 3.5, Supplemental Figures 3.9D-F).  In contrast, the data described that a 
group of up-regulated genes became more ‘closed’, suggesting these genes are being repressed 
during postnatal development (Figure 3.5B, Supplemental Figures 3.9D-F).  The group of down-
regulated genes also showed an increase in the active histone mark H3K4me2 and a decrease in 
H3K27me3 during postnatal development in WT retina (Figure 3.5B, Supplemental Figures 
3.9G-J), indicative of active chromatin remodeling.  Changes in these histone marks were not 
observed for up-regulated genes, suggesting these genes are not subject to this type of active 
chromatin remodeling.  Together, these results suggest that genes down-regulated in Crx mutant 
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models are direct targets of CRX and NRL that normally are activated during postnatal 
development through chromatin remodeling, while up-regulated genes are indirect targets of 
CRX and NRL that are normally repressed during postnatal development through an unknown 
mechanism.  CRX is known to recruit co-activators with positive chromatin remodeling capacity, 
such as CBP/p300 and the STAGA complex [Palhan et al., 2005; G. Peng & Chen, 2007]. Thus, 
CRX and its interacting co-activators may play an essential role in active chromatin remodeling 
during development for the direct target genes represented by the down-regulated groups in Crx 
mutants.  Future profiling of epigenetic changes in these Crx mutant models will provide 
additional support for this possibility.     
3.5.3 Crx mutations affect rod and cone development and transcriptional 
integrity 
 The graded expression changes in Crx mutant models have profound effects on the 
development of their rods and cones as illustrated by Figure 3.7.  Homozygous Crx-/-, E168d2, 
R90W, Rip and Rip/+ mice do not form physiologically functional photoreceptors, due to a strong 
reduction in both rod and cone phototransduction gene expression.  Other models show 
gradations in both retinal function and phototransduction gene expression.  In all models studied, 
the development and survival of cones are affected earlier and more severely than rods, 
implicating CRX in the terminal differentiation of cones.  Interestingly, in WT rods, CRX and 
NRL appear to mediate both the activation of rod-specific genes and the repression of cone-
specific genes.  The dual reduction in rod-gene expression and de-repression of cone genes in 
Crx mutant rods coincides with rods adapting more cone-like properties including less condensed 
chromatin and shorter outer segments [Roger et al., 2014; Tran et al., 2014].  In Rip/+ mice, this 
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shift was found to coincide with loss of NRL expression by P21, indicating a complete loss of 
rod cellular identity.  The loss of NRL expression does not occur in E168d2/+ mice by this age, 
but de-repression of cone-genes in rods is still observed.  While E168d2 protein does not affect 
the function of NRL in vitro [Tran et al., 2014], its effect on NRL in vivo is uncharacterized.  
Our results provide evidence that even though RIP and E168d2 mutant proteins act through 
different pathological mechanisms, the resulting pathologies arise from scaled changes in similar 
sets of genes.  
3.5.4 Gene expression dictates phenotypic thresholds 
The animal models used in this study have wide-ranging phenotypes that match those 
observed in human patients.  The magnitude of overall gene expression changes correlated with 
phenotype severity in every model tested, but not in a linear manner.  Instead, there are 
thresholds in gene expression that determine phenotypic presentation.  An example of this 
threshold effect is evident in the E168d2/+ and E168d2neo/+ mice.  These mice have drastically 
different phenotypes but have only small differences in gene expression.  As we have previously 
shown, the neomycin cassette retained in E168d2neo/+ mice suppresses an accumulation of the 
mutant transcript by an unknown mechanism [Tran et al., 2014].  qRT-PCR results (Table S1A) 
of the same biological samples used for RNA-seq confirm that the WT allele showed no 
compensation and maintained approximately 50% of its normal expression.  In contrast, the 
results of RNA-seq (Supplemental Figure 3.14) and qRT-PCR (Tables S1A,B), combined with 
previously published Western blots and immunohistochemistry [Tran et al., 2014], all support an 
significant overexpression of mutant Crx mRNA and protein in E168d2/+ mice. This mutant 
allele- specific overexpression was not evident in E168d2neo/+ mutants.  This difference in 
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expression of the dominant negative form of CRX resulted in very small difference in fold 
change of down-regulated genes  (median: -1.8 in E168d2/+ compared to -1.7 in E168d2neo/+ 
mice; Figures 3.3F,G).  Despite this slight difference, E168d2/+ mice had much more severe 
deficits in retinal function and photoreceptor degeneration.  Under normal light conditions, 
E168d2neo/+ mice had little photoreceptor degeneration in early adulthood.  However, 
E168d2neo/+ rods were highly sensitive to light damage while WT and E168d2/+ rods were 
largely resistant (Figure 3.8).  Targeting the visual cycle blocked sensitivity of E168d2neo/+ 
photoreceptors to LD, implicating this pathway in the degeneration phenotype.  In contrast, the 
degeneration of E168d2/+ photoreceptors was independent of light and the visual cycle.  
Sensitivity to LD requires phototransduction and is mediated by the visual cycle, both of which 
are affected in the E168d2 and E168d2neo mouse models.  However, these results suggest that 
the balance in function between these two pathways could be critical for determining sensitivity 
to damaging light.  Our data support the conclusion that phototransduction is too impaired and 
OS structural changes are already too severe in E168d2/+ mice to allow for further light-
mediated degeneration, while E168d2neo/+ photoreceptors largely preserve their structure and 
substantial levels of phototransduction components to reveal visual cycle defects under intense 
light.  These results highlight that even minor tuning differences in photoreceptor gene 
expression have a dramatic effect on the mechanisms of disease pathology.  These findings could 
have significant clinical importance as patients with CRX-associated retinopathies might have 
different responses to environmental factors like damaging light levels, which would affect their 
clinical outcome.  These results also provide clues for potential therapeutic intervention to target 
the visual cycle in patients with late-onset CRX-associated retinopathy.  
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3.5.5 Conclusions 
  Linking genotype to phenotype for CRX retinopathies remains imprecise [45].  Genomic 
assessment of retinal gene expression suggests that the range of phenotypes of Crx mutant mouse 
models are driven by graded changes in photoreceptor gene expression.  Since CRX has such 
wide-ranging function in photoreceptor transcription, mutations that sometimes just slightly alter 
the expression of many genes can have a profound effect on the resultant phenotype.  We relate 
retinal gene expression to phenotypic thresholds in rod and cone photoreceptor development, 
cellular integrity, function and degeneration in several Crx mutant mouse models.   We have 
utilized publicly available genomic datasets to gain insight into cell-type specific expression 
changes and the different modalities for gene down-regulation and up-regulation in these mice.  
We have demonstrated how slight differences in gene expression can alter retinal susceptibility 
to light-dependent degeneration in E168d2/+ and E168d2neo/+ mice. These findings provide 
evidence that CRX-retinopathies stem from graded changes in photoreceptor gene expression, 
which could significantly contribute to phenotypic variability.       
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Table 3.1: Phenotype summary of heterozygous Crx mutant mice 
Mouse  
(1) 
Mutation       
class  
(2) 
CRX 
expression (3) 
Rod Cone 
Disease 
model 
Phenotype 
severity  
(5) Function (4) Degeneration 
Function 
(4) Degeneration 
WT n/a + ++++ Undetectable ++++ Undetectable n/a n/a 
R90W I + ++++ Undetectable ++++ Undetectable CoRD mild 
E168d2neo III + +++ Undetectable ++ ≥1yr CoRD moderate 
E168d2 III ++ ++ 1-6mo + 1mo LCA severe 
Rip IV + - 1-18mo - Undetectable LCA very severe 
(1) Heterozygous mice harboring the indicated Crx mutations [Roger et al., 2014; Tran et al., 2014] are used for phenotype comparisons. "WT": 
C57BL/6J wild-type control;  "n/a": not applicable. 
(2) Classification described by [Tran & Chen, 2014]. 
(3) Grading based on quantitative Western blots [Tran et al., 2014]. Note a 2-fold increase in E168d2 but normal level in others. 
(4) Grading based on reduction of ERG peak amplitudes [Tran et al., 2014]. "-": undetected ERG signals.   
(5) Severity based on combined morphological and functional deficits. "n/a": not applicable 
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Table 3.2: List of RNA-seq experiments and number of genes with altered expression 
Mouse (1) 
Experiments & replicates (2) Down-regulated genes (3) Up-regulated genes (3) 
P10 P21 P10 P21 P10 P21 
WT 3 3 - - - - 
E168d2/d2 3 Not tested 425 - 248 - 
R90W/W 3 Not tested 195 - 70 - 
E168d2/+ 3 3 136 150 61 43 
E168d2neo/+ 3 3 85 83 38 19 
R90W/+ 3 3 20 27 12 27 
(1) All mutant mice were backcrossed to C57BL/6J (WT) control for >10 generations and genotyped for common variants [Tran et al., 2014] . 
(2) Numbers represent biological replicates. Each replicate contains 4 pooled retinas from a pair of male and female 
(3) Numbers represent transcripts significantly altered (FC ≥2, FDR ≤0.05) relative to WT control. "-": not applicable 
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Figure 3.1: Schematic diagram of WT and mutant CRX proteins made by the indicated 
mouse models.  The WT CRX protein shown on the top is 299 amino acids (A.A.) in length and 
contains the indicated DNA-binding and transactivation domains (indicated by bars above 
diagram) and several conserved motifs (marked by solid grey and black boxes). The substitution 
mutation R90W lies within the homeodomain and reduces DNA-binding [Tran et al., 2014].  The 
frameshift mutation E168d2 results in a C-terminus truncated CRX protein that retains DNA-
binding capability but fails to activate transcription, and therefore is antimorphic [Tran et al., 
2014].  The frameshift mutation G255d1 ‘Rip’ results in a non-homologous C-terminal extension 
(dark grey hashed box) creating an antimorphic protein that no longer binds DNA [Roger et al., 
2014]. The phenotypes of heterozygous mice carrying each of these mutations are summarized in 
Table 1.   
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Figure 3.2: RNA-seq analyses describe overlapping sets of affected genes in P10 
homozygous Crx mutant retinas.  (A-B) Gene expression [Log2 Count Per Million (CPM)] in 
the indicated homozygous mutants (y-axes) is compared with the WT control (C57BL/6J, x-axes) 
(A-B).  White highlighting indicates prototypical photoreceptor transcripts. White diagonal lines 
represent +/- 2 Fold Change.  (C-D) Venn diagrams illustrate the numbers of significantly 
affected genes that are shared or are uniquely changed in indicated mutants [fold change (FC) ! 
2, false discovery rate (FDR) " 0.05].  
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Figure 3.3: RNA-seq analyses detect graded changes in gene expression in P10 
heterozygous Crx mutant retinas. (A-C) Gene expression [Log2 CPM] in the indicated 
heterozygotes (y-axes) are compared with the WT control (C57BL/6J, x-axes).  White 
highlighting indicates prototypical photoreceptor transcripts. White diagonal lines represent +/- 2 
Fold Change. (D-E) Venn diagrams illustrate the numbers of significantly affected genes that are 
shared or are uniquely changed in the indicated mutants (FC ! 2, FDR " 0.05). (F-G) Analysis of 
the union of genes affected in heterozygous mutants (FC !2, FDR "0.05) presented as FC 
relative to WT control.  Significance calculated by Wilcoxon Rank-Sum Test with Bonferroni 
correction.  Notched Box Whisker plot describes median and quartiles of data.  
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Figure 3.4: Crx mutant retinas show graded changes in photoreceptor-specific gene 
expression. (A-B) Heatmaps present FC of gene expression in P10 Crx mutants relative to that 
of WT age-matched controls in subsets of genes with highest cell type specificity ratios for the 6 
retinal neurons (A) and photoreceptor-enriched genes involved in phototransduction (B).  (C) 
Changes in gene expression levels [Log2 CPM] are compared for E168d2/+ (x-axis) vs. 
E168d2neo/+ (y-axis). Highlighted genes represent 118 transcripts significantly differently 
expressed between the mutants (FDR !0.05, no FC cut-off; see Supplemental Figure 3.5 and 
Table S4 for designations).  (D-E) Top GO terms of down-regulated (D) and up-regulated (E) 
gene sets in E168d2/+ compared to E168d2neo/+.  
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Figure 3.5: Hierarchical clustering and epigenetic data reveal groups of similarly-regulated 
genes.  (A) Hierarchical clustering analysis of all genes that showed significantly altered 
expression (FC !2, FDR "0.05) in at least one mutant genotype relative to age-matched WT 
expression.  Expression levels in the indicated genotypes at the indicated ages are indicated by 
the blue-red heatmap.  Eight groups of genes (indicated by the bars on the right) are clearly 
defined by the results (see Table S4 for designations).  (B) Heatmaps showing the epigenetic 
landscape near the transcription start site (TSS) of genes in groups 1, 2, 3, and 6.  Each row 
represents +/- 1kb from the TSS (at center of panel) of individual genes contained within the 
groups as noted on the left; rows are ordered within each group by decreasing Dnase I 
hypersensitivity (DHS) at the TSS in the 8wk dataset. Columns 1 and 2: CRX binding 
determined by ChIP-seq in adult WT and Nrl-/- retinas, respectively; Column 3: NRL ChIP-seq 
in adult WT retinas; Columns 4-6: DHS of WT retinas at 3 indicated ages, Columns 7-8: 
H3K4me2 ChIP-seq in WT retinas at P1 and P15, Columns 9-10: H3K27me3 ChIP-seq in WT 
retinas at P1 and P15. Quantification is presented in Supplemental Figure 3.9.  
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Figure 3.6: Crx mutants lose rod gene expression but up-regulate many phototransduction-
unrelated cone gene transcripts.  (A) Classification of genes within groups 1, 2, 3, and 6 as 
rod-enriched (dark grey), cone-enriched (light grey), or not specific to a particular cell type 
(N.S., white) in the normal adult retina.  Rod and cone-enriched genes are defined based on the 
comparison of published P21 WT to NRL-/- RNA-seq data [Roger et al., 2014].  (Rod: FC !2, 
FDR !0.05; Cone: FC "2, FDR !0.05; Fishers Exact Test, * p<0.05, ***p<0.0005). (B-C) 
Heatmaps depict hierarchical clustering of FC relative to WT for all rod-enriched (B) and cone-
enriched (C) genes.  Expression data from a published RNA-seq study describing the Crx Rip/+, 
Rip/Rip, and Crx-/- mice are also separately presented in the order determined by the 
aforementioned clustering. Regions noted in (B) and (C) with asterisks are presented in larger 
format in Supplemental Figure 3.10 and represent many down-regulated genes involved in 
phototransduction in rods and cones. (D) Immunohistochemical staining for RXR!, CNGB3, and 
PNA in P10 WT and 3 CRX mutant retina sections. Scale bar: 100µm.  
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Figure 3.7: Model of how Crx mutation-caused gene expression changes affect rod and cone 
development.  Left panel describes the formation of cones in a subset of the Crx mutants and 
variable levels of those cells’ expression of phototransduction genes.  Right panel shows how 
development of rods in all models is related to their gene expression changes.  It also emphasizes 
the novel findings that Crx mutant rods display a graded phenotype of both the decreased 
expression of proper rod genes, and the mis-expression of cone genes.  
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Figure 3.8: Light-dependent photoreceptor degeneration in E168d2neo/+ mice. (A) Heatmap 
presents P21 Crx mutants FC relative to WT for genes involved in photoreceptor visual cycle.  
(B) Model for the RPE visual cycle: visual chromophore [11-cis-retinal (RAL)] is generated in 
the retinal pigmented epithelium (RPE) and delivered to the photoreceptor; stimulation of 11-cis 
RAL bound to an opsin protein activates the phototransduction cascade leading to photoreceptor 
membrane hyperpolarization; this process isomerizes 11-cis RAL into all-trans RAL, which is 
then recycled back into 11-cis-RAL through a series of enzymatic steps, known as the visual 
cycle, in the photoreceptor and RPE.  The drug 13-cis retinoic acid (13-cis-RA) blocks the 
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synthesis of 11-cis-RAL, effectively reducing the burden on the retinoid cycle.  (C-D) Retinal 
morphology of 6 wo mice with indicated genotypes under normal light conditions: (C) (12 hr 
room light-dark cycle) or (D) light damage (LD) treatments  [8 hr 11.5-13.5 kilolux (KLUX) 
bright light followed by 7 days of normal light-dark cycles]. Retinal morphology was assessed 
by hematoxylin and eosin (H&E) staining of sagittal retinal sections through the optic nerve 
(ON). Images were taken in the central superior retina (~500 µm from the ON).  (E) 
Morphometry quantification of ONL thickness for the samples presented in (C-D).  Error bars 
represent Standard error of mean (SE) from ≥3 biological replicates and significance was 
calculated using two-way ANOVA.  Data points that significantly differ from the control (p ≤ 
0.05) are marked by red asterisks.  (F-G) Effect of 13-cis-RA pretreatment on LD in 
E168d2neo/+ mutant mice: Retinal morphology (F) and morphometry (G) at 7 days following 
LD where mice were pretreated with 13-cis-RA or DMSO as control. Note the significant 
improvements of ONL thickness and photoreceptor OS length in the mice treated with 13-cis-
RA.  OS- outer segment, ONL- outer nuclear layer, OPL- outer plexiform layer, INL- inner 
nuclear layer, IPL- inner plexiform layer, GCL- ganglion cell layer.  Scale bar: 50 µm.  
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Supplemental Figure 3.1:  P10 and P21 biological replicates clustered by Principal 
Component Analysis. PCA plot shows expected distribution based on functional and 
morphological phenotypes.  PC1 and PC2 represent greater than 98% of the variance of the data 
in both analyses.  
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Supplemental Figure 3.2:  Browser images display RNAseq read depth of rod and cone 
transcripts. P10 (A) and P21 (B) browser shots of RPM normalized mapped read count for 
selected genes for each biological replicate show reproducibility of sequencing results between 
samples.  
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Supplemental Figure 3.3: Homozygous and heterozygous mutants show largely 
overlapping datasets. Venn diagrams comparing significantly affected transcripts (FC !2. FDR 
"0.05 relative to WT) in the indicated heterozygous and homozygous Crx mutant retinas.  
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Supplemental Figure 3.4: Crx mutants show little change to other non-photoreceptor 
phototransduction components.  Heatmap depicts P10 FC relative to WT for genes involved in 
phototransduction enriched in non-photoreceptor retinal cell types in the heterozygous mutants.  
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Supplemental Figure 3.5:  Biological replicates show consistency in expression changes 
between genotypes. Heat meat showing the Z-scores comparing 3 biological replicates of genes 
determined to be enriched in either E168d2/+ (A) or E168d2neo/+ (B) retinas.  Genes are 
arranged in rows, clustering dendrogram is shown on the left.  Patterns of expression across 
biological replicates are consistent, supporting the statistical significance of the difference 
calculated by EdgeR RNA-seq analysis.   
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Supplemental Figure 3.6: Crx mutants show graded changes in gene expression of 
overlapping gene sets at P21.  (A-C) Log2 CPM from P21 heterozygous E168d2/+ (A), 
E168d2neo/+ (B), and R90W/+ (C) mice (y-axes) are compared to Log2 CPM from age-
matched WT C57Bl/6J (x-axes) mice. White letters highlight prototypical photoreceptor 
transcripts. White diagonal lines represent +/- 2 Fold Change. (D-E) Venn diagrams illustrate the 
numbers of overlapping and distinct significantly affected genes (FC !2, FDR "0.05).  
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Supplemental Figure 3.7: Crx mutants do not abandon developmental program, but many 
genes fail to reach proper expression levels. (A) Heatmap, ordered by the magnitude of 
expression change between P10 and P21 in WT retina, depicts FC compared to P10 WT to 
analyze developmental dynamics.  (B) Top GO terms from analysis of top 100 genes that are 
down- (left panel) and up- (right panel) regulated normally during late postnatal retinal 
development (P21 WT vs. P10 WT; FC ! or "2, FDR !0.05). (C) Violin and boxplots quantifying 
median FC from P10 WT of each mutant.  
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Supplemental Figure 3.8:  Biological replicates show consistent expression changes within 
each genotype. Groups 1, 2, 3, and 6 genes (defined in Figure 5) presented as a heatmap with 
calculated fold-change values for each biological replicate compared to the mean age-appropriate 
WT value. All genes are ordered exactly as presented in Figure 5.  
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Supplemental Figure 3.9: Quantification of normal epigenetic marks near genes in Groups 
1, 2, 3, and 6 distinguishes up- and down-regulated genes in Crx mutants.  Control set of 
equal sized random group of mm9 genes used as background control (grey in all).  (A-C) 
Quantification of CRX ChIP-seq [Corbo et al., 2010] in rod dominant WT retina (A) and cone 
dominant Nrl-/- retina (B), and NRL ChIP-seq [Hao et al., 2012] in WT retina (C).  (D-F) DnaseI 
Hypersensitivity plots from WT retina at the three indicated ages [Vierstra et al., 2014].  (G-H) 
H3K4me2 ChIP-seq of WT retina at the two ages [Popova et al., 2012].  (I-J) H3K27me3 ChIP-
seq of WT retina at the two ages. All represent normalized mean read depth of each library 
centered on TSS of genes within Groups 1, 2, 3, and 6.  (K-N) Analysis of WT expression of 
each gene and average change in expression (blue line) from the age of P2 to P21 (raw data in 
[Roger et al., 2014]), presented as Log2 CPM.  
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Supplemental Figure 3.10: Loss of expression of key components of phototransduction. 
Expanded view of areas marked with asterisk (*) in Figure 6.  All data and presentation exactly 
as described previously.  
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Supplemental Figure 3.11: Changes in rod and cone enriched transcription factors are 
consistent with general patterns of rod and cone genes expression in CRX mutants.  (A-B) 
Heatmap describes FC relative to WT in each Crx mutant for rod (A) and cone (B) enriched 
genes annotated as transcription factors (Raw data [Roger et al., 2014]; WT vs Nrl-/- RNA-seq 
FC ! or "2 & FDR !0.05; GO: 0003700). ChIP-seq data is presented for 4 kb window 
surrounding TSS for each gene for CRX (in rods and cones) and NRL (in rods).  (C) Analysis 
detailing percent of rod enriched, cone enriched, or random set of genes with CRX ChIP-seq 
peak within 2kb of TSS in WT retina. Note the significant enrichment of CRX binding in the rod 
set over cone and random gene sets.  
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Supplemental Figure 3.12: Retinal function is affected by light damage (LD) in 
E168d2neo/+ but not E168d2/+ mutant mice.  (A) Intensity-response plots for dark-adapted 
ERG a-wave, dark-adapted b-wave and light-adapted b-wave from mice with the indicated 
genotypes, with or without LD treatment.  (B) Intensity-response plots for ERG responses 
following LD for mice pretreated with either 13-cis-RA or DMSO.  (C) Rod dark adaptation 
measured by recovery of maximal rod ERG a-wave following >90% rhodopsin photobleach for 
WT and E168d2neo/+ mice, with and without drug treatment. Error bars represent Standard 
error of mean (SE, n!3). “*” marks the data point of significant difference (p "0.05) from the 
control as determined by two-way ANOVA (see Appendix 2 Methods).    
114 
 
Supplemental Figure 3.13: E168d2/+ photoreceptor degeneration is light-independent.  
Retinal morphology of E168d2/+ mice raised under 12 hr light-dark cycle (normal light) or 
constant darkness (dark-reared) for 3  or 6 months.  Note that the dark rearing did not improve 
ONL thinning in the mutant retina.  OS- outer segment, ONL- outer nuclear layer, OPL- outer 
plexiform layer, INL- inner nuclear layer, IPL- inner plexiform layer, GCL- ganglion cell layer.  
Scale bar: 50 µM.  
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Supplemental Figure 3.14: Increased Crx expression in mutant lines at P10. (A) RNA-seq 
derived raw CPM values for each biological replicate (red circles) and mean (black bar).  Top 
panel of spreadsheet lists the EdgeR calculated FC and FDR for each genotype relative to WT 
control. Asterisk denotes samples where FDR < 0.05.  (B) qRT-PCR analysis of transcript levels 
of WT and mutant Crx alleles in each genotype.  Note the same trend of Crx expression changes 
in these mutants detected by both methods.  
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3.6 Supporting Information  
Supporting information including the following is available at: 
https://genomebiology.biomedcentral.com/articles/10.1186/s13059-015-0732-z 
Table S1 
Table S2 
Table S3 
Table S4 
Table S5 
3.7 Data Availability 
Raw RNA seq data and primary analysis are available in Gene Expression Omnibus (GEO) 
under accession GSE65506.   
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Chapter 4 
Meta-analysis of epigenetic remodeling reveals CRX’s 
mechanism of action in retinal development 
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analysis of epigenetic remodeling reveals CRX’s mechanism of action in retinal development.” 
Shiming Chen and I conceived of and planned the experiments, Xiaodong Zhang performed the 
ChIP and I performed all other experiments and analyses. Shiming Chen and I wrote the 
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4.2 Abstract  
Transcription factors (TFs) acting during development often direct chromatin remodeling 
to allow for and promote gene expression. However, our knowledge of TFs is largely limited to 
their regulatory activity in plasmid-based reporter assays. To overcome this limitation, we 
investigated the importance of the photoreceptor TF CRX in remodeling the rod epigenome over 
development. By performing ATAC-seq in WT and Crx-deficient retinas, and analyzing the data 
alongside other genome-wide datasets, we determined that CRX is only required for remodeling 
or sustaining activity of <1/3 of its binding sites. These CRX-Dependent sites are defined by 
developmental epigenetic remodeling and the expression of nearby genes that rely on CRX. 
Collectively, CRX acts as a master TF to execute rod differentiation by exerting distinct and 
overlapping functions in chromatin rearrangement. Our study serves as a model for investigating 
other cell type-specific TFs and highlights the importance of analyzing TF activities at multiple 
levels. 
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4.3 Introduction 
 The retina is the highly specialized portion of the central nervous system responsible for 
initiating and processing visual signals before they are transmitted to the brain. The retina 
consists of six major classes of neurons and one of glia, although numerous subtypes of these 
classes have been described morphologically, functionally, and molecularly.[Baden et al., 2016; 
Macosko et al., 2015; Shekhar et al., 2016; Siegert et al., 2012]  
Rods and cones are two types of photoreceptors responsible for the initial conversion of a 
photon of light into an electrical signal. Mouse retinas are rod dominant; rods constitute 80% of 
the retinal cells while cones comprise only 2%.[Jeon et al., 1998; Macosko et al., 2015] Retinal 
neurogenesis follows a stereotyped developmental program with overlapping waves of birthdates 
of specific cell types.[Young, 1985] In mice, rods are born over a long time window that peaks at 
postnatal day 0 (P0) and continues until P2.[Young, 1985] Postmitotic rod precursors undergo 
differentiation over an extended 2-week period, during which the cells establish a rod-specific 
gene expression profile, develop unique subcellular structures (OS and presynaptic terminals), 
and eventually can perform phototransduction. 
Precisely regulated gene expression is essential for rod structural/functional development 
and survival, as even subtle perturbations can result in blinding diseases.[Lem et al., 1999; 
Ruzycki et al., 2015] Rod gene expression is tightly regulated by a number of transcription 
factors (TFs), acting in a cascade during development. [Reviewed in Swaroop, et al.[Swaroop et 
al., 2010]] The homeodomain (HD) TF OTX2 specifies the photoreceptor lineage by turning on 
the expression of Cone Rod homeobox (CRX) and its downstream TFs. CRX is an OTX-like HD 
TF, whose expression coincides with the final mitotic event in rod and cone photoreceptors and 
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is maintained into adulthood.[S. Chen et al., 1997; Furukawa et al., 1997] CRX binds to the 
promoter of rod/cone genes and activates their expression via its transactivation domain.[S. Chen 
et al., 1997, 2002] Two rod-specific TFs, NRL and NR2E3, act together with CRX to direct rod 
differentiation by activating rod and silencing cone genes.[J. Chen et al., 2005; Mears et al., 
2001; Peng et al., 2005; Swaroop et al., 2010] General TFs involved in chromatin remodeling 
including MEF2D, CBP/P300, and the STAGA complex are also a part of the CRX regulatory 
network.[Andzelm et al., 2015; Hennig et al., 2013; La Spada et al., 2001] Together, these 
factors direct the proper establishment of the rod epigenome and transcriptome.  
CRX is essential for photoreceptor differentiation and functional development. A Crx 
null mutation (Crx-/-) produces a recessive phenotype in the mouse retina where the immature 
photoreceptor cells fail to differentiate and begin to degenerate at ~4 weeks of age.[Furukawa et 
al., 1999] Mutations in human CRX have been associated with dominant blinding retinopathies 
with varying severity and etiology [Reviewed in [Tran & Chen, 2014]]. Interestingly, in the 
corresponding mouse models, distinct Crx mutations all affect the expression of a common set of 
genes, but the degree of dysregulation correlates with phenotype severity.[Ruzycki et al., 2015] 
The mechanism for this misregulation remains to be determined, but a better understanding of 
CRX’s mechanism of action during photoreceptor development would provide insights into the 
pathogenicity of CRX mutations.  
Toward this goal, a number of studies have investigated the activity of CRX using 
plasmid-based assays. Luciferase reporter assays in heterologous systems have been employed to 
map the activation domain, demonstrate the synergy between CRX and NRL, and determine the 
functional effect of CRX mutations.[S. Chen et al., 2002; Roger et al., 2014; Ruzycki et al., 
2017; Tran et al., 2014] Plasmid based systems have been adapted to report the activity of 
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enhancers in vivo using GFP,[Corbo et al., 2010; Hsiau et al., 2007; Montana et al., 2011] but 
these experiments are limited in scope as each construct must be tested individually. Recent 
technological advances have overcome these throughput limitations. Massively Parallel Reporter 
Assays (MPRAs) performed in the retina confirmed that hundreds of CRX bound regulatory 
elements positively regulate transcription, while unbound regions did not.[White et al., 2013] 
Additional experiments suggested that motif affinity directly contributed to this regulatory 
potential.[White et al., 2016] However, a major limitation of all plasmid-based systems is the 
lack of the genomic chromatin context. Studies have shown that sites known not to be bound in 
the genome, when cloned in a plasmid reporter system, are bound by the TF simply based on the 
raw sequence and motif.[Grossman et al., 2017] This suggests that chromatin plays a major role 
in the specificity of TF binding. Additionally, plasmid-based systems only measure steady state 
activity of the complement of TFs, but are unable to report developmental epigenomic regulatory 
potential of key TFs. 
These concepts have been studied separately. Chromatin immunoprecipitation with high-
throughput sequencing (ChIP-seq) for CRX was performed in the adult retina.[Corbo et al., 
2010] Binding sites were enriched for a HD binding motif, and nearby genes represented many 
known photoreceptor specific elements. However, use of this data alone assumes TF binding is a 
binary control. Previous analysis of gene expression shows that many genes that lose expression 
in Crx mutant mice are in close proximity to CRX binding sites.[Tran et al., 2014] However, 
while this result displayed a very significant enrichment, it failed to explain why many more 
genes that are also ‘bound’ by CRX are not affected. 
 Other experiments have sought to understand normal epigenetic development of rods and 
cones.[Aldiri et al., 2017; Hughes et al., 2017; Mo et al., 2016; Yue et al., 2014] Dramatic 
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developmental remodeling was described by ChIP-seq of histones and regulatory proteins and by 
profiling of DNA methylation.[Aldiri et al., 2017] Other studies have profiled DNA accessibility 
through development or compared mature rods vs cones.[Hughes et al., 2017; Mo et al., 2016; 
Yue et al., 2014] These studies matched regulatory sites to CRX ChIP-seq data and predicted co-
factors based on motif enrichment. However, the adult profiling of normal cells limited the 
interpretation to a static prediction and was unable to directly attribute the activation of any site 
to a particular factor. 
To bridge this gap in the understanding of TF binding vs regulatory potential, here we use 
ATAC-seq to show that CRX is only responsible for the epigenomic rearrangement of a subset 
of its binding sites. These ‘Dependent’ sites reside within a variety of chromatin environments 
and are highly correlated with the genes affected in mutant retinas. By applying this technique, 
we clarify the role of this important TF in retinal development and disease and provide a model 
for future studies of other TFs essential in the development of other cell types.  
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4.4 Results 
4.4.1 CRX binds ATAC sensitive regulatory sites 
 To determine active regulatory regions in the genome of mouse rod photoreceptors, we 
performed whole retina ATAC-seq,[Buenrostro et al., 2015] a technique that profiles open 
chromatin regions. We chose to profile at postnatal day 14 (P14), because all retinal cell types 
are born by this age [Young, 1985] and photoreceptor specification is completed. Replicate 
experiments on whole retina of C57BL/6J (WT) mice, where rods comprise ~80% of the 
cells,[Jeon et al., 1998; Macosko et al., 2015] were consistent with available DNase1 data 
profiling of adult (8wk) whole retina (Figure 4.1a), where areas enriched for ATAC data also 
showed enrichment of signal by ENCODE DNase1 hypersensitivity datasets.[Yue et al., 2014] 
 We overlapped these regulatory sites (ATAC-seq peaks) with those sites bound by CRX 
(detected by ChIP-seq).[Corbo et al., 2010] The majority (>98%) of CRX binding sites were 
contained within ATAC-sensitive genomic regions, while many ATAC-sensitive sites showed no 
CRX enrichment (Figure 4.1a, b). This comparison both supports the specificity of the CRX 
ChIP and the unique role of CRX in binding a subset of regulatory sites to control gene 
expression. 
 To understand the role of these CRX binding sites in the regulation of gene expression, 
we first analyzed their distribution around the transcription start site (TSS) of each gene 
expressed in the retina, in the context of that gene’s dysregulation in Crx-/- cells (Figure 4.1c, 
left panel). While all ATAC-sensitive regulatory sites showed a strong preference to be located 
near the TSS, there was no preference for genes that were determined to be up- or down-
regulated in the Crx-/- retina (top or bottom of plot as genes ordered by fold-change in WT/Crx-/-
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; Figure 4.1c, right panel). We also plotted in the same manner the subset of ATAC regions 
bound by CRX (Figure 4.1d). While these sites showed a similar distribution near the TSS of 
expressed genes, they displayed a preference for genes that lose expression in the Crx-/- retina. 
However, to our surprise, many CRX bound sites were near genes that had no transcriptional 
changes. This data suggested that while CRX is a strong transcriptional activator,[S. Chen et al., 
1997] not every binding site has the same regulatory potential or dependency upon CRX activity. 
4.4.2 Crx-/- retinas have an altered photoreceptor epigenome 
 To determine the functional implications of the loss CRX on the epigenome of 
photoreceptors, we also performed duplicate ATAC-seq experiments on P14 Crx-/- retinas and 
compared the results to those of WT retinas. Again, Crx-/- replicates were highly consistent with 
one another (Figure 4.1a). Although many of the ATAC peaks qualitatively resembled WT 
signal, some (e.g. those spanning Gnat1) appeared much weaker in Crx-/- than WT (Figure 4.1a). 
Since no photoreceptor degeneration or cell death is detected in Crx-/- at this age,[Furukawa et 
al., 1999; Tran et al., 2014] differential ATAC signals between the two mouse lines are 
indicative of changes in the photoreceptor epigenome. Indeed, by quantitative comparison of WT 
and Crx-/- datasets, Crx-/- retinas display a widely disturbed epigenome with both increased 
(“up”) or decreased (“down”) activity at potential regulatory sites (Figure 4.2a). Roughly 25% of 
ATAC peaks were altered, with virtually equivalent proportions “up” as those that were “down” 
(Figure 4.2b).   
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4.4.3 Crx-/- photoreceptors fail to close and open developmentally-modulated 
regulatory sites 
 Previous DNase1 hypersensitivity data analyzed three stages of retinal development: P1, 
P7 and Adult.[Yue et al., 2014] We can generalize these samples based on the over-
representation of rods in the mouse retina to represent early progenitor, immature, and mature 
rod photoreceptors, respectively. At a gross level, comparison to these datasets delineated 
distinct patterns at our classified genomic sites (Figure 4.2c-e). Sites that were not changed 
between WT and Crx-/- were generally open at all three stages (Figure 4.2d). However, sites that 
are affected display contrasting dynamics over the course of development: The set that loses 
activity in the Crx-/- retina normally would be activated, while the set that gains activity in the 
mutant retina would be closed over normal development (Figure 4.2c vs 2e). 
 These sites also show differential tissue specificity. When compared to other DNase1 
data, unaffected sites are also generally active in the brain and liver (Figure 4.2d). Again, 
affected sites show contrasting patterns, where those lost in Crx-/- retinas are largely retina 
specific (Figure 4.2e) while those that gain accessibility in mutant retinas are also very active in 
the brain (Figure 4.2c). This data suggests that Crx-/- retinas maintain a majority of their basic 
epigenetic state that would be similar in all cell types. However, they fail to turn on a highly 
photoreceptor specific set of sites and to inactivate many sites that are used generally in 
unspecified neurons. 
We next tested what types of genes were likely regulated by these sites using GREAT 
Gene Ontology (GO) analysis (Supplemental Table 4.1).[McLean et al., 2010] “Down” sites are 
highly enriched for a number of categories of genes involved in “phototransduction,” “detection 
of light,” and microtubule related processes. “Up” sites were enriched for categories that 
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involved general development or differentiation of oligodendrocytes, somatic motor neurons, and 
peripheral nervous system. There was also an enrichment for a single retinal related category 
‘detection of visible light.’ Further investigation discovered the enriched genes to primarily be 
cone related (Cnga, Cngb, and Gnat2, among others), which are present in developing 
“immature” rods or transfated S-cones in the absence of NRL.[Brooks et al., 2011; Mears et al., 
2001] 
4.4.4 CRX binding is strongly enriched at sites that lose activity in Crx-/- 
To understand the primary role of CRX in this dynamic chromatin environment, we 
classified ATAC sites based on the presence of an overlapping CRX ChIP signal (Figure 4.2f, g). 
Nearly half of the ATAC peaks that are reduced in the Crx-/- retina are bound by CRX [CRX 
Dependent] compared to a very small fraction (<1%) of those peaks that show increased signal 
(Figure 4.2f, g and 4.2c vs e). There was also a significant enrichment of CRX binding within 
ATAC sites that were unchanged in the Crx-/- retina [CRX Independent], although to a lesser 
degree than the “down” group, (Figure 4.2d, f, g; Table 4.1). 
 We next sought to determine the relationship between changes in ATAC and local gene 
expression. CRX bound ATAC sites that are decreased in Crx-/- compared to WT show a very 
strong preference for the TSS of genes that lose expression (Supplemental Figure 4.1f vs d). A 
similar trend was also observed for non-CRX bound ATAC sites that lose signal in Crx-/- retina 
(Supplemental Figure 4.1e). Conversely, ATAC sites that are increased in the Crx-/-, nearly all 
of which lack CRX binding, are greatly enriched near genes that increase in expression in the 
Crx-/- retina (Supplemental Figure 4.1a, b). Both CRX bound and unbound sites that are 
unchanged in the mutant retina show no strong association with any changes in gene expression 
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(Supplemental Figure 4.1c, d). Together, these data show the strong correlation between activity 
of local regulatory sites and gene expression, but indicate that only a subset of CRX bound sites 
are affected upon the loss of CRX.  
4.4.5 CRX acts within a variety of chromatin environments 
We decided to explore the differences between these CRX binding sites that were either 
lost [CRX Dependent] or maintained [CRX Independent] in the Crx-/- retina. Previous studies 
have classified TF binding sites into promoter or enhancer classes based on distance from the 
TSS. This approach is much more straightforward, but with new studies showing the breadth of 
local regulatory domains, [Benayoun et al., 2014; Whyte et al., 2013] it likely does not reflect the 
true biology or regulatory role of each site. Instead, we decided to distinguish binding sites based 
on the local epigenetic state. CRX binding sites were located in four distinct chromatin 
environments defined by ChIP-seq of H3K4me3 and H3K27Ac at P14 in WT retinas (Figure 
4.3a, b). Groups A and C represent the largest proportion of the CRX binding sites and are 
located in local regulatory domains and distal enhancers, respectively (Fig 3, Supplemental 
Figure 4.2a). Group D represents CRX sites where neither active histone mark is present, these 
are located similar to distal enhancer Group C, far from annotated genes (Supplemental Figure 
4.2a). Group B includes a very small number of CRX sites that are near genes expressed at a 
much lower level than the three other Groups (Supplemental Figure 4.2a, b). We found a 
relatively equal representation of Dependent and Independent CRX sites within the three main 
groups (Figure 4.3c), although Group A displayed some overrepresentation of Independent sites. 
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4.4.6 CRX is required to activate a subset of local regulatory regions 
 To investigate the differential influence of CRX at local regulatory regions (Figure 4.3; 
Group A), we first analyzed the temporal changes in the activation state as profiled by DNase1. 
CRX Dependent local sites show strong retinal specificity and developmental activation (Figure 
4.4a (left panel), Supplemental Figure 4.3a). This pattern is in stark contrast to Independent sites 
that display strong signal also in brain and liver samples and retinal accessibility at all ages 
(Figure 4.4a (right panel), Supplemental Figure 4.3b). 
 We next sought to understand whether these ATAC signals correspond to changes in 
other epigenetic marks. To understand the epigenetic state of these sites over normal retinal 
development, we analyzed data recently published by Aldiri et al.[Aldiri et al., 2017] By both the 
analysis of individual ChIP datasets (data not shown) and the aggregate of this data in the HMM 
classification of the binding sites (Supplemental Figure 4.4a, b), Independent sites were nearly 
all classified as HMM classes 1-4 at E14.5 while Dependent sites displayed temporal remodeling 
up to P7. 
To determine whether the loss of CRX affected the local histone modifications at 
Dependent sites, we performed ChIP-seq for H3K4me3 in WT and Crx-/- retinas. Peaks 
containing CRX Independent sites largely maintained H3K4me3 presence in mutant retinas, 
while peaks containing CRX Dependent sites display a significant loss of signal in Crx-/- 
(Supplemental Figure 4.3c, d). 
 We sought to determine the effects of these epigenetic changes on gene expression. 
RNAseq data profiling WT development and changes in Crx-/- was consistent with ATAC and 
DNase1 data. Genes near CRX independent sites show very little developmental expression 
changes and are relatively unaffected in mutant retinas. In contrast, those near Dependent sites 
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increase dramatically over development but largely fail to do so in the Crx-/- (Figure 4.4b). Gene 
Ontology (GO) analysis of these genes suggests Dependent genes are largely photoreceptor 
related, while the Independent set is comprised of some genes with photoreceptor function, but 
also genes with more general functions (protein transport, RNA processing, protein localization, 
etc; Supplemental Table 4.1). 
4.4.7 CRX is required to activate a set of distal enhancers 
 CRX also binds sites marked by H3K27Ac (Figure 4.3; Group C), traditionally thought to 
be active distal enhancers. Dependent and Independent sets of enhancers both displayed dynamic 
changes over development and a high degree of retinal specificity (Figure 4.5a and Supplemental 
Figure 4.5a, b). However, by more careful comparison of the temporal dynamics of this 
activation, we observed that Independent sites showed earlier activation than Dependent sites 
(Supplemental Figure 4.5a vs b). We again analyzed other epigenomic data to determine if they 
also would support this subtle temporal difference. HMM classification of the sites was nearly 
identical by P14, but comparison of P0 and P3 data showed differences where Independent sites 
were switching to more active classifications earlier than Dependent (Supplemental Figure 4.4c, 
d).  
 To test whether ATAC signal changes correlated with the mutant epigenome, we 
performed ChIP-seq for H3K27Ac at P14 in WT and Crx-/- retinas. As expected, Dependent sites 
displayed a significant decrease in H3K27Ac deposition in Crx-/- retinas while Independent sites 
largely maintained this mark (Supplemental Figure 4.5c, d). 
Expression of the nearest gene to each enhancer also highlights differences between CRX 
binding sites. Genes near both Dependent and Independent sites increased in expression over 
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development in WT retinas (Figure 4.5b). However, this increase is attenuated for the Dependent 
set, while there was no decrease observed in the Independent set (Figure 4.5b). GO analysis 
showed a very clear distinction where Dependent genes are photoreceptor related, while 
Independent genes have a variety of general functions (Supplemental Table 4.1). 
4.4.8 CRX controls distal regulatory sites in the absence of active histone 
marks 
 A significant number of CRX bound sites were not marked by either H3K4me3 or 
H3K27Ac (Figure 4.3; Group D). When we analyzed the DNase1 and HMM data at these sites, 
the pattern looked similar to Group C enhancers where CRX dependent sites opened later than 
Independent and were more retina specific (Supplemental Figure 4.6a, d, e & Supplemental 
Figure 4.4e, f). One notable difference was that HMM classification highlighted a subset of 
Independent sites classified throughout development as Class 11 [Insulator] (Supplemental 
Figure 4.4e). 
Interestingly, gene expression data highlighted a different scenario than other groups. The 
expression of the nearest gene to CRX Dependent sites displayed no significant differences 
(Supplemental Figure 4.6b). While differences in gene expression were statistically significant in 
the Independent set, the degree of change was very modest. 
4.4.9 Base composition and conservation differentiate CRX sites 
 Our epigenome analyses identified distinct types of CRX sites, but raised the question 
whether there are sequence characteristics ‘coding’ for these differences. As base composition, 
such as CpG density, can determine the general regulatory role of genomic locations, we 
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analyzed nucleotide frequency across CRX regulatory sites (Figure 4.6a). This analysis 
uncovered several very interesting differences. First, Group A Dependent sites show a fairly 
equal nucleotide distribution, especially within the central 200 bp of the CRX bound regulatory 
site. This is in dramatic comparison to the Independent Group A sites that are within highly GC 
rich regions. Group C and D distal regulatory elements did not show any obvious differences 
between Independent or Dependent sites. Both have balanced content within the regulatory site, 
but lie within AT enriched domains. 
 We also analyzed the extent to which the sequences were conserved across vertebrate 
evolution (Figure 4.6b). All groups display a central region that is more conserved than the 
surrounding environment (Figure 4.6b), supporting the importance of the ATAC and CRX ChIP 
specified regulatory sites. Surprisingly, Independent sites of all three classes showed 
significantly higher conservation than their Dependent counterpart. We also noted that Group D 
Dependent sites and surrounding genomic regions were less conserved than Dependent Group A 
or C regions. 
4.4.10 CRX has different affinity for Dependent vs Independent sites 
 We next sought to determine whether the predicted binding affinity of CRX could 
distinguish sites. In Group A proximal regulatory regions, significantly more Dependent than 
Independent sites contained the canonical CRX site (Supplemental Figure 4.7a). This difference 
was reflected in re-analysis of the CRX ChIP-seq, where quantification shows a higher read 
depth at Dependent sites (Supplemental Figure 4.7b). Group C and D sites displayed the opposite 
characteristics, where Independent sites were more likely to contain the CRX motif 
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(Supplemental Figure 4.7a), although there was no difference in the intensity of the original ChIP 
data (Supplemental Figure 4.7c, d). 
 We also predicted CRX occupancy using an algorithm that takes into account the relative 
ratio of protein to DNA.[White et al., 2016; Zhao et al., 2009] At both low and high ratios (µ 
values), Group A Dependent sites displayed higher binding occupancy than Independent sites 
(Figure 4.6c, d). However, when Groups C and D were analyzed at a low protein:DNA ratio 
(µ=0.5), Independent sites have a significantly higher occupancy score, consistent with the 
traditional motif search data (Figure 4.6c). When analyzed at a high protein:DNA ratio, this 
relationship inverted and Dependent sites instead showed higher predicted occupancy (Figure 
4.6d). This suggests that Dependent distal regulatory sites have more low affinity CRX binding 
sites that could additively contribute to CRX recruitment and perhaps inform functional 
differences. 
4.4.11 Other TFs may compensate or be more influential at Independent 
sites 
 We also wondered whether binding sites for other TFs could differentiate CRX 
Dependent vs Independent sites. We analyzed +100bp from the center of each CRX peak for 
enrichment of sequences de novo (Table S2) and motifs included in the JASPAR database 
(Supplemental Figure 4.8a). Both methods reported the highest enriched motif in all Groups to 
be a canonical homeobox (Supplemental Figure 4.8a marked by *, Supplemental Table 4.2). 
 The most striking difference we noted by both methods was a unique enrichment of many 
TF motifs in Group A Independent sites. Known TFs included KLF4, ELK1/4, E2F1, and NFYa 
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(Supplemental Figure 4.8a, marked by **) while de novo motifs included promoter elements 
(GC-box), NFY, NRF1, BHLH among others (Supplemental Table 4.2). 
 The other five sets shared enrichment of many known factors including GATA, LHX, 
and NKX family motifs (Supplemental Figure 4.8a), although there were also notable 
differences. Both methods suggested an enrichment of CTCF specifically in Group D 
Independent sites (Supplemental Figure 4.8a, marked by ***; Supplemental Table 4.2), and 
known motif analysis suggested that ESRRB and FOXC1 are enriched only in Dependent sites 
(Supplemental Figure 4.8a, marked by ****). De novo methods also indicated strong unique 
enrichment of NEUROD1, MEF2D, and MEIS1 motifs in Group C Independent sites 
(Supplemental Table 4.2). 
 To confirm and explore the relevance of the motif analysis, we chose to focus on the 
enrichment of MEF2D and CTCF sites. The CTCF motif was enriched only in Group D 
Independent sites by both methods. As previously discussed, this set contains many sites with 
Insulator function (Supplemental Figure 4.4e, HMM Class 11 purple). We reanalyzed CTCF 
ChIP-seq data and confirmed that CTCF is enriched at Group D Independent sites throughout 
development, and this binding was reasonably specific with minimal enrichment at Independent 
Group A sites but none at any Dependent sites (Supplemental Figure 4.8c, d).  
 We also explored the enrichment of the MEF2D motif in Group C Independent sites 
(Supplemental Table 4.2). Analysis of previously published ChIP-seq data[Andzelm et al., 2015] 
showed that MEF2D binds both Dependent and Independent enhancers in WT retina, but this 
signal is dramatically reduced only at Dependent sites in the Crx-/- retina (Supplemental Figure 
4.8b). Together, these data support the relevance and interpretation of the motif enrichment 
analyses.  
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4.5 Discussion 
 By comparing the genome-wide changes of activity in WT vs Crx-/- retinas, we have 
determined that the loss of CRX causes significant changes in activity at ~25% of all regulatory 
sites. Even though CRX is an activating TF, sites that increase were as prevalent as those that 
lose activity (Figure 4.2). By analyzing these sites alongside time course DNase1 
hypersensitivity data, we have confirmed previously hypothesized mechanisms of CRX-
associated disease, that the rod photoreceptors are stuck in a pre-developmental state; sites that 
were supposed to close remain active, and sites that were supposed to progressively open did not 
do so (Figure 4.2e-g). This model of CRX disease explains previous findings that Crx mutants 
over express ‘cone’ related transcripts.[Ruzycki et al., 2015] Together with this data, recent 
reports that suggest a more common developmental path of rods and cones than previously 
recognized[Kim et al., 2016] support the model that Crx mutant retinas resemble a premature 
state prior to the dramatic epigenetic switch toward rod photoreceptor identity. 
 Many of the peaks that lose activity are normally bound by CRX itself, consistent with 
these sites being Dependent on its activity. CRX showed virtually no binding at peaks with 
increased activity, but surprisingly did bind many peaks that were unchanged, or Independent 
(Figure 4.2c, d). These CRX Dependent and Independent sites were located throughout the 
genome. Our method that incorporated other aspects of the local epigenetic neighborhood, 
including two active histones, clearly establishes distinct types of CRX binding sites beyond 
simply TSS proximal and TSS distal. We propose this classification system is more informative 
and biologically relevant to the function of individual TFs. 
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CRX is activated in early born photoreceptors and maintains expression in mature cells. 
Both developmental DNase1 and HMM classifications showed that all CRX Dependent sites 
normally undergo dramatic activation over retinal development. By ChIP-seq, we showed that 
H3K4me3 and H3K27Ac marks were lost at Group A and C Dependent sites respectively, and 
by RNAseq that nearby genes were not properly activated over development in Crx-/- retina. 
Together, this suggests that CRX is involved in this activation likely through its direct binding 
and recruitment of other general TFs and co-regulators. Previous work has already shown clear 
roles of such co-factors including CBP/P300, Ataxin7-STAGA, and DNMT1 among others in 
retinal development.[Hennig et al., 2013; Nasonkin et al., 2013; Palhan et al., 2005; La Spada et 
al., 2001] 
Independent sites showed two very different patterns when data was analyzed (Figure 
4.7). Group A (TSS proximal) Independent sites were open constitutively. These regions showed 
no evidence of developmental remodeling, and were also active in other tissues. This suggests 
that these sites are generally used regulatory elements, and GO analysis of the nearby genes 
supports this interpretation as these genes were categorized as having very general cellular 
functions. Conversely, Independent Group C and D sites did show temporal activation, but 
quantitative analysis of the DNase1 and HMM data suggests they begin remodeling prior to CRX 
expression and their respective Dependent group sites. The ability of the photoreceptor to 
maintain or continue activating these Independent sites and properly express nearby genes 
suggest that the binding of CRX here is not essential. However, we cannot formally exclude the 
possibility that other homeodomain TFs (such as OTX2) compensate in the Crx-/- retina. 
 We analyzed the affinity of CRX by two distinct methods. Both predict that CRX binds 
more efficiently to Dependent than Independent Group A sites, which was supported by analysis 
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of ChIP-seq data (Supplemental Figure 4.7). We were surprised to find that Dependent distal 
elements (Groups C and D) display less high but more low-quality binding sites. Differences in 
activity relevant to binding affinity have already been predicted for CRX.[White et al., 2016] 
This difference could inform a fundamental mechanism for CRX activity at enhancers, but 
alternative biochemical experiments would be necessary to study binding efficiency, on/off rates, 
and functional effects of these different types of sequences. 
 De novo motif analysis did not reveal any differences in the homeodomain site between 
Dependent and Independent sites. This is not unexpected, as this motif is shared among many 
homeodomain TFs expressed throughout the body, including others expressed in the retina 
(OTX2 in particular). These results together suggest that CRX binding is directed by the 
presence of a strong consensus HD motif, but this association cannot blindly be interpreted as an 
important functional interaction (Figure 4.7). At proximal Independent regulatory sites, CRX 
binding may simply be the byproduct of accessibility of the HD element used either by another 
retinal HD TF, or more important in other cell types. Similarly, at distal Independent elements 
the HD motif may be required only for activation in other neuronal cell types (Group C) or may 
be recognized by another HD factor in the retina itself; only the precise mutation of these 
elements in the genomic context could answer this question. 
 Previous work had noted that CRX bound within many GC rich genomic regions.[Corbo 
et al., 2010] Our analysis discovered that these constitute proximal Independent regulatory sites. 
While GC rich areas are normally thought to represent repressed CpG islands, other reports have 
noted that ubiquitously expressed promoters display high GC content while cell type specific 
promoters are AT rich.[Landolin et al., 2010] We expected that CRX Dependent sites would be 
very highly conserved across species. While it was the case that the regulatory elements were 
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more conserved than flanking sequences, Independent sites were more conserved than 
Dependent counterparts. De novo and known motif analyses discovered that Independent sites, 
especially Group A promoters, were enriched for a variety of TF motifs. Together, these data 
suggest that Independent sites are active in other cell types of the body and are regulated by 
shared or more general TFs. 
 Analysis of Dependent sites did suggest several CRX interacting partners, although 
motifs for known partners NRL and NR2E3 that synergize or bind with CRX [S. Chen et al., 
2002; Peng & Chen, 2005] were not observed. This supports the model that while all three 
factors are necessary for proper gene expression, CRX acts as the primary sequence specific 
targeting factor for the three as a complex. Group C sites in particular displayed enrichment for a 
number of other factors including NKX, ESRRB, and FOXC. These could represent new TFs 
that either act in coordination with CRX to activate these enhancers, or could represent pioneer 
factors that opened the sites to allow for CRX to bind and fully activate. 
Our analyses have emphasized that every TF binding site is not equal. While CRX or any 
other homeodomain TF may bind thousands of sites, only a subset of those sites (for CRX, <1/3) 
require the TF to establish or maintain the local epigenetic state. We propose these elements and 
the homeodomain motifs within Dependent sites are excellent candidates where non-coding 
variants may cause human retinal disease. Our findings are based on an embryonic loss-of-
function study. In this setting, CRX acts as an “acceleratory factor” required for enhancing 
Dependent site activity. However, these experiments do not address if CRX is sufficient for 
achieving the active chromatin state and when CRX’s epigenomic activity is required (plasticity 
of the system). Ectopic expression of CRX in cultured HEK293 and Y79 retinoblastoma cells 
failed to produce a rod-like epigenome, even with co-expression of NRL (Ruzycki and Chen, 
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unpublished results), suggesting CRX is not a “pioneer” factor that can bind to fully closed sites 
to mediate de novo chromatin remodeling for cell fate specification. Instead, CRX appears only 
able to act on those sites that are “primed” for photoreceptor rearrangement in the precursor 
cells. Indeed, even CRX Dependent sites do show some level of ATAC sensitivity, perhaps 
evidence for prior opening by another factor, although we cannot exclude that this is the result of 
compensation. Future studies, such as temporal knockout or ectopic expression of CRX in 
developing or mature photoreceptors are needed to address the sufficiency and plasticity 
questions, important for understanding and treating CRX-linked diseases.  
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Table 4.1: ATAC-seq peaks lost in Crx-/- show enrichment for CRX binding in WT 
 
  
Table	1
Total CRX	bound %
Up 6,259 33 0.5
No	Change 32,105 3,883 12.1
Down 4,586 1,992 43.4
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Figure 4.1: CRX binds a subset of active regulatory sites in the rod photoreceptor. (a) 
Browser track displays ATAC-seq, DNase1 and CRX ChIP-seq read depth. (Scale bar 5kb) (b) 
Venn diagram depicting number of CRX ChIP-seq-defined binding sites that overlap with 
regulatory sites defined by ATAC-seq. (c, d) Meta-gene plots of all genes expressed in P21 WT 
and Crx-/- retinas, ordered by [log2] fold-change (as depicted in plot on left). Black dots 
represent the center of ATAC regulatory site relative to TSS of all ATAC peaks. c and of only 
the subset bound by CRX. (d) Histograms of X and Y axes display density and distribution of the 
data. 
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Figure 4.2: Loss of CRX affects many developmentally activated regulatory sites. (a, b) 
Comparison of WT and Crx-/- ATACseq data shows highly disturbed epigenome in Crx-/- 
retinas where significant numbers of sites display increased (red) or decreased (blue) signal. (c-e) 
Read density heatmaps display reproducibility of ATAC experiments (WT1 & 2 vs Crx-/- 1 & 2), 
overlap of CRX binding signal, and regulatory activity as defined by DNase1 in P1, 1wk, and 
8wk retina, Brain, and Liver samples. (f) Scatterplot displays distribution of the subset of CRX 
bound ATAC sites over the comparison of WT vs Crx-/- data. (g) Proportion of total sites within 
each ATAC class bound by CRX (black) are displayed in pie charts. 
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Figure 4.3: CRX binds within four chromatin environments. (a) Pie chart depicts number of 
CRX binding sites that reside within Groups A-D as defined by overlap with (b) ChIP-seq data 
of H3K4me3 and H3K27Ac datasets in P14 WT retina. (c) Size of circle represents number of 
CRX sites within each group A-‘D,’ and displays distribution relative to ATAC-seq comparison 
between WT and Crx-/-.  
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Figure 4.4: CRX is only required for activity and remodeling of a subset of local regulatory 
sites. (a) Plots display read density of DNase1 experiments centered on CRX binding site of 
Dependent and Independent Group A sites. (b) Analysis of RNAseq of nearest gene to each 
peak, displayed as boxplot of normalized RPKM values at P2 and P21 in WT and P21 in Crx-/-. 
(Wilcoxon Rank Sum Test, Paired; * p < 0.05, ** p < 2.2x10^-5, *** p < 2.2x10^-10, **** p < 
2.2x10^-16) 
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Figure 4.5: CRX activates a subset of distal enhancers over development. (a) Plots display 
read density of DNase1 experiments centered on CRX binding sites of Dependent and 
Independent Group C sites. (b) Analysis of RNAseq of nearest gene to each peak, displayed as 
boxplot of normalized RPKM values at P2 and P21 in WT and P21 in Crx-/-. (Wilcoxon Rank 
Sum Test, Paired; * p < 0.05, ** p < 2.2x10^-5, *** p < 2.2x10^-10, **** p < 2.2x10^-16) 
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Figure 4.6: Sequence analyses differentiate Dependent and Independent CRX sites. (a) 
Nucleotide density and (b) conservation scores display differences between Groups A, C and D, 
and between Dependent and Independent classes of CRX sites in each group. Both are calculated 
in 20bp windows +/- 1kb from center of CRX peak. (Wilcoxon Rank Sum Test, * p < 0.05, ** p 
< 2.2x10^-5, *** p < 2.2x10^-10, **** p < 2.2x10^-16). (c, d) CRX occupancy scores, as 
defined by BEEML algorithm are displayed for two DNA:protein ratios (u values).  
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Figure 4.7: Model of CRX mechanism of action. Model synthesizes new insights into 
difference in CRX activity and mechanism of action at CRX Dependent vs Independent proximal 
and distal regulatory sites. The model describes differences in activity state over time (left), and 
distils motif analysis and base conservation data. 
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Supplemental Figure 4.1: CRX bound ATAC peak signal changes correlate with expression 
changes of nearby genes. (a, c, e - left panel) Meta-gene plots of all genes expressed in P21 WT 
and Crx-/- retinas, ordered by [log2] fold-change (as depicted in plot on left). Black dots 
represent the center of ATAC regulatory site relative to TSS of all ATAC peaks not bound by 
CRX (a, c, e - right panel) and of only the subset bound by CRX (b, d, f). Peaks are divided by 
their changes in ATAC signal- sites increased in Crx-/- relate to WT (a, b), those that are not 
changed (c, d), and those that decrease in Crx-/- (e, f). Histograms of X and Y axes display 
density and distribution of the data.  
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Supplemental Figure 4.2: CRX binds in distinct regulatory environments. (a) Quantification 
of the distribution of peaks within Groups A-D and their distance to the nearest TSS. (b) 
Boxplots represent normalized expression (RPKM) of the nearest gene to each peak within 
Groups A-D. 
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Supplemental Figure 4.3: CRX is required to activate Dependent local regulatory elements 
and to remodel chromatin. Plots display mean and SEM of DNase1 data presented in Figure 
4.4a for Dependent (a) and Independent (b) CRX sites. (c) Scatterplot displays changes in 
H3K4me3 deposition at all peaks (light gray). Black and red denote the subset of H3K4me3 
peaks that contain Independent and Dependent CRX Group A sites. (d) Quantification of the fold 
change of H3K4me3 deposition in WT vs Crx-/-. (Wilcoxon Rank Sum Test; **** p < 2.2x10^-
16) 
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Supplemental Figure 4.4: Dependent and Independent sites show different chromatin state 
dynamics. (a, c, e) Stacked bargraphs represent proportion of Group A-B sites that are contained 
within each HMM defined chromatin state at 8 developmental ages. (b, d, f) Quantification of 
data binned into HMM classes 1-4, 5-7, 8-10, and 11, for Dependent and Independent sites show 
different dynamics of reorganization over development. Legend defines basic classification of 
HMM classes.[Aldiri et al., 2017]  
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Supplemental Figure 4.5: CRX is required to activate Dependent enhancer elements and 
remodel chromatin. Plots display mean and SEM of DNase1 data presented in Fig.5a for 
Dependent (a) and Independent (b) CRX sites. (c) Scatterplot displays changes in H3K27Ac 
deposition at all peaks (light gray). Black and red denote the subset of H3K27Ac peaks that 
contain Independent and Dependent CRX Group C sites. (d) Quantification of the fold change of 
H3K27Ac deposition in WT vs Crx-/-. (Wilcoxon Rank Sum Test; **** p < 2.2x10^-16) 
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Supplemental Figure 4.6: CRX is required to activate Dependent distal regulatory 
elements. (a) Plots display read density of DNase1 experiments centered on CRX binding site of 
Dependent and Independent Group D sites. (b) Analysis of RNAseq of nearest gene to each 
peak, displayed as boxplot of normalized RPKM values at P2 and P21 in WT and P21 in Crx-/-. 
Plots display mean and SEM of DNase1 data above for Dependent (d) and Independent (e) CRX 
sites. (Wilcoxon Rank Sum Test, Paired; * p < 0.05, ** p < 2.2x10^-5, *** p < 2.2x10^-10, **** 
p < 2.2x10^-16) 
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Supplemental Figure 4.7: Sites display different presence of CRX motif and binding. (a) 
Proportion of sites within each of the noted groups that contains the published CRX motif. (b-d) 
Quantification of read depth of CRX ChIP-seq at Dependent (red) and Independent (blue) sites 
within the specified groups. (Fisher’s exact test; *** p = 0.0001, **** p < 0.0001)  
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Supplemental Figure 4.8: TF motifs explain nature of Independent site activation in 
absence of CRX. (a) Heatmap shows unsupervised clustering of [-log10] transformed p-values 
representing the significance of representation of the noted TF motif within the set of sites. (* - 
****) represent TFs referenced in details in the text. (b) Quantification of MEF2D ChIP-seq data 
at Group C enhancer sites displays loss of signal specifically at Dependent sites (red) in the Crx-
/-. Independent sites (blue) show no change in signal. (c) Quantification of CTCF binding over 
time (maximum peak intensity over development) and (d) relative to CRX bindings site at P21 
display consistent signal at Group D Independent sites.  
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Supplemental Table 4.1: GREAT analysis of CRX bound regulatory sites. Each table lists 
the top 10 enriched GO categories for the specified group of sites.  
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Group A Dependent
Rank Motif Best Match/Details P-value log P-pvalue% of Targets% of BackgroundSTD(Bg STD)
1 Crx/MA0467.1/Jaspar(0.914) 1.00E-244 -5.63E+02 66.19% 12.18% 36.2bp (74.4bp)
2 PITX3/MA0714.1/Jaspar(0.769) 1.00E-23 -5.37E+01 6.42% 0.90% 40.1bp (76.7bp)
3
RORgt(NR)/EL4-RORgt.Flag-ChIP-
Seq(GSE56019)/Homer(0.895) 1.00E-18 -4.31E+01 9.56% 2.59% 50.5bp (62.3bp)
4 PH0130.1_Otx2/Jaspar(0.609) 1.00E-16 -3.78E+01 1.00% 0.00% 42.3bp (36.2bp)
5 LIN54/MA0619.1/Jaspar(0.761) 1.00E-13 -3.01E+01 6.56% 1.77% 48.6bp (75.1bp)
6 SMAD2::SMAD3::SMAD4/MA0513.1/Jaspar(0.565) 1.00E-12 -2.90E+01 1.28% 0.03% 60.7bp (54.4bp)
7 POU6F2/MA0793.1/Jaspar(0.788) 1.00E-12 -2.81E+01 1.00% 0.01% 40.7bp (12.5bp)
Group A Independent
Rank Motif Best Match/Details P-value log P-pvalue% of Targets% of BackgroundSTD(Bg STD)
1 OTX1/MA0711.1/Jaspar(0.963) 1e-452 -1.04E+03 46.35% 9.95% 36.9bp (75.6bp)
2 POL003.1_GC-box/Jaspar(0.918) 1.00E-152 -3.52E+02 31.89% 11.54% 51.3bp (69.7bp)
3 NFY(CCAAT)/Promoter/Homer(0.911) 1.00E-144 -3.33E+02 25.36% 7.94% 51.4bp (74.1bp)
4 GFY(?)/Promoter/Homer(0.985) 1.00E-118 -2.74E+02 7.25% 0.63% 53.2bp (74.8bp)
5 Crem/MA0609.1/Jaspar(0.733) 1.00E-103 -2.38E+02 65.97% 43.96% 55.0bp (75.5bp)
6
NRF1(NRF)/MCF7-NRF1-ChIP-
Seq(Unpublished)/Homer(0.989) 1.00E-46 -1.08E+02 9.64% 3.22% 55.7bp (71.1bp)
7
RORgt(NR)/EL4-RORgt.Flag-ChIP-
Seq(GSE56019)/Homer(0.927) 1.00E-32 -7.51E+01 3.31% 0.59% 48.0bp (60.8bp)
8 BHLHE41/MA0636.1/Jaspar(0.901) 1.00E-28 -6.59E+01 18.73% 10.95% 53.6bp (68.7bp)
9 ZBED1/MA0749.1/Jaspar(0.833) 1.00E-24 -5.69E+01 12.87% 6.89% 53.3bp (75.5bp)
10
Atf1(bZIP)/K562-ATF1-ChIP-
Seq(GSE31477)/Homer(0.959) 1.00E-22 -5.26E+01 6.71% 2.76% 45.9bp (63.9bp)
11 YY1(Zf)/Promoter/Homer(0.849) 1.00E-20 -4.76E+01 3.02% 0.78% 56.4bp (69.0bp)
12
Pbx3(Homeobox)/GM12878-PBX3-ChIP-
Seq(GSE32465)/Homer(0.955) 1.00E-20 -4.71E+01 2.72% 0.65% 51.0bp (58.5bp)
13 STAT3/MA0144.2/Jaspar(0.849) 1.00E-18 -4.37E+01 9.18% 4.77% 53.1bp (65.2bp)
14 FOXI1/MA0042.2/Jaspar(0.684) 1.00E-17 -4.08E+01 5.95% 2.63% 49.3bp (81.6bp)
15 ETV2/MA0762.1/Jaspar(0.671) 1.00E-16 -3.74E+01 5.74% 2.61% 56.8bp (70.0bp)
16
PAX3:FKHR-fusion(Paired,Homeobox)/Rh4-PAX3:FKHR-
ChIP-Seq(GSE19063)/Homer(0.630) 1.00E-16 -3.70E+01 0.42% 0.01% 44.4bp (35.9bp)
17 Atf1/MA0604.1/Jaspar(0.710) 1.00E-15 -3.63E+01 2.81% 0.85% 52.9bp (76.1bp)
18 PB0077.1_Spdef_1/Jaspar(0.664) 1.00E-15 -3.52E+01 2.05% 0.50% 43.6bp (72.5bp)
19 NFY(CCAAT)/Promoter/Homer(0.668) 1.00E-12 -2.83E+01 3.39% 1.37% 61.8bp (63.6bp)
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Group C Dependent
Rank Motif Best Match/Details P-value log P-pvalue% of Targets% of BackgroundSTD(Bg STD)
1 OTX1/MA0711.1/Jaspar(0.928) 1.00E-244 -5.63E+02 68.30% 15.88% 37.0bp (73.4bp)
2 PB0048.1_Nkx3-1_1/Jaspar(0.782) 1.00E-75 -1.73E+02 24.94% 5.38% 42.9bp (72.0bp)
3 PH0045.1_Hoxa1/Jaspar(0.716) 1.00E-31 -7.37E+01 22.48% 8.69% 50.4bp (73.7bp)
4 MEF2B/MA0660.1/Jaspar(0.937) 1.00E-30 -6.99E+01 9.95% 2.03% 42.1bp (74.3bp)
5
E2A(bHLH),near_PU.1/Bcell-PU.1-ChIP-
Seq(GSE21512)/Homer(0.753) 1.00E-19 -4.49E+01 3.93% 0.44% 45.4bp (60.4bp)
6 PH0130.1_Otx2/Jaspar(0.622) 1.00E-19 -4.43E+01 12.29% 4.38% 48.0bp (71.2bp)
7
Smad3(MAD)/NPC-Smad3-ChIP-
Seq(GSE36673)/Homer(0.638) 1.00E-15 -3.67E+01 38.57% 25.42% 56.1bp (66.9bp)
8
RORgt(NR)/EL4-RORgt.Flag-ChIP-
Seq(GSE56019)/Homer(0.961) 1.00E-14 -3.30E+01 2.95% 0.35% 51.7bp (61.9bp)
9 TFCP2/MA0145.3/Jaspar(0.708) 1.00E-13 -3.06E+01 6.27% 1.80% 51.8bp (65.3bp)
Group C Independent
Rank Motif Best Match/Details P-value log P-pvalue% of Targets% of BackgroundSTD(Bg STD)
1 OTX1/MA0711.1/Jaspar(0.944) 1e-437 -1.01E+03 77.17% 14.24% 36.1bp (72.7bp)
2
NeuroD1(bHLH)/Islet-NeuroD1-ChIP-
Seq(GSE30298)/Homer(0.961) 1.00E-37 -8.57E+01 13.66% 3.76% 52.2bp (67.2bp)
3
RORgt(NR)/EL4-RORgt.Flag-ChIP-
Seq(GSE56019)/Homer(0.947) 1.00E-34 -7.93E+01 9.07% 1.82% 45.5bp (64.7bp)
4
Mef2d(MADS)/Retina-Mef2d-ChIP-
Seq(GSE61391)/Homer(0.961) 1.00E-31 -7.32E+01 4.49% 0.38% 45.6bp (64.3bp)
5
MyoG(bHLH)/C2C12-MyoG-ChIP-
Seq(GSE36024)/Homer(0.653) 1.00E-19 -4.52E+01 6.58% 1.67% 40.9bp (73.8bp)
6
Meis1(Homeobox)/MastCells-Meis1-ChIP-
Seq(GSE48085)/Homer(0.894) 1.00E-17 -4.00E+01 19.24% 10.14% 54.1bp (68.3bp)
7
USF1(bHLH)/GM12878-Usf1-ChIP-
Seq(GSE32465)/Homer(0.959) 1.00E-15 -3.65E+01 4.89% 1.16% 52.2bp (63.4bp)
8 RHOXF1/MA0719.1/Jaspar(0.622) 1.00E-14 -3.24E+01 10.57% 4.64% 52.8bp (65.6bp)
9
GATA3(Zf)/iTreg-Gata3-ChIP-
Seq(GSE20898)/Homer(0.699) 1.00E-13 -3.06E+01 2.79% 0.45% 52.7bp (68.7bp)
10 Nr2e3/MA0164.1/Jaspar(0.699) 1.00E-12 -2.88E+01 3.29% 0.68% 44.3bp (65.7bp)
11 PH0040.1_Hmbox1/Jaspar(0.727) 1.00E-12 -2.86E+01 6.98% 2.61% 52.2bp (69.9bp)
12 GMEB2/MA0862.1/Jaspar(0.726) 1.00E-12 -2.85E+01 14.56% 7.81% 55.8bp (67.2bp)
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Group D Dependent
Rank Motif Best Match/Details P-value log P-pvalue% of Targets% of BackgroundSTD(Bg STD)
1 Crx/MA0467.1/Jaspar(0.886) 1.00E-64 -1.49E+02 75.30% 15.58% 37.0bp (76.3bp)
2 Crx/MA0467.1/Jaspar(0.690) 1.00E-18 -4.17E+01 24.10% 4.37% 45.2bp (72.7bp)
3
SCL(bHLH)/HPC7-Scl-ChIP-
Seq(GSE13511)/Homer(0.564) 1.00E-14 -3.33E+01 8.43% 0.37% 35.3bp (71.3bp)
4
Pitx1(Homeobox)/Chicken-Pitx1-ChIP-
Seq(GSE38910)/Homer(0.743) 1.00E-13 -3.12E+01 13.86% 1.74% 42.9bp (73.1bp)
5 ISL2/MA0914.1/Jaspar(0.680) 1.00E-12 -2.97E+01 13.86% 1.88% 57.7bp (74.2bp)
Group D Independent
Rank Motif Best Match/Details P-value log P-pvalue% of Targets% of BackgroundSTD(Bg STD)
1
CRX(Homeobox)/Retina-Crx-ChIP-
Seq(GSE20012)/Homer(0.995) 1.00E-107 -2.48E+02 77.08% 14.85% 38.5bp (77.1bp)
2
CTCF(Zf)/CD4+-CTCF-ChIP-
Seq(Barski_et_al.)/Homer(0.908) 1.00E-32 -7.46E+01 13.44% 0.67% 44.2bp (69.2bp)
3 YY2/MA0748.1/Jaspar(0.646) 1.00E-14 -3.45E+01 4.74% 0.13% 48.8bp (59.8bp)
4 PB0048.1_Nkx3-1_1/Jaspar(0.754) 1.00E-14 -3.23E+01 25.30% 8.82% 51.3bp (70.8bp)
5 E2F8/MA0865.1/Jaspar(0.589) 1.00E-13 -3.08E+01 1.98% 0.00% 41.1bp (0.0bp)
6 PHOX2A/MA0713.1/Jaspar(0.835) 1.00E-12 -2.90E+01 6.32% 0.48% 45.1bp (78.1bp)
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Supplemental Table 4.2: De novo motif analysis identifies sequences enriched in different 
sets of CRX bound regions. Data presented in columns A-C & E-I are generated by HOMER 
(see Appendix 2 methods). Column D represents the scanning of the identified sequence back 
across the 6 classes of CRX sites (+/- 1kb from peak center). The plot in line 1 depicts the layout 
of the plot, and the y axis quantifies ‘motifs per bp.’ 
  
	 163 
4.6 References 
Aldiri, I., Xu, B., Wang, L., Chen, X., Hiler, D., Griffiths, L., Valentine, M., et al. (2017). The Dynamic 
Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis. 
Neuron, 94, 550–568. 
Andzelm, M. M., Cherry, T. J., Harmin, D. A., Boeke, A. C., Lee, C., Hemberg, M., Pawlyk, B., et al. 
(2015). MEF2D drives photoreceptor development through a genome-wide competition for tissue-
specific enhancers. Neuron, 86, 247–263. 
Baden, T., Berens, P., Franke, K., Roman-Roson, M., Bethge, M., & Euler. (2016). The functional 
diversity of mouse retinal ganglion cells. Nature, 529, 345–350. 
Benayoun, B. A., Pollina, E. A., Ucar, D., Mahmoudi, S., Karra, K., Wong, E. D., Devarajan, K., et al. 
(2014). H3K4me3 Breadth Is Linked to Cell Identity and Transcriptional Consistency. Cell, 158, 
673–688. 
Brooks, M. J., Rajasimha, H. K., Roger, J. E., & Swaroop, A. (2011). Next-generation sequencing 
facilitates quantitative analysis of wild-type and Nrl(-/-) retinal transcriptomes. Molecular Vision, 
17, 3034–54. 
Buenrostro, J. D., Wu, B., Chang, H. Y., & Greenleaf, W. J. (2015). ATAC-seq: A method for assaying 
chromatin accessibility genome-wide. Current Protocols In Molecular Biology, 2015, 21.29.1-
21.29.9. 
Chen, J., Rattner, A., & Nathans, J. (2005). The rod photoreceptor-specific nuclear receptor Nr2e3 
represses transcription of multiple cone-specific genes. The Journal Of Neuroscience, 25, 118–29. 
Chen, S., Wang, Q. L., Nie, Z., Sun, H., Lennon, G., Copeland, N. G., Gilbert, D. J., et al. (1997). Crx, a 
novel Otx-like paired-homeodomain protein, binds to and transactivates photoreceptor cell-specific 
genes. Neuron, 19, 1017–30. 
Chen, S., Wang, Q., Xu, S., Liu, I., Li, L. Y., Wang, Y., & Zack, D. J. (2002). Functional analysis of cone 
– rod homeobox ( CRX ) mutations associated with retinal dystrophy. Human Molecular Genetics, 
11, 873–884. 
Corbo, J. C., Lawrence, K. a, Karlstetter, M., Myers, C. a, Abdelaziz, M., Dirkes, W., Weigelt, K., et al. 
(2010). CRX ChIP-seq reveals the cis-regulatory architecture of mouse photoreceptors. Genome 
Research, 20, 1512–25. 
Furukawa, T., Morrow, E. M., & Cepko, C. L. (1997). Crx, a novel otx-like homeobox gene, shows 
photoreceptor-specific expression and regulates photoreceptor differentiation. Cell, 91, 531–41. 
Furukawa, T., Morrow, E. M., Li, T., Davis, F. C., & Cepko, C. L. (1999). Retinopathy and attenuated 
circadian entrainment in Crx-deficient mice. Nature Genetics, 23, 466–70. 
Grossman, S. R., Zhang, X., Wang, L., Engreitz, J., Melnikov, A., Rogov, P., Tewhey, R., et al. (2017). 
Systematic dissection of genomic features determining transcription factor binding and enhancer 
function. Proceedings Of The National Academy Of Sciences Of The United States Of America, 114, 
E1291–E1300. 
Hennig, A. K., Peng, G.-H., & Chen, S. (2013). Transcription Coactivators p300 and CBP Are Necessary 
for Photoreceptor-Specific Chromatin Organization and Gene Expression. PloS One, 8, e69721. 
Hsiau, T. H.-C., Diaconu, C., Myers, C. A., Lee, J., Cepko, C. L., & Corbo, J. C. (2007). The cis-
	 164 
regulatory logic of the mammalian photoreceptor transcriptional network. PloS One, 2, e643. 
Hughes, A. E. O., Enright, J. M., Myers, C. A., Shen, S. Q., & Corbo, J. C. (2017). Cell Type-Specific 
Epigenomic Analysis Reveals a Uniquely Closed Chromatin Architecture in Mouse Rod 
Photoreceptors. Scientific Reports, 7, 43184. 
Jeon, C. J., Strettoi, E., & Masland, R. H. (1998). The major cell populations of the mouse retina. The 
Journal Of Neuroscience, 18, 8936–46. 
Kim, J.-W., Yang, H.-J., Oel, A. P., Brooks, M. J., Jia, L., Plachetzki, D. C., Li, W., et al. (2016). 
Recruitment of Rod Photoreceptors from Short-Wavelength-Sensitive Cones during the Evolution of 
Nocturnal Vision in Mammals. Developmental Cell, 37, 520–532. 
Landolin, J. M., Johnson, D. S., Trinklein, N. D., Landolin, J. M., Johnson, D. S., Trinklein, N. D., 
Aldred, S. F., et al. (2010). Sequence features that drive human promoter function and tissue 
specificity. Genome Research, 20, 890–898. 
Lem, J., Krasnoperova, N. V, Calvert, P. D., Kosaras, B., Cameron, D. a, Nicolò, M., Makino, C. L., et al. 
(1999). Morphological, physiological, and biochemical changes in rhodopsin knockout mice. 
Proceedings Of The National Academy Of Sciences Of The United States Of America, 96, 736–41. 
Macosko, E. Z., Basu, A., Satija, R., Nemesh, J., Shekhar, K., Goldman, M., Tirosh, I., et al. (2015). 
Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets. Cell, 
161, 1202–1214. 
McLean, C. Y., Bristor, D., Hiller, M., Clarke, S. L., Schaar, B. T., Lowe, C. B., Wenger, A. M., et al. 
(2010). GREAT improves functional interpretation of cis-regulatory regions. Nature Biotechnology, 
28, 495–501. 
Mears, A., Kondo, M., Swain, P. K., Takada, Y., Bush, R. A., Saunders, T. L., Sieving, P. A., et al. 
(2001). Nrl is required for rod photoreceptor development. Nature Genetics, 29, 447–52. 
Mo, A., Luo, C., Davis, F. P., Mukamel, E. A., Henry, G. L., Nery, J. R., Urich, M. A., et al. (2016). 
Epigenomic landscapes of retinal rods and cones. ELife, 5, 1–29. 
Montana, C. L., Lawrence, K. a, Williams, N. L., Tran, N. M., Peng, G.-H., Chen, S., & Corbo, J. C. 
(2011). Transcriptional regulation of neural retina leucine zipper (Nrl), a photoreceptor cell fate 
determinant. The Journal Of Biological Chemistry, 286, 36921–31. 
Nasonkin, I. O., Merbs, S. L., Lazo, K., Oliver, V. F., Brooks, M., Patel, K., Enke, R. A., et al. (2013). 
Conditional knockdown of DNA methyltransferase 1 reveals a key role of retinal pigment 
epithelium integrity in photoreceptor outer segment morphogenesis. Development, 140, 1330–1341. 
Palhan, V. B., Chen, S., Peng, G.-H., Tjernberg, A., Gamper, A. M., Fan, Y., Chait, B. T., et al. (2005). 
Polyglutamine-expanded ataxin-7 inhibits STAGA histone acetyltransferase activity to produce 
retinal degeneration. Proceedings Of The National Academy Of Sciences Of The United States Of 
America, 102, 8472–7. 
Peng, G.-H., Ahmad, O., Ahmad, F., Liu, J., & Chen, S. (2005). The photoreceptor-specific nuclear 
receptor Nr2e3 interacts with Crx and exerts opposing effects on the transcription of rod versus cone 
genes. Human Molecular Genetics, 14, 747–64. 
Peng, G.-H., & Chen, S. (2005). Chromatin immunoprecipitation identifies photoreceptor transcription 
factor targets in mouse models of retinal degeneration: new findings and challenges. Visual 
Neuroscience, 22, 575–86. 
Roger, J. E., Hiriyanna, A., Gotoh, N., Hao, H., Cheng, D. F., Ratnapriya, R., Kautzmann, M. I., et al. 
	 165 
(2014). OTX2 loss causes rod differentiation defect in CRX-associated congenital blindness. The 
Journal Of Clinical Investigation, 124, 631–643. 
Ruzycki, P. A., Linne, C. D., Hennig, A. K., & Chen, S. (2017). CRX-L253X Mutation Produces 
Dominant Photoreceptor Defects in TVRM65 Mice. Investigative Opthalmology & Visual Science, 
58, 4644–4653. 
Ruzycki, P. A., Tran, N. M., Kefalov, V. J., Kolesnikov, A. V., & Chen, S. (2015). Graded gene 
expression changes determine phenotype severity in mouse models of CRX-associated retinopathies. 
Genome Biology, 16, 171. 
Shekhar, K., Lapan, S. W., Whitney, I. E., Tran, N. M., Macosko, E. Z., Kowalczyk, M., Adiconis, X., et 
al. (2016). Comprehensive Classification of Retinal Bipolar Neurons by Single-Cell 
Transcriptomics. Cell, 166, 1308–1323. 
Siegert, S., Cabuy, E., Scherf, B. G., Kohler, H., Panda, S., Le, Y.-Z., Fehling, H. J., et al. (2012). 
Transcriptional code and disease map for adult retinal cell types. Nature Neuroscience, 15, 487–95. 
La Spada, A. R., Fu, Y., Sopher, B. L., Libby, R. T., Wang, X., Li, L. Y., Einum, D. D., et al. (2001). 
Polyglutamine-Expanded Ataxin-7 Antagonizes CRX Funtion and Induces Cone-Rod Dystrophy in 
a Mouse Model of SCA7. Neuron, 31, 913–927. 
Swaroop, A., Kim, D., & Forrest, D. (2010). Transcriptional regulation of photoreceptor development and 
homeostasis in the mammalian retina. Nature Reviews. Neuroscience, 11, 563–576. 
Tran, N. M., & Chen, S. (2014). Mechanisms of blindness: animal models provide insight into distinct 
CRX-associated retinopathies. Developmental Dynamics, 243, 1153–66. 
Tran, N. M., Zhang, A., Zhang, X., Huecker, J. B., Hennig, A. K., & Chen, S. (2014). Mechanistically 
Distinct Mouse Models for CRX-Associated Retinopathy. PLoS Genetics, 10, e1004111. 
White, M. A., Kwasnieski, J. C., Myers, C. A., Shen, S. Q., Corbo, J. C., & Cohen, B. A. (2016). A 
Simple Grammar Defines Activating and Repressing cis-Regulatory Elements in Photoreceptors. 
Cell Reports, 17, 1247–1254. 
White, M. A., Myers, C. A., Corbo, J. C., & Cohen, B. A. (2013). Massively parallel in vivo enhancer 
assay reveals that highly local features determine the cis-regulatory function of ChIP-seq peaks. 
Proceedings Of The National Academy Of Sciences Of The United States Of America, 110, 11952–
11957. 
Whyte, W. A., Orlando, D. A., Hnisz, D., Abraham, B. J., Lin, C. Y., Kagey, M. H., Rahl, P. B., et al. 
(2013). Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity 
Genes. Cell, 153, 307–319. 
Young, R. W. (1985). Cell differentiation in the retina of the mouse. The Anatomical Record, 212, 199–
205. 
Yue, F., Cheng, Y., Breschi, A., Vierstra, J., Wu, W., Ryba, T., Sandstrom, R., et al. (2014). A 
comparative encyclopedia of DNA elements in the mouse genome. Nature, 515, 355–364. 
Zhao, Y., Granas, D., & Stormo, G. D. (2009). Inferring binding energies from selected binding sites. 
PLoS Computational Biology, 5, e1000590. 
 
	 166 
 
 
 
 
Chapter 5 
Organization of the photoreceptor genome 
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5.1 Author Contributions 
This project was conceived of by Shiming Chen and Philip Ruzycki to build upon past 
work by former lab member Guang Hua Peng [Peng & Chen, 2011, 2012] and to address several 
questions in the growing field of genomic organization as we think the rod photoreceptor is a 
useful model system for this purpose. 
I optimized Circularized Chromosome Conformation Capture (4C) and Fluorescence in 
situ hybridization (FISH) protocols for retinal tissue. Irina Solovei, LMU München, 
 was very generous in sharing her protocols for FISH probe generation and tissue preparation. I 
performed all 4C molecular biology, RNA-seq, and qRT-PCR and related data analyses. 
Morphometry and FISH data collection and analyses were performed by myself and Courtney 
Linne. This project is a work in progress, and the contents of the chapter will be submitted for 
publication soon. 
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5.2 Abstract  
Purpose:  The packaging of DNA is a highly regulated and critical process of cellular 
differentiation. Euchromatin and heterochromatin territories must be determined to assure both 
proper gene expression and repression. In mouse rod photoreceptors, this packaging is unique as 
nuclei are inverted; euchromatin occupies only the outer ring of the nucleus while 
heterochromatin is packaged densely into the nuclear core. While studies have generally 
described this packaging in terms of gene-rich vs gene-poor, very little is known about the 
organization at a molecular scale. 
Methods: To interrogate fragments of DNA that interact with Rhodopsin (Rho), the highest 
expressed gene in the cell, we have performed Circularized Chromosome Conformation Capture 
(4C) and confirmed our analysis with DNA Fluorescence in situ Hybridization (FISH). We 
generated a mouse model where Rho has been inactivated and assessed the effects on Rho-
contacting loci using FISH and RNA-seq. 
Results: 4C data suggested a majority of Rho interactions were very local, and restricted to a 
stretch of multiple topologically associated domains (TADs) that are all segregated to the A 
compartment (active territory). Distant trans interactions that were confirmed using FISH were 
also within A compartment DNA and were highly enriched for active chromatin and known 
photoreceptor regulatory elements. Inactivation of the Rho promoter resulted in a loss of distal 
contacts, and an increase in gene expression within the interacting cis TADs. 
Conclusion: This data shows that the rod photoreceptor genome, although very distinct at 
microscopic resolution, is packaged into a very similar A/B compartment structure as other cell 
types. This data also suggests that the active A compartment can be subdivided into distinct 
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units, perhaps based on chromatin state. The inclusion of Rho into this sub compartment was 
dependent upon the activity state of Rho. RNA-seq further suggested that within a compartment, 
machinery is a resource that when otherwise not in use, can affect the expression of other genes.  
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5.3 Introduction 
 At the molecular level, each chromosome is packaged into the nucleus to ensure proper 
expression and repression of genes. Previous work has focused on the role of epigenomic gene 
regulation on the relatively local state of the region surrounding a particular gene. New 
technologies now allow for the interrogation of the compaction of DNA on a local scale 
(promoter-enhancer interactions), and beyond to understand how 2 meters of DNA is folded to 
fit into each nucleus.  
The chromosome is first segregated into discrete topologically associated domains 
(TADs), which serve as ‘genomic neighborhoods’ (~1Mb in size) thought to isolate and ensure 
proper connections of enhancers and promoters.[Reviewed in [Bonev & Cavalli, 2016]] Indeed, 
the disruption of a single TAD boundary has been shown to result in the improper spread of 
repressive or active chromatin while their global depletion results in a gross change in genomic 
organization; both experiments cause changes to gene expression. [Narendra et al., 2015, 2016; 
Rao et al., 2017; Schwarzer et al., 2017] Many of these transcriptional changes were spurious 
novel transcripts from enhancers, thought to result from the lack of a directed connection with its 
proper promoter.[Schwarzer et al., 2017]  
Both studies that depleted TADs genome wide by interfering with the boundary cohesin 
protein found that the loss of TADs resulted in the strengthening of the next level of 
“compartment domain” organization.[Rao et al., 2017; Schwarzer et al., 2017] Each chromosome 
can be subdivided into 5-10Mb alternating fragments that segregate into either the A (active) or 
B (inactive) compartments, synonymous with eu- and hetero- chromatin.[Lieberman-Aiden et al., 
2009] The segregation of a fragment into A or B is surprisingly well conserved across cell types, 
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with only minimal switching of individual segments between compartments associated with cell 
type specific gene expression.[Dixon et al., 2015; Schmitt et al., 2016] Within either 
compartment, there is limited evidence of further sub-compartments (A1/2 & B1/2/3) that are 
loosely defined by the epigenetic state of the contained DNA.[Rao et al., 2014] 
The role of TADs and A/B compartments are still under debate as there is only limited 
direct evidence for the local regulatory potential of a TAD and the mechanism of inclusion of a 
fragment into a particular compartment or sub-compartment has not yet been elucidated. 
However, the fact that interactions defined by epigenetic state can supersede compartment 
domain structure upon the loss of TADs, suggests that these are opposing forces constantly in 
play within the nucleus. Previous studies have been limited in their ability to test the 
inclusion/exclusion of individual loci in A/B compartments, the effect of the exclusion of any 
individual gene, and to this point there is little evidence of further specialization (finer 
organization) within these compartments. 
The rod photoreceptor presents an excellent system in which to test these questions. The 
rod photoreceptor is a highly specialized neuron responsible for the initial conversion of a photon 
of light into an electrical signal. Rods comprise ~80% of the cells in the mouse retina, [Jeon et 
al., 1998; Macosko et al., 2015] making them an accessible system for cell fate, epigenetic, and 
gene expression studies. Rod birth peaks at postnatal day 0 (P0), and the cells are specified by 
P14 and fully differentiated by P21.[Young, 1985] During this prolonged developmental 
window, studies have defined dramatic changes to the rod epigenome, gene expression, and even 
to microscopically visible genomic organization. [Aldiri et al., 2017; Hughes et al., 2017; Kim et 
al., 2016; Mo et al., 2016; Solovei et al., 2009] 
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 Mouse rods have an inverted nuclear architecture that is characteristic of many nocturnal 
mammals,[Solovei et al., 2009] and the result of the lack of Lbr and Lmna expression, normally 
required to tether heterochromatin to the nuclear lamina.[Hughes et al., 2017; Solovei et al., 
2013] This organization is perturbed in many models of photoreceptor disease. Several models 
never assume the proper organization,[Corbo & Cepko, 2005; Hennig et al., 2013; Tran et al., 
2014] while others show misorganization that manifests with disease progression.[Helmlinger et 
al., 2006] It is currently unknown why diseased rods would show clear changes in genomic 
organization, but could be related to the many gene expression changes observed in retinas of 
these mouse models.[Kim et al., 2016; Roger et al., 2014; Ruzycki et al., 2015] 
To function properly, rods pack a modified cilia structure called the outer segment (OS) 
with Rhodopsin, the photopigment essential for capturing light.(Reviewed in [Arshavsky et al., 
2002; Kefalov, 2012]) The rod sheds a portion of this structure every day, and thus must 
maintain an extraordinary high rate of expression of this transcript. (~2% of the total RNA within 
the cell- [Blackshaw et al., 2001]) The Rho locus thus must be highly epigenetically active, as 
evidenced by strong ATAC, histone, and cell type specific transcription factor signals.[Aldiri et 
al., 2017; Corbo et al., 2010; Hao et al., 2012; Mo et al., 2016]  
In this work, we use the mouse photoreceptor to explore several principles of genomic 
organization. We show that Rho is located within the A compartment, and it co-localizes with 
other very epigenetically active areas across the chromosome. We also thoroughly characterize a 
new mouse model where we have inactivated Rho, and determine the effects on its localization 
and on expression of other genes within the A compartment.  
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5.4 Results 
5.4.1 Rho displays strong interactions with local stretch of ‘A’ compartment 
DNA 
 We performed Circularized Chromosome Conformation Capture (4C) on P14 retinas of 
WT and Nrl-/- mice. NRL is a TF essential for rod development and gene expression, that when 
removed (Nrl-/-), the cells instead develop into functionally mature S-cones.[Mears et al., 2001] 
We selected a bait region just upstream of Rho in the middle of a number of known regulatory 
elements and within the larger H3K27Ac marked domain (Figure 5.1a). 4C raw read counts 
showed the expected strong enrichment for fragments of DNA in very close proximity to Rho 
(Supplemental Figure 5.1a). Raw data suggested that compared to Nrl-/-, WT retinas show more 
interaction with an actively marked and CTCF bound enhancer 30kb upstream (marked by **). 
When Rho is inactive in Nrl-/- mice, there was increased interaction with a regulatory site further 
upstream also bound by CTCF as well as a broad relatively inactive region downstream of Rho 
(marked by * and *** respectively). 
We analyzed the 4C data with a novel scoring algorithm that ranks based on the 
consistency of local coverage compared to a background average (see Appendix 2 Methods 
section for more details). This analysis clearly identified a strong region of interacting DNA 
within 1Mb in both libraries that corresponded well with the local TAD boundaries of the closest 
related tissue analyzed by HiC, the mouse cortex (Figure 5.1b).[Dixon et al., 2012] Both libraries 
also displayed significant interactions with a larger local ~5Mb region of Chr6 surrounding Rho 
that extended beyond the boundaries of the local TAD. We wondered whether this larger region 
represented another level of genomic organization. By computing the Pearson Correlation of the 
HiC data, we determined that this extended region identified by our analysis included more than 
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50% of a linear stretch of DNA segregated to the A compartment (termed cis), but the 
interactions abruptly stopped before the flanking B compartment DNA segments (Figure 5.1c-d 
and Supplemental Figure 5.1b). 
Our analysis also noted positive associations between Rho and other fragments of DNA 
beyond these boundaries. These trans interacting fragments were also predominantly located 
within A compartment chromatin (Figure 5.1c and Supplemental Figure 5.1b), but represented 
only a small subset of the rest of A compartment DNA (Figure 5.1e). Together, A Compartment 
DNA represented a significant majority of the DNA identified as interacting with Rho (Figure 
5.1f). 
5.4.2 Distal interactions are dependent on Rho activation 
 To test the effect of local epigenetic state on this genomic organization, we created two 
new mouse lines that lack either ~200bp of the Rho promoter (PPR-/-) or the Rhodopsin 
Enhancer Region (RER-/-) that lies 2kb upstream (Figure 5.2a). As expected, deletion of PPR 
completely abrogated expression of Rho, and largely inactivated the locus as measured by 
ATAC-seq (Figure 5.2). Surprisingly, even though previous data has suggested the RER is a very 
strong enhancer,[Corbo et al., 2010; Nie et al., 1996] its deletion had no effect on local 
epigenetic state or gene expression (Figure 5.2). Morphometric analysis showed that the PPR-/- 
retina displays dramatic shortening of the OS as early as P14, (Supplemental Figure 5.2c) but 
cells do not die until after P21,(Supplemental Figure 5.2e vs h) consistent with the previously 
published Rho-/- that removed exon 2 [Humphries et al., 1997; Toda et al., 1999]. This analysis 
also confirmed that loss of the RER has no effect on photoreceptor morphology (Supplemental 
Figure 5.2). 
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 We chose four sites spanning Chromosome 6 to test and verify our 4C analysis. Regions 
1 and 3 represent positive interactions as determined by 4C that lie 86 and ~9 Mb away 
respectively (Figure 5.3a). Both 4C peaks included a number of genes active in photoreceptors, 
but we chose to generate FISH probes using BACs that spanned the most epigenetically active. 
Site 1 includes a cluster of very highly expressed miRNAs (mir182/183/96) and the lncRNA 
Rncr4, the loss of which cause severe retinal defects [Krol et al., 2015] (Supplemental Figure 
5.3b). Site 3 includes many regulatory elements and active genes, but we chose to focus on Ptms 
which has a very strong enrichment of H3K27Ac (Supplemental Figure 5.3d). Sites 2 and 4 both 
represent control fragments that were not identified by 4C analysis. Site 2 includes the Tcrb 
locus that lies within a distal B compartment stretch of Chromosome 6, and is not near any 
retinal active regulatory sites (Supplemental Figure 5.3c). Finally, site 4 includes the cone 
photoreceptor expressed Pde6h gene. This gene is classified within the A compartment, but is 
inactive in rods (Supplemental Figure 5.3e). 
We performed FISH and measured the distance between pairs of probes in P14 retinal 
sections of a number of mouse models. In WT and RER-/- retinas, the Rho locus is epigenetically 
and functionally normal. These were compared to mutants in which Rho is inactive and not 
expressed including the PPR-/- and models lacking transcription factors important in rod 
differentiation and gene expression (Nrl-/- and Crx-/-). 
FISH results first and foremost confirmed our novel 4C analysis (Figure 5.3b-e). We 
noted strong co-localization between Rho and regions 1 (mir182) and 3 (Ptms), but not with 
regions 2 (Tcrb) and 4 (Pde6h) in WT rods. This pattern was the same when analyzed in the 
phenotypically normal RER-/-, but positive interactions were lost in PPR-/-, Nrl-/- and Crx-/- 
retinas. 
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We wondered whether regions 1 and 3 that showed strong interactions with Rho in WT 
and RER-/- rods would also show interactions independently with each other. Region 1 displayed 
a higher rate of association with region 3 than with inactive region 2, even though 2 is much 
closer on the linear genome. Importantly, this interaction was unaffected in PPR-/- or either TF 
mutant (Figure 5.3f-g). Together, these data support our novel 4C data analysis, and suggest that 
the long-range interactions of Rho are dependent upon its activity or chromatin state, but that 
Rho is not responsible for ‘recruiting’ or establishing the state of other genes. 
5.4.3 Distal interactions enriched for highly active chromatin 
 To better understand the nature of the regions identified as interacting with Rho, we 
analyzed the ChromHMM state within P14 retina.[Aldiri et al., 2017] As expected, the cortex 
defined A Compartment was enriched for active chromatin and facultative heterochromatin. The 
B compartment was specifically enriched for Class 9 (empty) which likely reflects the 
constitutively repressed nature of such DNA (Figure 5.4a). This stark distinction suggests that 
mouse cortex and rod photoreceptors have a very similar compartmental organization even 
though their nuclei are organized very differently at the microscopic scale.  
We also compared the regions defined by 4C data as interacting with Rho. These regions 
showed even stronger enrichment for active HMM states (Figure 5.4a). Further subdivision of 
these interactions as cis or trans displayed a stronger enrichment for highly active promoter and 
enhancer chromatin within trans loci (Supplemental Figure 5.4a). 
 We chose several aspects of this data to explore further. As trans interacting regions 
displayed stronger enrichment for the most active HMM states, we wondered whether a new 
class of very active regions of the genome would be enriched within the interacting sites. These 
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‘Super Enhancers’ (SEs) [Hnisz et al., 2013] were indeed highly enriched within trans contacted 
regions (Figure 5.4b). In fact, Rho, Ptms, and mir182/183/96 are all specifically contained within 
SEs. We also found significant enrichment at both cis and trans interacting regions for binding of 
the photoreceptor master TF CRX and regions termed insulators (CTCF bound), but no 
enrichment for repressed chromatin (Figure 5.4c-e). We wondered whether there was any 
specificity for Dependent or Independent CRX sites (see Chapter 4 of this dissertation). Trans 
interacting fragments showed very significant enrichment for CRX Group A (promoter 
proximal) Dependent and Independent sites, but interestingly only Independent Group C (active 
enhancer) sites (Supplemental Figure 5.3b-e). Together, these comparisons suggest that Rho 
interacts with regions with dense CRX and CTCF binding sites and fragments that are also 
highly epigenetically active. 
 5.4.4 Inactivation of Rho affects expression of other genes 
 As Rho is the most transcriptionally active gene in the rod photoreceptor, we wondered 
what effect its inactivation would have on other genes. RNA-seq data profiling P14 WT and 
PPR-/- retinas showed very similar gene expression between the two models, with few genes 
other than Rho affected more than 2-fold (Figure 5.5a, Rho marked in red). We compared the 
expression of annotated transcripts identified as interacting with Rho with all transcripts on 
Chromosome 6 and found a modest but significant increase in gene expression. We binned the 
genes into those within the cis A Compartment vs trans interactions, and found that this signal 
largely originated from genes within the cis Compartment (Figure 5.5b). While the A 
Compartment as a whole showed no significant difference from the B Compartment (Figure 
5.5c), we further binned this data to the 11 linear segments of the A Compartment (A1-A11). 
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Contacted genes within A2 and A5 showed significant changes from other genes within that 
segment as well as the chromosome on a whole, but the number of genes within each was very 
small (Supplemental Figure 5.5).  
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5.5 Discussion 
5.5.1 General principles of genomic organization 
 By analyzing the organization of the highly active Rho gene within the rod photoreceptor 
nucleus we have uncovered several novel insights into genomic organization. First, although the 
rod nucleus is inverted and microscopically differently from virtually every other cell type in the 
body, it’s genome still organized at the molecular scale into a very similar TAD and A/B 
Compartment structures. This is both surprising and reassuring as even though it varies so 
dramatically, the forces working to maintain these structures are still in play and likely 
important.  
 We have shown through comparison of the interactions of Rho with other active regions 
of the genome in WT and mutant retinas, that this organization depends on the activity of the Rho 
locus. Even though we predict in the PPR-/- retina that CRX and NRL could still bind enhancer 
elements and other nearby regulatory sites, the activity of the locus is necessary for the co-
localization. We showed the clear loss of this activity by ATAC-seq, but future ChIP 
experiments for H3K27Ac would be necessary to prove that the broad ‘Super Enhancer’ domain 
is in fact disrupted. 
 The discovery that the loss of the RER had no effect on Rho expression was very 
surprising. This enhancer has been studied extensively previously and it has proven to be very 
active at increasing transcription both in vitro and in vivo.[Corbo et al., 2010; Nie et al., 1996] 
However, as browser shots display, (Supplemental Figure 5.1 and Figure 5.1) there are many 
other regulatory elements that may compensate. Future work will be necessary to test the role of 
these elements individually and in combination (see preliminary results in Appendix 1). 
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5.5.2 Rho interacts with other active regions of its chromosome 
 By analyzing the nature of the regions of Chr6 identified as interacting with Rho in trans, 
we determined that Rho is in contact with regions of DNA that are also very active.  As depicted 
in the model (Figure 5.6a), these regions are highly enriched for Super Enhancers, CTCF binding 
sites, and regulatory elements bound by photoreceptor master TF CRX. This analysis of the 4C 
data used a relatively broad window to score, further analyses comparing smaller windows to 
determine if more discrete signals are more relevant or selective for these important genomic 
regulatory elements. 
5.5.3 Promoters do not act independently 
 Finally, by comparing the transcriptome of the PPR-/- mutant with WT litter mate 
controls, we have determined that the loss of such a strong promoter as that of Rho can affect the 
expression of other genes. These effects were extremely modest, but the significant increase in 
expression of genes within the local A compartment suggests that the machinery that would have 
been active at the Rho promoter was instead available to be used at other promoters in proximity 
to Rho (Figure 5.6b). This finding is not surprising, as past experiments have previously shown 
the association of certain active genes with nuclear speckles.[Brown et al., 2008; Khanna et al., 
2014; Lamond & Spector, 2003]  
Together, our data supports the model put forward in Figure 5.6 where genes, like Rho, 
are within physical proximity with other regions of the chromosome that are most similar 
epigenetically. Especially on a local scale, the activity of a promoter is actually in constant 
balance with every other promoter. When a strong promoter such as Rho is removed, the 
machinery can be mis-used by others. Future work will be necessary to test this in other cell 
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types that display such strong expression of individual genes and to determine any functional 
consequences of these small changes to gene expression.  
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Figure 5.1: Rho displays strong interactions with local DNA in both WT and Nrl-/- retinas 
(a) Browser tracks display relevant epigenetic marks in the P14 WT retina and the fragment of 
DNA used at the 4C bait (red). Raw (gray) and analyzed (blue and purple) 4C data display strong 
association of Rho with local TAD structure as defined in cortex (bracketed in matrix in black) 
(b), and with larger A compartment DNA when data is analyzed as Pearson Correlation matrix 
(c) (area enlarged in Supplemental Figure 5.1b highlighted in orange). Proportion of cis (d) and 
trans (e) linear segments of A Compartment that are identified as interacting with Rho. (f) 
Proportion of interacting regions within A compartment compared to permutation of fragments 
(see Appendix 2 Methods) (**** p<0.0001; Fisher’s Exact Test). 
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Figure 5.2: Disruption of the Rho promoter affects local epigenetic landscape 
(a) ATAC-seq of P14 retinas displays epigenetic accessibility changes in mutants. Red marks 
deleted sequences in the RER-/- and PPR-/- strains. (b) ddPCR analysis of Rho expression (Actb 
as stable reference) in P14 retinas. (**** p<0.0001; ANOVA with Tukey’s multiple comparison 
test) 
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Figure 5.3: FISH confirms Rho interactions with distal fragments of its chromosome 
(a) Browser track displays raw and scored 4C data from WT and Nrl-/- retinas for all of 
Chromosome 6. A/B Compartments are labelled by analysis of cortex HiC data (blue and yellow 
respectively). Regions selected for further analysis are marked ‘1-4’ above track. (b-g) Analysis 
of FISH data quantified as the proportion of probe-pairs co-localized (centers of mass within 
0.5um). Representative images of WT (b’-g’) and PPR-/- (b’’-g’’) are displayed below 
associated data. (mean + SEM, **p<0.01, **** p<0.001, **** p<0.0001; ANOVA with Tukey’s 
multiple comparison test) 
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Figure 5.4: Rho trans interactions are enriched at active segments of the genome 
(a) Heatmap displays relative enrichment of P14 retina ChromHMM state [Aldiri et al., 2017] in 
all of Chromosome 6 compared to Compartments A/B and those regions identified by 4C as 
interacting with Rho. (b-e) Bargraphs show quantification of the proportion of Super Enhancers, 
CRX binding sites, CTCF binding sites (ChromHMM state 11), and repressed chromatin 
(ChromHMM state 10) covered by cis and trans 4C positive regions. Expected values represent 
permutation of the marks within that cis or trans genomic region (see Appendix 2 Methods). 
(*p<0.05, *** p<0.001, **** p<0.0001; Fisher’s Exact Test) 
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Figure 5.5: Loss of Rho expression affects other genes that interact with Rho 
(a) Scatterplot displays very consistent expression of all genes except Rho (highlighted in red) in 
WT and PPR-/- retinas at P14 as measured by RNA-seq. Red lines denote 2-fold change. 
Analysis of fold-change of genes (PPR-/- vs WT) that interact with Rho by 4C (b) and all genes 
within Chromosome 6 A and B Compartments (c). (Wilcoxon Rank Sum test) 
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Figure 5.6: Model of Rho genomic interactions and effects of loss 
Model describes local interactions of Rho in WT retina that are lost when Rho is inactivated and 
the competition between these genes for transcription and activity associated proteins. 
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Supplemental Figure 5.1: 4C detects interactions of Rho within its TAD and local region of 
A compartment 
(a) Browser tracks display relevant epigenetic marks in the P14 WT retina and the raw 4C data 
from WT and Nrl-/- retina. (b) Raw and scored 4C data from WT and Nrl-/- retina with A/B 
compartment designation and Pearson Correlation matrix of cortex HiC.  
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Supplemental Figure 5.2: Morphometric analysis of PPR-/- and RER-/- retinas 
Measurement of thickness of indicated layers at P14 (a-c), P21 (d-f), and P200 (g-i) in WT, RER-
/-, PPR-/-, and PPR+/- retinas. (mean ± SEM, n ≥ 3; * p<0.05, ** p<0.01, *** p<0.001, **** 
p<0.0001; 2-Way Anova with Tukey’s Multiple Comparisons Test). 
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Supplemental Figure 5.3: BAC selection for FISH analysis 
Browser shots display relevant epigenetic data and raw and scored 4C data surrounding Rho (a) 
and regions 1-4 (b-e) selected for FISH experiments. Location of BAC is indicated by red / 
orange bar above gene track.  
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Supplemental Figure 5.4: Trans interacting regions show very strong enrichment for active 
epigenetic state 
(a) Heatmap displays relative enrichment of P14 retina ChromHMM state [Aldiri et al., 2017] in 
all of Chromosome 6 compared to Compartments A/B and cis and trans regions identified by 4C 
as interacting with Rho. (b-e) Bargraphs show quantification of the proportion of types of CRX 
sites (see Chapter 4 of this dissertation) covered by cis and trans interactions. Expected values 
represent permutation of the marks within that cis or trans genomic region (see Appendix 2 
Methods). (*** p<0.001, **** p<0.0001; Fisher’s Exact Test)  
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Supplemental Figure 5.5: A Compartment segments show differential effects upon loss of 
Rho activity 
(a) Browser track displaying the locations of the 11 linear segments of Chromosome 6 that are 
designated as A compartment DNA (blue vs yellow compartment track). (b) Plot displays the 
Fold Change (log2) between WT and PPR-/- retina of individual genes and the median of 4C+ 
genes (blue) and those not contacted (green) located within each of the segments. Each 4C+ set 
is also compared to the changes in expression of all Chromosome 6 genes. (black dots represent 
individual genes; blue, green and gray bars represent median; * p< 0.05, ** p<0.01; Wilcoxon 
Rank Sum Test)	  
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Chapter 6 
Conclusions and Future Directions 
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In this dissertation I have thoroughly investigated and demonstrated novel insights into 
the following: The disease inheritance and mechanism of a new model of CRX-associated 
disease (Chapter 2), the principles of gene mis-regulation across several classes of CRX-
associated retinal diseases (Chapter 3), the role of CRX in establishing the epigenome of a 
mature photoreceptor and its specific function at individual regulatory elements (Chapter 4), and 
the organization of the genome within the rod photoreceptor nucleus and the regulating 
principles of this structure (Chapter 5). 
6.1 A cohesive understanding of CRX related diseases 
In Chapters 2 and 3, I expanded our knowledge of the diversity of and shared mechanism 
between CRX disease models.[Ruzycki et al., 2017, 2015] Mutations to CRX result in a broad 
range of phenotypic severity in human patients, the diversity of which has been carefully 
modelled and characterized in several knock-in or naturally occurring mutant mice.[Roger et al., 
2014; Tran et al., 2014] By analyzing and comparing the transcriptomes of several Crx mutant 
mouse models, I determined that the severity of the phenotype directly corresponds with the 
effects on transcription of a core set of rod photoreceptor genes. The classification of the L253X 
mutant as a dominant Class III mutant shed new light on this phenotypic continuum, and further 
supports the understanding that very small changes to the transcriptome can have clinically 
relevant effects on photoreceptor development and maintenance. 
This research serves as the basis for several new lines of investigation. First, the 
classification of L253X as a Class III mutant expands our understanding of dominant CRX 
disease. Class III mutants are categorized by a premature termination codon that causes 
hyperstability of the mutant transcript. We discovered that the late L253X mutation does cause an 
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increase in transcript stability, but to a lesser degree than that observed in the more severe 
E168d2 model. The only difference between these mutant transcripts is the length of the apparent 
UTR, suggesting that distinct elements additively contribute to hyperstability. High throughput 
analysis of deletion libraries could uncover the mechanism of this hyperstability. Experiments 
testing the effects of variants of the Crx UTR on the stability of a transcript should elucidate the 
RNA encoded stabilizing elements or the structural form of the folded RNA structure that makes 
this RNA resistant to degradation.  
Second, this data suggests that even though patients may have very different mutations 
and phenotypes, a potential therapeutic ‘target’ or strategy can be similar for all CRX related 
disease. Gene therapy now offers a viable option to deliver a copy of normal CRX to mutant 
photoreceptors in vivo. Our findings demonstrate that very small perturbations to the target gene 
set can have dramatic effects on phenotype which suggests that even inefficient gene therapy 
treatments could benefit Class I and less dramatic Class III mutants like the L253X model. Future 
efforts to treat severe Class III mutations may require a combined augmentation based gene-
therapy with concurrent knockdown of the hyperstable mutant transcript. 
6.2 A comprehensive genomic map of CRX regulatory 
activity 
 Previous efforts to understand the in vivo molecular mechanism of CRX have focused 
primarily on the transcriptional changes in mutant animals. Studies have shown that genes that 
lose expression are strongly enriched for those that are near CRX bound regulatory elements. 
However, no study had asked the reciprocal question and discovered that there are actually more 
CRX bound regulatory elements near genes that show no expression changes. In Chapter 4, I 
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discovered that CRX binds within a variety of chromatin environments, and is only responsible 
for the activity of a small subset (~1/3) of these sites. These ‘CRX Dependent’ sites represent 
those that are near genes that lose expression in the Crx mutant retinas. By comparing these with 
the ‘CRX Independent’ sites that show no change in activity upon the loss of CRX, I discovered 
several key factors including developmental activation, conservation, and motif enrichment that 
distinguish a CRX Dependent vs Independent site.  
These findings influence how we understand the global role of a transcription factor (TF). 
In this case, we are studying CRX, but the fact that a TF does not necessarily have a functionally 
relevant role at every ChIP-seq defined binding site is important for the study of all TFs 
regardless of the cell type. The work presented here shows that, especially for developmentally 
important TFs, ATAC-seq is an important and useful tool to elucidate this functional role. 
ATAC-seq is relatively inexpensive, highly reproducible, and the data corresponded well with 
downstream read-outs of activation state such as histone ChIP-seq data. Future experiments 
should be designed to understand the effects of other retinal TF mutant models. In particular, a 
thorough combined analysis with data from Nrl-/-, Nr2e3rd7/rd7, among others would allow for a 
better understanding of the relationship between these key factors and could explain the shared 
or unique activity of each at the many co-bound regulatory sites. Experiments that profile at 
higher developmental resolution (daily from P3-P10) may determine a finer resolution to the 
temporal activation state of CRX Dependent vs Independent sites than that described in my 
work. This high-resolution approach may also be mandatory to understand the role of NRL as 
Nrl-/- results in a different transcriptional program to activate in the absence of this positive rod 
signals prior to P14. 
	200 
The TF network of the rod photoreceptor that includes CRX, NRL, and NR2E3 is largely 
based on developmental and cell fate decision analyses. The findings presented in Chapter 4 
show that CRX is required developmentally to activate certain sites, but raise the question 
whether CRX is also required to maintain that activity in the mature photoreceptor. By 
generating a conditional Crx allele and utilizing a tamoxifen responsive Cre line, future 
experiments could allow the rod to develop normally but deplete CRX only after epigenetic and 
functional maturity. A time course of ATAC-seq over the subsequent weeks would define the 
role of CRX in maintaining a mature epigenome. A similar experiment was performed testing the 
effect of adult loss of Nrl. Authors determined that while expression of many genes was lost, 
DNA methylation remained unchanged.[Montana et al., 2012] This result suggests that the 
epigenome was left unperturbed, perhaps due to the sustained expression of CRX. Our 
conditional deletion of Crx will test this question and determine whether NRL and/or NR2E3 can 
compensate and continue to promote gene expression alone upon loss of CRX.  
Finally, these data highlight a core set of CRX regulatory sites. We predict that the 
mutation of these sites would have unique consequences on rod photoreceptor development but 
largely spare other neuronal or unrelated tissues. We predict that this finding is directly relevant 
to the understanding of non-coding variants in human disease. As more families with retinal 
specific disorders undergo whole genome sequencing, we propose that these sites represent a list 
of high priority sites to analyze for variants, especially within the CRX homeodomain motif. 
Additional experiments could investigate this hypothesis by employing a CRISPR screening 
technique in mice. By constructing a dual guide RNA library to remove the regulatory elements, 
mass electroporation of this library into the retina of a Rho-GFP mouse would test for the 
functional relevance of each regulatory site in the development of a mature rod photoreceptor (as 
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marked by GFP expression). This experiment could further define the most relevant binding sites 
that globally affect photoreceptor development and maintenance. 
6.3 The rod photoreceptor as a model for genomic 
organization 
 Previous work in the retina had thoroughly described the unique inverted nuclear 
organization of the mouse rod photoreceptor nucleus.[Solovei et al., 2009, 2013] Meanwhile, 
studies have made tremendous strides in the past several years to understand the organization of 
DNA within the nucleus primarily using cell culture systems. In Chapter 5, I described ongoing 
work where I use the rod photoreceptor as a model to understand organizing principles of the 
genome in vivo. My data suggests a complex relationship between expressed genes and has 
uncovered basic principles governing the inclusion of genomic regions within a highly active 
sub-compartment of the nucleus. 
 This study suggests a number of future experiments to further understand genomic 
organization in the rod photoreceptor. First, although the analysis presented here suggested the 
relevance of HiC data from a related neuronal tissue (cortex), such a whole genome ‘all vs all’ 
approach comparing rods and cones (WT vs Nrl-/-) would be useful. This data could highlight 
key differences between the two cell types and display the general nature of compartmental 
organization upon inversion of the rod nucleus. Future experiments could attempt to ‘recover’ a 
conventional organization by expressing LBR or LMNA/C under a rod photoreceptor specific 
promoter. Full morphological and functional characterization would determine whether the 
inversion of the nucleus is required for proper gene expression, while molecular assessment by 
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4C, HiC or FISH would report any effects on TAD/Compartmental organization or 
establishment. 
Our 4C and FISH data suggested a strong association of Rho with other active regions of 
the chromosome that were lost when Rho was inactivated (in the PPR-/- retina). However, our 
data that assessed the relative position of Rho and other genes did not have the resolution to 
determine what interactions Rho gained. Future 4C or HiC experiments comparing PPR-/- and 
WT photoreceptors would first ensure that the rest of Chromosome 6 maintains the same 
conformation, and determine whether Rho has been relegated to the B compartment or just out of 
a highly active A sub-compartment. Our data only showed a strong correlation between 
chromatin state and association with Rho, but did not test any active mechanism for this 
organization. Previous efforts to perform dual IHC/FISH experiments failed in retinal tissue 
sections. However, new FISH variations have not yet been tested. These experiments could be 
useful to determine how close Rho is to the nuclear lamina, or its proximity to nuclear speckles 
or densities of other active chromatin associated proteins in WT vs PPR-/- cells. 
Our data suggested that, when Rho was inactivated, genes within close proximity showed 
excess transcriptional activation. This is evidence that local genes compete for transcriptional 
machinery. Rho is a relatively unique gene in that it is so highly expressed relative to all other 
transcripts in the cell. However, epigenetically it looks quite similar to other highly active 
chromatin regions (super enhancers in particular). Future experiments could test whether similar 
effects are observed when other highly expressed genes or ‘super enhancer’ regions are 
inactivated in rods or even in other cell types. 
 Finally, on a ‘local’ chromatin scale, this study has challenged the conventional 
understanding of Rho expression regulation and the function of upstream enhancers. We 
	203 
generated the RER-/- mutant mouse and discovered that the RER has very little if any 
contribution to bulk Rho expression. Gene expression was only assessed at P14, so additional 
experiments will be necessary to test whether the RER is necessary for proper expression earlier 
in development or in adult photoreceptors. Alternatively, the more distal CBR1 could be 
compensating for the loss of the RER. Ongoing experiments will test the combined and unique 
activities of the CRB1 and RER regulatory elements (see preliminary data in Appendix 1).  
6.4 Conclusions 
 The work presented in this dissertation has investigated the mechanisms that establish 
and the importance of the rod photoreceptor epigenome. My results have specific implications 
for the understanding of retinal development and disease pathogenesis as well as broadly 
applicable principles important for the understanding of gene regulation and genomic 
organization. In the retina, I have elucidated the role of the TF CRX, implicated in a number of 
severe blinding disorders. These experiments provide a better understanding of the disease 
mechanisms of distinct classes of CRX mutations and identify specific non-coding elements in 
the genome that are likely critical for proper CRX directed photoreceptor gene expression. More 
broadly, this work suggests that all TFs involved in cellular development likely have complex 
and diverse roles, and their binding at a particular site cannot be interpreted as important or 
indicative of activity. Finally, my work presented here regarding genomic organization offers 
further support that we cannot think of each gene as being controlled independently; expression 
is influenced by that of nearby genes, and this organization within the nucleus is highly regulated 
and likely a fundamental and important part of cellular development and homeostasis.  
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The role of the Rhodopsin enhancers 
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Early efforts to understand the very high rod photoreceptor specific expression of 
Rhodopsin focused on the discovery and classification of the promoter and nearby 
enhancers.[Chen & Zack, 1996; Corbo et al., 2010; Nie et al., 1996] These experiments 
discovered three highly conserved ~200bp elements termed the proximal promoter region (PPR), 
Rhodopsin enhancer region (RER; 2kb upstream of PPR), and the CRX bound region 1 (CBR1; 
4kb upstream of PPR). All elements drove strong retinal expression by plasmid reporter assays, 
and the PPR and RER showed similar specificity in transgenic animals.[Jimeno et al., 2006; Nie 
et al., 1996] All elements have since shown strong in vivo binding of both important transcription 
factors CRX and NRL (Figure A1.1).[Corbo et al., 2010; Hao et al., 2012] 
 In Chapter 5 of this dissertation, I presented an experiment where we used CRISPR-Cas9 
to create germline knockout mouse lines lacking either the PPR or the RER (PPR-/- and RER-/- 
respectively). We analyzed both the epigenome and transcriptome of these mice by ATAC-seq 
and ddPCR and were surprised to find that there was no detectable defect in the RER-/- retina. 
While PPR-/- mice displayed dramatic loss of Rho expression, thinning of the outer nuclear layer 
(ONL), and loss of local ATAC-seq signal at nearby regulatory elements, RER-/- mice showed 
no detectable differences from WT (Chapter 5: Figure 5.2 and Supplemental Figure 5.2). 
 We noticed that the PPR-/- retina still displayed strong ATAC-seq sensitivity at the 
CBR1, but this signal was largely lost at the RER (Figure A1.1). This data suggests that, at P14, 
the activity of the RER is dependent upon promoter activation, but the state of the CBR1 is 
independent. Interestingly, in the RER-/-, the CBR1 and PPR were both fully activated, 
(consistent with normal Rho expression) suggesting that the RER alone was not essential for the 
activation of the CBR1 or PPR. 
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Together, this data suggest that the CBR1 may compensate for the loss of the RER. To 
test this question, we again used CRISPR-Cas9 to generate two new mouse lines; the first lacks 
only the CBR1 (CBR1-/-) and the second lacks both the RER and the CBR1 (RER-/-;CBR1-/-) 
(Figure A1.1). 
Experiments are ongoing to determine the epigenomic consequences of the loss of the 
CBR1 alone or in conjunction with the RER. However, initial results do strongly support a role of 
the CBR1 in Rhodopsin gene expression regulation. To test Rhodopsin expression, I collected 
retinas at P14 from all mouse lines and performed ddPCR. Results show that the loss of the 
CBR1 alone leads to a ~40% reduction in Rho expression (Figure A1.2). Surprisingly the 
combined loss in the RER-/-;CBR1-/- retina showed no additional deficit in expression. 
In conclusion, these results suggest that the CBR1 is critical for proper Rho expression, 
but leave the role of the RER unanswered. Ongoing experiments will test the epigenomic 
landscape of CBR1-/- and RER-/-;CBR1-/- retinas at P14, and expression of Rhodopsin at earlier 
and later time points in development.  
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Figure A1.1: Epigenetic landscape of Rhodopsin 
Browser tracks display relevant epigenomic data showing temporal activation of PPR, RER, and 
CBR1 (by DNase1) and steady state mature profiles of other data. ATAC-seq tracks show 
changes in ATAC-seq sensitivity as a result of perturbations to Rho regulatory elements. Areas 
deleted in various lines are marked with red box. 
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Figure A1.2: Disruption of CBR1 affects Rho expression 
ddPCR analysis of Rho expression (Actb as control) in designated mouse lines at P14. All 
samples are littermate controls (n=3; mean + SEM; ; *** p<0.01, *** p<0.001;One-way 
ANOVA). 
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Chapter 2 Methods 
Nomenclature for the TVRM65 mutation 
There are several annotated transcripts for the murine Crx locus. The previously 
published amino acid change in the TVRM65 mouse was based on isoform 2 (NM001113330.1) 
that encodes a CRX protein with 323 amino acids.[Chau et al., 2000; Won et al., 2011] However, 
the major transcript in the retina is isoform 1 (NM_007770.4), which encodes a CRX protein 
homologous to human CRX, with 299 amino acids. Thus, here we refer to the TVRM65 mutation 
as p.L253X, based on isoform 1 numbering.   
Mice 
Crx-L253X (TVRM65) mice[Won et al., 2011] were obtained from Jackson Laboratory 
(Bar Harbor, ME, MGI ID: 4867395).  Mice were mated and maintained with C57BL/6J (JAX 
Stock number 000664), and confirmed free of rd1 and rd8 mutations by PCR genotyping. Crx 
null mice (Crx-/-) were provided by Dr. Constance Cepko, Harvard University (Boston, 
MA)[Furukawa et al., 1999] and back-crossed onto C57BL/6J for more than 10 generations.  All 
mice were housed in a barrier facility in the Division of Comparative Medicine of Washington 
University School of Medicine.  All procedures involving the use of mice were approved by 
Washington University’s Animal Care and Use Committee and followed ARVO guidelines for 
the Use of Animals in Ophthalmic and Vision Research. 
PCR Genotyping, RNA Purification and Reverse Transcription, and qRT-
PCR  
Genotyping, RNA purification and reverse transcription, and qRT-PCR were performed 
as previously described.[Tran et al., 2014a] Primer sets for genotyping and RT-PCR are listed in 
Supplemental Table 1.  For qRT-PCR, all primers were tested for proper amplification efficiency 
prior to use. Relative gene expression was normalized to the retinal constitutively expressed 
genes Ubb, Tuba1B, and Gapdh. Data for 3 biological replicates were then analyzed using the 
Delta Cq method in QBase software (Biogazelle, Ghent, Belgium).  The results are presented by 
the heatmap.2 function of the R gplots package (v3.0.1). 
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Droplet digital PCR (ddPCR) 
 Confirmatory genotyping and allelic expression data were generated using the droplet 
digital PCR system (BioRad, Hercules, CA).  A 20ul ddPCR reaction mixture containing 
custom-designed normal and mutant primer/probe sets (see Supplemental Table 2) was prepared 
according to manufacturer’s directions, droplets generated, and nano-reactions cycled on a 
C1000 Touch Thermal Cycler (BioRad). The average number of allelic transcripts per biological 
replicate (n=3) was then determined with the QX 200 Droplet Reader and QuantaSoft Analysis 
Pro (BioRad). 
Transient Transfection Luciferase Reporter Assays 
 HEK293T cells (ATCC CRL-11286) were cultured in Dulbecco’s Modified Eagle 
Medium with 10% fetal bovine serum and Penicillin/Streptomycin. Cells were transfected using 
conventional CaCl and Boric Acid Buffered Saline Method in 6-well plates as previously 
described.[Chen et al., 2002; Tran et al., 2014a]  Experimental plasmids and transfection 
amounts included BR130-luc [2 ug] (a Rho promoter-luciferase reporter)[Chen et al., 2002], 
pRL-CMV [1 ng] (transfection normalization control) and protein expression vectors PED-NRL 
[100 ng], pcDNA3.1-hCrx, Crx1-254, and Crx-E168d2. Cells were harvested 48 hours post 
transfection and assays performed using the Dual-Luciferase Reporter Assay System (Promega, 
Madison, WI).  
Electroretinogram (ERG) and Statistical Analyses 
 ERGs and statistical analyses were performed as previously described in [Tran et al., 
2014a].  Briefly, tests were performed on a UTAS-E3000 Visual Electrodiagnostic System 
running EM for Windows (LKC Technologies, Inc., Gaithersburg, MD) while mouse body 
temperature was maintained at 37±0.5°C with a heating pad controlled by a rectal temperature 
probe (FHC Inc., Bowdoin, ME). Pupils were dilated with 1.0% atropine sulfate (Bausch & 
Lomb, Tampa, FL) and dilation and corneal hydration maintained during testing by positioning 
the platinum wire loop recording electrodes in a mixture of atropine and 1.25% hydroxypropyl 
methylcellulose (GONAK; Akorn Inc., Buffalo Grove, IL).  Mice were tested without knowledge 
of genotype. Bilateral flash ERG responses were obtained; the set of recordings giving the higher 
amplitudes was correlated with genotype info for statistical analyses including two-way ANOVA 
and post-hoc multiple comparison tests were performed using Prism (GraphPad, La Jolla, CA).  
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Quantitative Western blot analysis  
Western Blots were performed as previously described.[Tran et al., 2014a] Experiments 
were performed using three biological replicates (15ug total protein extract from homogenates of 
two retinas). Membranes were probed with mouse monoclonal anti-CRX antibody M02 
(Abnova, 1:200) and anti-GAPDH antibody (Sigma G9545, 1:10,000), visualized with donkey 
anti-rabbit 680nm and donkey anti-mouse 800nm IRDyes (LI-COR, Lincoln, NE) (1:10,000), 
then imaged and quantified using the Odyssey Infrared Imager and ImageStudio 6 software (LI-
COR).  
Histology, Morphometry, Immunohistochemistry, and Statistical Analyses  
Histology, morphometry, immunohistochemistry and statistical analyses were performed 
as previously described.[Tran et al., 2014a] 4um sagittal sections of paraffin-embedded eyecups, 
cut through the optic nerve head, were either stained with hematoxylin and eosin (H&E) or 
prepared for immunofluorescence staining. Slides containing sections were incubated overnight 
with primary antibody at 4oC (1:400 anti-Rhodopsin monoclonal RetP1, Sigma), washed, and 
incubated with secondary antibody (1:500 Alexa 568-goat-anti-mouse, Invitrogen) for 2 hours at 
room temperature. Coverslips were mounted with Vectashield Hard Set mounting medium with 
DAPI (Vector Labs, Burlingame, CA). All imaging was performed using a Leica DM5500B 
microscope and Leica DFC365FX camera (Leica Microsystems, Buffalo Grove, IL). 
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Chapter 3 Methods 
Mice 
 Mice were housed in a barrier facility operated and maintained by the Division of 
Comparative Medicine of Washington University School of Medicine.  All mice used in this 
study were backcrossed to C57BL6/J mice obtained from Jackson Laboratories (Bar Harbor, ME, 
Stock number 000664) for at least 10 generations. Each line was genotyped for common rd1, 
rd8, and Rpe65 variants that affect retinal structure and function; all lines were negative for rd1 
and rd8 and contain the C57BL/6J RPE65450M isoform. The Crx mutant lines E168d2, 
E168d2neo and R90W and their genotyping procedures were published previously [Tran et al., 
2014b].  
All procedures involving mice were approved by the Animal Studies Committee of 
Washington University in St. Louis (IACUC 20120246, expiration date 01/18/2016). 
Experiments were carried out in strict accordance with recommendations in the Guide for the 
Care and Use of Laboratory Animals of the National Institutes of Health (Bethesda, MD), the 
Washington University Policy on the Use of Animals in Research; and the Guidelines for the 
Use of Animals in Visual Research of the Association for Research in Ophthalmology and 
Visual Science (http://www.arvo.org/animals/). 
 RNA collection & library preparation 
For each genotype and time point: three biological replicates were analyzed, and each 
replicate consists of four retinas from one male and one female mouse.  P21 WT samples 
represent a randomized sampling of WT littermates of Crx mutants.  Retinas were immediately 
processed for RNA using the PerfectPure RNA tissue kit (5 Prime).  The quantity and quality of 
the RNA was assayed using a Bioanalyzer (Agilent).  Samples with a minimum RIN score of 8.0 
were then selected for library construction. Library construction was performed by the Genome 
Technology Access Center (GTAC) (Washington University in St. Louis).  mRNA was isolated 
by poly-A selection using Oligo-dT beads (mRNA Direct Kit, Ambion).  mRNA was then 
fragmented by incubation at 94C for 2.5min in an alkaline buffer (40mM Tris Acetate pH 8.2, 
100mM Potassium Acetate, 30mM Magnesium Acetate) and reverse transcribed using Super 
Script III enzyme (Invitrogen) and random hexamers to yield double stranded cDNA.  The 
cDNA was blunt ended using Klenow DNA polymerase, followed by addition of an A base  and 
ligation of  Illumina sequencing adapters to the 3’ ends.  All enzymes including DNA 
polymerase, Klenow DNA polymerase, Klenow exo-, RnaseH, T4 DNA polymerase, and T4 
Polynucleotide Kinase were purchased from New England BioLabs (NEB). Ligated fragments 
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were amplified for 12 cycles using primers incorporating the unique index tags before sequenced 
on the Illumina Hi-Seq 2000 using single reads extending 42 bases. 
RNA sequencing data analysis 
 1x42bp reads were aligned to the mouse genome (version mm9) with the sequence 
aligner TopHat2 (Versison v2.0.5) using the following parameters: -a 5 -m 1 -i 10 -I 500000 -r 
100 –p 4 --microexon-search  –no-coverage-search -x 20 --segment-length 25.  Dependencies 
included Bowtie (v0.12.8) and Samtools (v0.1.18).  Bedgraph files were generated using 
BEDTools (v2.23.0) and visualized using IGV (Broad Institute).  The HTSeq package (Version 
0.6.1p1) was used to assign aligned reads to the gene annotation reference track (UCSC Genes 
Track, UCSC Table Browser, NCBI37/mm9, accessed July 16, 2014). This generated a raw read 
count per gene which was used in EdgeR [Nikolayeva & Robinson, 2014] for detecting 
differentially expressed genes. For each of the genotype comparisons, genes that did not pass the 
filter criteria of counts per million (CPM) ≥5 in all replicates of at least one comparison group 
were removed prior to the analysis. Filtered count data was normalized by the EdgeR default 
normalization method, TMM, and differential expression analysis for each of the comparison 
groups were performed by the exact test. P-values were subjected to Bonferroni and Hochberg 
multiple testing correction to include false discovery rate (FDR). Downstream analysis was 
performed using custom Perl and R scripts. Principal Component Analysis was performed using 
the princomp function in the stats R package (v3.1.1).  Gene expression heatmaps were 
generated using the heatmap.2 function of the gplots R package (Version 2.16.0).  As several 
heatmaps have included too many genes to properly label each row, we have included a 
supplemental file that lists the genes included in each heatmap in the order in which they were 
presented (Table S4). 
Raw RNA-seq data was also obtained from previously published work: Gene Expression 
Omnibus (GEO) accession: GSE52006 [Roger et al., 2014].  This data was aligned also using 
TopHat and analyzed as described above using HTSeq and EdgeR. 
Epigenetic data analysis 
 Data was obtained from GEO under accession numbers GSE20012 [Corbo et al., 2010], 
GSE38500 [Popova et al., 2012], and GSM1014198/GSM1014175/GSM1014188 [Vierstra et al., 
2014].  NRL ChIP seq [Hao et al., 2012] was downloaded from the NEI Data Share website, 
accessible through the following link (http://datashare.nei.nih.gov/dataShareMain.jsp).  Data 
were analyzed based on mouse reference genome (NCBI37/mm9) and UCSC known gene table.  
Heatmaps and line graphs depicting epigenetic data were generated using the UCSC defined TSS 
for each gene and the UNIX software package HOMER (Version 4.7) [Heinz et al., 2010].  
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Heatmaps were generated by importing the HOMER generated counts back into R, ordering by 
adult DNase1 level at the TSS, and visualized by the heatmap.2 function in the gplots R package.  
Gene Ontology Analysis 
Gene ontology analysis (GO Analysis) [Ashburner et al., 2000] was performed using the 
online g:Profiler tool [Reimand et al., 2011].  Terms were filtered to only include the best per 
parent term. 
Light damage (LD) and 13-cis-RA treatment   
For light damage (LD) analysis, mutant mice and littermate controls were dark adapted 
overnight.  Eyes were dilated with 1% Cyclogyl and 2.5% phenylephrine hydrochloride.  Mice 
were then placed in darkness for 30 min before LD.  LD was performed in a temperature 
controlled rat cage with the top removed and lined with reflective material to provide even 
illumination.  Exposure was performed using white fluorescent light and the intensity was 
measured using a lux meter.  Light intensity was 11-13.5 KLUX in all experiments.  Mice were 
placed into cages containing moistened food pellets, and each animal received damaging light for 
8 hrs.  Mouse pupils were re-dilated and the cage position was rotated every 2 hours.   
For 13-cis-RA treatments, 13-cis-retinoic acid (RA) (Isotretinoin, Accutane) (Sigma-
Aldrich, R3255) was reconstituted in DMSO to a concentration of 0.013 mg/µl.  40 mg/kg 13-
cis-RA or an equal volume of DMSO vehicle control was injected into the mouse's 
interperitoneal cavity 12 hrs before LD and mice were dark-adapted overnight.  Mice were re-
dosed with 40 mg/kg 13-cis-RA 30 min before LD.  
Following all LD experiments, mice were returned to a 12 hr light-dark cycle under 
normal ambient light conditions (~100 LUX) for 7 days.  After 7 days, retinal function was 
tested by electroretinography (ERG). The peak amplitude responses for rod-driven dark-adapted 
a-waves, rod ON bipolar cell-driven dark-adapted b-waves and cone bipolar cell-driven light-
adapted b-waves were measured for a series of increasing light intensities as described below.  
Mice were then sacrificed and eyes were collected for retinal histology assessment (see below).  
Images were taken in the central superior retina (~500 µm from the optic nerve (ON)), which is 
the area of the retina that is most strongly affected by LD [38].  
Histology, immunohistochemistry and microscopy 
Histology analyses of hemotoxylin and eosin-stained (H&E) paraffin-embedded retinal 
sections were performed as described previously [Tran et al., 2014b].  For ONL morphometry, 
20X composites of whole retinal sagittal sections stained with H&E were analyzed using ImageJ 
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software [Schneider et al., 2012].  The distance from the ON was determined by drawing a 
curved line along the outer limiting membrane.  The ONL thickness was measured at 100 µm, 
500 µm, 1000 µm, and 1500 µm from the ON and 200 µm from the peripheral edge on both the 
superior and inferior retina.  Results are presented by a ‘spider graph’.  The between-group 
differences in ONL thickness were determined by testing overall genotype*distance interactions 
(p<0.05, n≥3) of each treatment.  Statistical comparison of data at each distance was performed 
using two-way ANOVA for repeated measurement data, followed by a post-hoc test to adjust p-
value for multiple comparisons between each genotype and the WT control group SAS 9.3 (SAS 
Institutes, Cary, NC).  
Fluorescence immunohistochemistry was performed on frozen retinal sections. Eyes were 
enucleated and fixed for 30 minutes in 4% paraformaldehyde (PFA) on ice.  Eyes were washed 
in PBS and left overnight in 30% sucrose in PBS at 4 °C.  50% volume of OCT was added and 
rocked at room temperature for 1 hr.  Eyes were then transferred to 100% OCT for 1 hr before 
frozen in OCT on dry ice.  Blocks were cut onto polylysine (Thermo Scientific) slides and stored 
at -80 °C.  For staining, slides were removed and allowed to dry for 30 min before 10 min 4% 
PFA fixation.  Slides were washed (2 x 5 min) with PBS and blocked at room temperature with 
5% nonfat dry milk/2% bovine serum albumin (BSA)/10% normal goat serum (NGS) for 2 hrs.  
Slides were washed (3 x 5 min) with PBS before overnight incubation with primary antibody at 4 
°C.  Antibodies were diluted as below in PBS with 1% BSA and 0.5% Triton X-100.  Slides 
were washed (3 x 5 min) in PBS. Secondary antibodies (and PNA antibody) were diluted in the 
same buffer as primaries, applied to the slides, and incubated for 1 hr at RT, and washed again (3 
x 5 min) with PBS before the application of coverslip. 
Primary antibodies and dilutions used are as follows: rabbit anti-RXRγ (1:500, Santa 
Cruz Biotechnology, sc-555), rabbit anti-CNGB3 (1:500, from Xi-Qin Ding, University of 
Oklahoma), peanut agglutinin (PNA) conjugated to Rhodamine (1:500, Vector Labs).  Secondary 
antibodies (1:400): goat anti-rabbit or mouse IgG antibodies coupled to Alexa Fluor A488 and 
Rhodamine 568 (Invitrogen). All slides were counterstained with hard-set mounting medium 
with DAPI (Vectashield). 
Brightfield and fluorescent imaging was performed using either an Olympus BX51 
microscope and Spot RT3 Cooled Color Digital camera (Diagnostic instruments Inc.) or a Leica 
DM5500B microscope and Leica DFC365FX camera (Leica Microsystems, Buffalo Grove, IL) 
Electroretinography (ERG)  
Mice were dark-adapted overnight and anesthetized with intraperitoneal injection of a 
mixture of ketamine (80 mg/kg) and xylazine (15 mg/kg). Pupils were dilated with 1% atropine 
sulfate. A passive-heating pad maintained animal’s body temperature at 37 oC. Scotopic ERG 
responses were measured from both eyes using corneal platinum-ring electrodes held in place by 
a drop of Gonak solution. Full-field ERGs were recorded with the UTAS-E 3000 system (LKC 
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Technologies, Inc.), using Ganzfeld-derived test stimuli of calibrated white light intensity. The 
amplitude of ERG a-wave was determined from the baseline to the primary negative peak of the 
photoresponse. The amplitude of ERG b-wave was measured from the a-wave peak to the 
maximum of the secondary positive peak. Photopic ERG recordings were performed under room 
illumination (~ 25 cd·s m-2) after 5–10 min of light adaptation. 
The rate of rod dark adaptation was determined from the recovery of maximal ERG a-
wave amplitude after 30-second exposure to light bleaching of > 90% of rhodopsin (delivered by 
520 nm LEDs focused at the surface of mouse eye cornea and producing ~ 2.5 x 108 photons µm-
2s-1), using test flashes of ~ 470 cd·s m-2 at indicated times after the bleach. In these experiments, 
mice were re-anesthetized subcutaneously every 30–40 min with a smaller dose of ketamine 
(~50% of the initial dose). In addition, at the same times a drop of 1% atropine sulfate was added 
to the eye surface to keep pupils dilated, and a 1:1 mixture of PBS and Gonak solutions was 
applied to the eyes to protect them from drying and maintain electrode contacts during extended 
recording sessions. 
qRT-PCR  
RNA used for assays included RNA used for Illumina RNAseq library preparation and 
additional biological replicates.  For each genotype, n≥3 biological replicates, each replicate 
consisting of four retinas from one male and one female mouse, were collected. RNA isolation, 
cDNA preparation, and qRT-PCR reactions were performed as previously described [21].  
Briefly, retina tissue was immediately processed for RNA using the PerfectPure RNA tissue kit 
(5 Prime) and quantified.  cDNA was synthesized from 1 µg of RNA using the Transcriptor First 
Strand cDNA Synthesis kit (Roche Applied Science). A 10 µl QRT-PCR reaction mixture 
containing 1× EvaGreen with Low Rox reaction mix (BioRad), 1 µM primer mix, and diluted 
cDNA was prepared and run on a BioRad CFX thermocycler in triplicate. Data was analyzed 
using QBase software (Biogazelle).  Relative gene expression was normalized 
to Ubb and Tuba1b and fold-change from WT was determined.  Kruskal-Wallis and Dunn's 
Multiple Comparison tests were used to determine significant fold change differences from WT 
(P<0.05).  Primer sets were designed using MacVector software and synthesized by IDT DNA 
technologies (Table S5).  
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Chapter 4 Methods 
ATAC-seq library prep and sequencing 
ATAC-seq was performed as published in Buenrostro, et al.[Buenrostro et al., 2015] 
Briefly, retinas were dissected from P14 WT and Crx-/- mice and washed in PBS. Tissue was 
dissociated at 37C using 2% Collagenase in TESCA buffer for 13 min, and the reaction stopped 
by the addition of 2X volume of DMEM + 10% FBS. DNase1 (0.5 Units) was added for the final 
3 minutes to minimize clumping of cells. Cells were counted with hemocytometer, and 50,000 
re-suspended in TD buffer for a 1 hour incubation with TDE1 at 37C. Remaining library prep 
was performed as published. Libraries were pooled and sequenced using the Illumina 2500. 
Chromatin Immunoprecipitation 
Chromatin immunoprecipitation (ChIP) assay was performed as previously 
described.[Tran et al., 2014b] In summary, 6 pooled P14 C57BL/6J Wild type, or Crx-/- mouse 
retinas per sample were dissected and chromatin was cross-linked with 1% formaldehyde in PBS 
for 10 minute at room temperature. Crosslinked cells were lysed and fragmented by sonication. 
Chromatin fragments were immunoprecipitated with the Histone H3 (acetyl K27 - ab4729) 
(Abcam, Cambridge, UK) and trimethyl-Histone H3 (Lys4) (Millipore, 07-473) antibodies, or 
normal rabbit / mouse IgG (Santa Cruz Biotechnology, Dallas, TX) bound to Protein A beads 
(Millipore, 16-125), or A/G beads (Santa Cruz Biotechnology). After extensive washing, the 
immunoprecipitated chromatin was eluted, heated to 67°C to reverse the cross-links, and the 
DNA purified by ethanol precipitation. Libraries were prepared using the DNA SMART ChIP-
Seq Kit (Clonetech, Mountain View, CA). 10ng of ChIP DNA was used as input for each 
sample. 
Mapping of ATAC-seq and ChIP-seq data 
Libraries were de-multiplexed according to barcodes inserted in the P7 adaptor, and 
mapped to mm9 using Novoalign (V3.04.06). Alignments were cleaned using Samtools (V1.3.1); 
duplicate and reads mapping to mitochondrial genome were removed. All other processing for 
visualization in IGV was performed using samtools and bedtools (V2.24.0). For visualization, 
bedtools slop function was used to extend reads 300 bp. 
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Peak Calling and Genotype Comparison 
Peak calling was performed using MACS2 (V2.1.0.20140616). Peak calling was 
performed on replicate samples independently. Only peaks that replicated in both samples were 
kept, by comparing peak files using the bedtools intersect function. Intersecting peaks were 
merged using bedtools merge function. Peaks were analyzed for number of reads within each 
library using bedtools coverage, and statistical comparison for ATAC-seq data was performed 
using EdgeR (V3.18.1). Histone read count for FC analysis was computed by normalizing all 
libraries to RPM before subtraction of read count of appropriate input sample within same 
region.. 
Detection of overlapping ChIP, ATAC, and ChromHMM location 
All co-localization detection of genome-wide datasets was performed using the bedtools 
intersect function. ChromHMM bed files were graciously provided by Dr. Issam Aldiri, St. 
Jude’s Children’s Research Hospital. 
Read coverage epigenetic analysis 
Heatmaps and line graphs depicting epigenetic data were generated using the UNIX 
software package HOMER (V4.7).[Heinz et al., 2010] Heatmaps were generated by importing 
the HOMER generated counts back into R, and visualized by the heatmap.2 function in the 
gplots (V3.0.1) R package.  
Motif calling 
Known motif analysis was performed using Transcription Factor Affinity Prediction 
(TRAP) web Tools.[Manke et al., 2008] Analysis was performed on Jaspar vertebrate matrix file, 
with mouse promoter background model, and multiple test correction was Benjamini-Hochberg. 
Heatmap visualizes the –log(10) converted corrected p-value of each TF motif. De novo motif 
analysis was performed using the HOMER findmotifsgenome tool  (V4.7).  
BEEML calculation of affinity 
Analyses were performed as in White et al (2016).[White et al., 2016] Custom scripts to 
calculate TF occupancy were graciously provided by authors. 
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Nucleotide density and motif density 
All analyses were centered on the CRX ChIP peak and utilized the HOMER 
annotatepeaks function. Matrix outputs from de novo motif analysis were tested for motif density 
using the HOMER annotatepeaks function in 20bp windows. 
Gene Ontology (GO) analysis 
Gene Ontology (GO) analyses were performed using the GREAT tool (Ver 3.0).[McLean 
et al., 2010] Peak files used were centered on the CRX binding site, and associations were with 
the settings ‘single nearest gene- no limit on distance.’ These same associations were used as the 
basis of regulatory site- gene determination for RNA-seq comparisons. 
RNA-seq 
RNA-seq data was obtained from GSE52006. Data was analyzed as described previously 
in [Ruzycki et al., 2015]. Briefly, 1x42bp reads were aligned to the mouse genome (version 
mm9) with the sequence aligner TopHat2 (Versison v2.0.5) using the following parameters: -a 5 
-m 1 -i 10 -I 500000 -r 100 –p 4 --microexon-search  –no-coverage-search -x 20 --segment-
length 25.  Dependencies included Bowtie (v0.12.8) and Samtools (v0.1.18).  Bedgraph files 
were generated using BEDTools (v2.23.0) and visualized using IGV (Broad Institute).  The 
HTSeq package (Version 0.6.1p1) was used to assign aligned reads to the gene annotation 
reference track (UCSC Genes Track, UCSC Table Browser, NCBI37/mm9, accessed July 16, 
2014). This generated a raw read count per gene which was used in EdgeR [Nikolayeva & 
Robinson, 2014] for detecting differentially expressed genes. For each of the genotype 
comparisons, genes that did not pass the filter criteria of counts per million (CPM) ≥5 in all 
replicates of at least one comparison group were removed prior to the analysis. Filtered count 
data was normalized by the EdgeR default normalization method, TMM, and differential 
expression analysis for each of the comparison groups were performed by the exact test. P-values 
were subjected to Bonferroni and Hochberg multiple testing correction to include false discovery 
rate (FDR). Downstream analysis was performed using custom Perl and R scripts. 
External Datasets 
Other data used in this study were retrieved from the following accession locations on NCBI: 
CRX ChIP-seq: GSE20012 
CTCF ChIP-seq: GSE87064 
DNase1: Retina P1 GSM1014188, Retina P7 GSM1014198, Retina 8wk GSM1014175; 
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Liver GSM1014195, Brain GSM1014151 
RNA-seq: GSE52006 
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Chapter 5 Methods 
4C Cell Collection 
P14 retinas were dissected and dissociated at 37C using 2% Collagenase (Sigma Aldrich, 
St. Louis, MO) in TESCA buffer (50mM TES ph7.4, 0.36mM CaCl2) for 15 minutes. DNase1 
(0.5 U) was added for an additional 3 minutes to avoid clumping of cells. Reaction was stopped 
by addition of 2X volume 37C DMEM+10% FBS and incubation for 5min at RT. Cells were 
strained through a 40um filter, before fixation in 2% Formaldehyde at room temperature (RT) for 
10 minutes. Reaction was stopped by addition of cold glycine to a final concentration of 0.125M 
on ice. Cells were pelleted, re-suspended in PBS+1%FBS+1%EDTA, and counted using a 
hemocytometer. Aliquots of cells were pelleted and stored at -80C. 
4C Template Preparation 
4C libraries were prepped essentially as described in [van de Werken et al., 2012]. 10^7 
cells were thawed and resuspended in 500ul Cutsmart buffer (NEB, Ipswitch, MA). Cells were 
permeabilized using SDS and Triton-X100 before addition of 400U NcoI-HF restriction enzyme 
(NEB). Digestion was left overnight at 37C. After cutting efficiency was established, DNA was 
ligated with 100U T4 DNA Ligase (NEB) for 1 hour at 37C. After ligation, cells were de-
crosslinked using Proteinase K (Qiagen, Hilden, Germany) and heated to 65C overnight. DNA 
was recovered by phenol-chloroform extraction. The DNA was again digested by addition of 
100U MspI (NEB) overnight at 37C. Reaction was cleaned by phenol-chloform precipitation, 
and again ligated with 100U T4 DNA Ligase (NEB) overnight at 16C. DNA was retrieved by 
ethanol precipitation and cleaned using Qiaquick PCR purification columns (Qiagen). 
4C Inverse PCR 
4C Inverse PCR was performed essentially as described in [van de Werken et al., 2012] 
with slight modifications. To increase the specificity of the inverse PCR, a nested approach was 
employed. Initial PCR was performed with the following primers: [F- 
GCATCACAACCTGTCCCTGC, R- GTTCCCAAACAAGACACCTGC]. 200ng 4C template 
was amplified using using Klentaq enzyme (DNA Polymerase Technology, St. Louis, MO) for 
25 cycles divided over 8x50ul reactions. The products were cleaned using PCR purification 
columns (Qiagen). Second PCR to add Illumina tails was performed using the following primers:  
   F-AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCTAGTGCAATCGAGGCTCCATG,  
   R- CAAGCAGAAGACGGCATACGAGATGCTAAGCAAACATCTAGGAATCCCG  
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Elution from first PCR were again split into 8x50ul reactions and amplified using using Klentaq 
enzyme (DNA Polymerase Technology) for 10 cycles. Products were cleaned using PCR 
purification columns (Qiagen). Finally, libraries were size-selected by gel electrophoresis (200-
1600bp) and cleaned using the QiaexII Gel Extraction Kit (Qiagen). Libraries were pooled and 
sequenced (1X50bp) by the Genome Technology Access Center (GTAC) at Washington 
University, St. Louis using the Illumina HiSeq 2000 (Illumina, San Diego, CA).  
4C data analysis 
Reads were demultiplexed and mapped to the mouse genome (mm9) using bowtie 
(V1.1.1) with options (-S -v 2 -y -k 1 -m 1 -p 3 –trim5 [length of inver PCR primer sequence]). 
Resultant bam files were converted to bed format by Samtools (V1.3.1) and processed to count 
reads per known NcoI fragment using custom perl scripts. Raw data was then visualized using 
the IGV Browser [Robinson et al., 2011]. Scoring of distant interactions was performed using 
custom perl scripts. Current scoring methods focused on either binary or quantitative methods of 
analyzing 4C data. We chose to integrate these two methods together as follows: A running 
window test/background approach was employed to score the enrichment of our designated score 
within the test window compared to the much larger background area. All data presented in this 
Chapter used a 50/500 analysis of restriction enzyme fragments. This represents an enrichment 
area of approximately 100kb/1Mb and was determined empirically. We tested a range of 
windows and all highlighted similar areas of interaction. Smaller windows displayed more noise, 
and thus for this analysis we focused on a wider window. 
Score= 1/(standard deviation(read coverage of contained fragments)/(total reads 
within window/number of fragments tested)) * (# positive fragments) 
For each window, the score of the test window was divided by that of the background. All scores 
for the chromosome were shuffled 10K times to determine FDR 0.01 threshold. 
HiC data usage/programs 
HiC data was visualized (observed and observed pearson) using Juicebox [Durand et al., 
2016] with data generated by Dixon et al[Dixon et al., 2012]. Compartment analysis was 
performed as described previously [Dixon et al., 2015]. Briefly, observed/expected matrix at 
1Mb resolution for Chromosome 6 was retrieved from Juicebox. Data was processed in R 
(V3.4.1), where Pearson Correlation matrix and principal component analyses were performed 
using the ‘cov’ and ‘eigen’ functions. 
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ATAC-seq library prep and sequencing 
ATAC-seq was performed as published in Buenrostro, et al.[Buenrostro et al., 2015] 
Briefly, retinas were dissected from P14 WT and Crx-/- mice and washed in PBS. Tissue was 
dissociated at 37C using 2% Collagenase in TESCA buffer for 13 min, and the reaction stopped 
by the addition of 2X volume of DMEM + 10% FBS. DNase1 (0.5 Units) was added for the final 
3 minutes to minimize clumping of cells. Cells were counted with hemocytometer, and 50,000 
re-suspended in TD buffer for a 1 hour incubation with TDE1 at 37C. Remaining library prep 
was performed as published. Libraries were pooled and sequenced using the Illumina 2500. 
RNAseq library prep mapping and genotype comparison 
Retinas were dissected from P14 mice and immediately frozen on dry ice. Samples were 
stored at -80C. When all samples had been collected, retinas from 2 mice (1M, 1F) were pooled 
and RNA was collected using the 5Prime PerfectPure RNA Tissue Kit (Fisher Scientific). 
Libraries were prepared, sequenced and data analyzed as described in Chapter 3 Methods. All 
data represent comparisons between 3 WT and 4 PPR-/- biological replicate samples.  
4C Interaction enrichment and RNA analyses 
All overlap of 4C data with previously published datasets were performed using bedtools 
(V2.24.0) intersect function. Expected values were computed by merging adjacent 4C positive 
regions, and permuting these either over the whole chromosome, within only their same 
compartment, or only within the cis/trans areas of the A compartment using the bedtools shuffle 
function. RNAseq analysis was performed by determining the TSS of each gene, which was used 
to overlap with 4C positive and AB compartment regions using bedtools intersect. 
External datasets used in these experiments include the following 
- CRX ChIP-seq: GSE20012 
- CTCF ChIP-seq: GSE87064 
- ChromHMM classifications generated in [Aldiri et al., 2017]; bed files generously 
provided by the authors 
- DNase1Retina 8wk: GSM1014175; 
- WT P14 H3K27Ac and H3K4me3 ChIP-seq were generated and discussed within 
Chapter 4 of this dissertation 
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Droplet digital PCR (ddPCR) 
 Gene expression analysis was performed using the digital PCR system (BioRad, 
Hercules, CA).  A 20ul ddPCR reaction mixture with ddPCR Supermix for Probes (no dUTP; 
(BioRad) containing Rho and Actb probe sets (Mm01184405_m1 and Mm02619580_g1 
respectively; Thermo Fisher Scientific, Waltham, MA) was prepared according to 
manufacturer’s directions, droplets generated, and nano-reactions cycled on a C1000 Touch 
Thermal Cycler (BioRad). The average number of allelic transcripts per biological replicate 
(n=3) was then determined with the QX 200 Droplet Reader and QuantaSoft Analysis Pro 
(BioRad). 
FISH Probe Generation 
BAC cultures were obtained from the CHORI BACPAC repository (Oakland, CA). 
Clones used are listed below. E. coli were grown under normal conditions and BAC DNA 
harvested using the Nucleobond Xtra BAC Purification Kit (Machery-Nagel, Duren, Germany). 
5ug of BAC DNA was used for probe generation using the Nick Translation Kit with either 
Digoxigenin-11-dUTP or Biotin-16-dUTP (Roche, Basel, Switzerland). Probe was cleaned using 
PCR purification columns (Qiaquick, Qiagen, Hilden, Germany) and resuspended in 100ul EB 
and frozen. 
Rho  RP24-288F10 
mir182  RP24-314K9 / RP23-385J22 
Ptms  RP24-330J12 
Pde6h  RP23-79O6 
Trcb  RP23-421M9 
FISH Tissue Preparation and in situ hybridization 
Retinas were dissected into 4% PFA and fixed overnight at 4C. Tissue was washed in 
PBS and dehydrated using a sucrose (in PBS) gradient at 4C as follows: 10% 1hr, 20% 1hr, 30% 
overnight. An equal volume OCT (Tissue-Tek, optimum cutting temperature formulation; 
Sakura, Netherlands) was added and incubated at 4C for 8 hours before tissue was transferred to 
100% OCT for overnight incubation at 4C. Tissue was frozen with dry ice in OCT and stored at -
80C for later use. Tissue sections (20um) were cut by cryostat and stored on slides also at -80C. 
Slides were removed from -80C and dried on a hot plate (37C) for 1 hour. OCT was 
removed by 5min incubation with PBS, and tissue was briefly fixed to the slide to avoid release 
(5min 4% PFA), before slides were once again washed with PBS (5min). Slides were 
equilibrated in 10mM Sodium Citrate (pH 6) for 5 minutes before transferred into the same 
buffer at 95C and incubated for 5min. The coplin jar was removed from the double boiler and 
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allowed to cool at room temperature for 1 hour. Slides were transferred to 2XSSC (5min) and 
equilibrated in 2XSSC+50% Formamide (Millipore-Sigma, St. Louis, MO) for 5min. Slides were 
incubated on hot plate with 2XSSC+50% formamide for 3 minutes before being submersed into 
ice cold (-20C) 70% EtOH for 2 min. Slides were then further dehydrated in 90% EtOH (2min) 
and 100% EtOH (5min) before being allowed to dry at room temperature for 15min. Probe 
mixture for each slide was prepared as follows: 2ul DIG labelled probe, 2ul Biotin labelled 
probe, 2ul salmon sperm DNA (Invitrogen, Carlsbad, CA), 11ul formamide, and 6.6ul 3.3X 
FISH buffer (6.6XSSC, 33% Dextran Sulfate (Fisher Scientific, Hampton, NH)). This mixture 
was pre-incubate for 30min at 37C. Hydrophobic barriers were drawn on slides, allowed to dry, 
and slides were pre-warmed on 37C hotplate. Probe was on a coverslip to the tissue, and 
coverslip was affixed to the slide with rubber cement to prevent dessication. Slides were 
incubated at 37C in humidified chamber for 72 hours. Slides were removed from incubator, 
rubber cement removed and washed in 2XSSC at 37C for 5 min. Slides were transferred to 60C 
Wash 1 (0.4XSSC, 0.3% NP40) for 5 minutes, followed by room temperature Wash 2 (2XSSC, 
0.1% NP40) for 5 minutes. Slides were again washed in 2XSSC for 5 min at room temperature 
before application of Rhodamine labelled anti-Digoxigenin (Roche) and Alexa Fluor 488 
conjugated Streptavidin (Life Technologies, Carlsbad, CA) in blocking buffer (2XSSC, 0.2% 
Tween20, 1% BSA) and incubated at 37C for 1hr. Slides were washed 3x10min in wash buffer 
(4XSSC, 0.2% Tween20), followed by 2x5min in 2XSSC. Coverslips were applied using 
Vectashield hard-mount media with DAPI (Vector Labs, Burlingame, CA). 
FISH imaging and analysis 
Slides were imaged at 100X magnification on a Leica DM5500B microscope with Leica 
DFC365FX camera (Leica Microsystems, Buffalo Grove, IL) with at least 40 optical sections (z-
step 0.194um). Stacks of images were first processed using the Leica software deconvolution 
algorithm before export. 21 sections from the center of the stack were imported to the ImageJ 
image analysis program (all analysis was performed using Fiji [Schindelin et al., 2012]). Images 
were converted to a stack and a large region of interest was cropped that included only the outer 
nuclear layer (mainly rod photoreceptors). Channels were split, and filtered using the Mean 3D 
and 3D Fast Filters (TopHat) functions of ImageJ. Positive probe locations and centers of mass 
were then determined in red and green channels using the 3D Objects Counter. Center of mass 
information was saved in text files, and custom perl scripts were used to determine and report 
distance between nearest independent pairs of probes in 3-dimensional space. 
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Table A2.1: Number of FISH experiments completed for each probe set 
 
 
 
 
 
  
		 WT	 RER-/-	 PPR-/-	 Crx-/-	 Nrl-/-	
Rho	-	mir182	 4	 3	 6	 3	 3	
Rho	-	Tcrb	 1	 1	 1	 1	 1	
Rho	-	Ptms	 4	 4	 4	 4	 4	
Rho	-	Pde6h	 3	 2	 3	 3	 2	
mir182	-	Ptms	 2	 2	 2	 2	 2	
Tcrb	-	Ptms	 1	 1	 1	 1	 1	
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